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// ( 
The universe is infinite in all directions. not only above us in the large but also 
below us in the small. If we start from our human scale of existence and explore the 
content of the universe further and further, we will finally arrive. both in the large 
and in the small, at misty distances where first our senses and then even our concepts 
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Abstract 
Expression in Xenopus oocytes revealed differential modes of regulation of the 
constitutive trans~activation domains present in the thyroid hormone receptor (TR) 
and its oncogenic homolog v-ErbA. The nuclear environment of oocytes induced a 
constitutive trans~activation function in TR, but not v~ErbA, at hormone-inducible 
thyroid hormone response elements (TREs), which was further enhanced by thyroid 
hormone at a subset of TREs. In contrast, DNA~protein interactions at a response 
element which is induced by unliganded TR in mammalian cells mediated 
constitutive trans~activation by both TR and v-ErbA. These findings indicate that the 
responses of the ligand-independent trons-activation domains of TR and v-ErbA to 
cell~specific and TRE-mediated induction are not equivalent. Pre~injection of nuclear 
protein extract from anterior pituitary cells converted v-ErbA into a strong 
constitutive activator at a response element from the rat growth hormone gene. Thus, 
the dominant negative phenotype of v-ErbA can be abolished by direct or indirect 
interactions with tissue-specific proteins. 
The growth-promoting properties of the v-erbA oncogene have so far exclusively 
been linked to dominant repression of the anti-mitogenic roles of TR and retinoic 
acid receptor. Ultrastructural analysis revealed that, when expressed in Xenopus 
oocytes, v-ErbA induced early to intermediate meiotic changes occurring prior to 
chromosome condensation. The effects of v-ErbA on cell cycle reentry in oocytes 
were not mimicked by a dominant negative mutant of TR, suggesting that v-ErbA did 
not initiate meiosis by antagonizing endogenous TR. v-ErbA-induced meiosis 
occurred independently of the cAMPIMPF signal pathway, but required mRNA 
synthesis and translation. These findings suggest that v-ErbA mediated the release 
from G2 arrest by activating expression of a cell cycle inducer(s). 
I. 
Introduction 
1. General Introduction 
(1) Cancer as a disease of cellular signalling nehfJorks 
The question of what causes cancer is central to biology, since malignancy 
represents disturbances in two fundamental processes of higher organisms. These 
two characteristics are, firstly, the ability to proliferate or make identical copies of 
individual cells and, secondly, the ability to differentiate, which allows cells with a 
shared genetic make-up to perform fUnctions which are extremely varied and 
. complex. Cancer can be viewed as a disease of the signalling networks through 
which growth factors and other mitogenic stimuli cause cells to proliferate and 
differentiate. Defects leading to abnormal regulation of any of the network 
components, encoded by proto-oncogenes and tumour suppressor genes, may result in 
uncontrolled cell growth and neoplasia (Weinberg, 1989a). 
An oncogene is a dominantly acting gene of cellular or viral origin that can induce 
one or more features of neoplastic transformation when introduced into cells, either 
alone or in combination with another gene. Normal cellular genes that can be 
converted to active .oncogenes by mutation are called proto-oncogenes. Activated 
A bbreviations used in this chapter: AEV, avian erythroblastosis virus; AP-l, 
activator protein-I; DR4, direct repeat of TRE half sites separated by 4 nucleotides; 
MAPK, mitogen-activated protein kinase; NlPF, maturation-promoting factor; RAR, 
retinoic acid receptor; T3, 3,5,3'-L-triiodothyronine, thyroid hormone; TR, thyroid 
hormone receptor; TRE, thyroid hormone response element. 
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proto-oncogenes are thought to provide continuous proliferation signals that enhance 
cell growth. For example, the oncogenic protein tyrosine kinase of Rous sarcoma 
virus, pp60v-src, transforms cells through unregulated phosphorylation of cellular 
proteins (reviewed in Hunter, 1989); while the oncogenic activity of p21 nu proteins, 
carried by murine sarcoma viruses, correlates with abnormal signal transduction by 
these proteins, resulting from a reduction in their GTPase activity (reviewed in 
McCormick, 1989). Another class of oncogenes encodes factors involved in gene 
transcription, such as the v-jun and v-fos products of two murine retroviruses, whose 
cellular homologs make up the AP-l transcription complex. In infected mice, v-Jun 
and v-Fos induce sarcomas by acting as continuously active transcription factors 
(reviewed in Eisenman, 1989; Hunter, 1989). 
Tumour suppressor genes, on the other hand, are recessive genes that may counter 
the effects of oncogenes by either suppressing proliferation or inducing 
differentiation. For example, retinoblastoma, a cancer of embryonal retina cells, 
arises through the loss of both functional RB-l alleles (Cavenee et al., 1983; 
Knudson, 1971); and Wilms' tumour, a cancer of embryonal kidney stem cells, is 
associated with the inactivation of both copies of the WTl tumour suppressor gene 
(Call et aI., 1990; Gessler et al., 1990; reviewed in Feinberg, 1994). Tumour 
suppressor genes can contribute to neoplastic transformation when they become 
inactivated by dominant negative mutations, leading to the expression of abnormal 
proteins that inhibit the functions of their normal counterparts. 
In this present study, novel modes of action of the v-erbA oncogene and of its 
cellular progenitor, the thyroid hormone receptor (TR), were characterized. v-erbA, 
carried by the avian erythroblastosis virus (AEV), constitutes a prototypic example of 
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a dominant negative oncogene, derived from a tumour suppressor gene. v-ErbA 
antagonizes the action of its cellular counterpart, c-erbA a, the chicken TRa (Damm 
et al., 1989; Sap et al., 1989; Weinberger et al., 1986). TRa, a hormone-regulated 
transcription factor involved in the control of diverse cellular processes, has been 
classified as a tumour suppressor, because it helps regulate the differentiation of 
haematopoietic progenitor cells (Disela et al., 1991; Fuerstenberg et al., 1992; 
Gandrillon et al., 1994; Rascle et al., 1994; Schroeder et al., 1990, 1992a, 1992b; 
Zenke et al., 1988; 1990; reviewed in Damm, 1993). Thyroid hormone (3,5,3'-L-
triiodothyronine; T3), being a relatively small, lipophilic molecule, diffuses into cells 
through the plasma membrane and binds to TRs in the nucleus (reviewed in Brent et 
al., 1991; Glass and Rosenfeld, 1991). Thus, by linking the extracellular hormonal 
signal directly to transcriptional processes, TR acts as an abbreviated signal 
transduction pathway. 
(2) Retroviral oncoge1U!s llI'e essential tools for contemporary oncogene reselll'Clt 
The RNA tumour viruses, now known as retroviruses, were among the first 
recognized oncogenic agents of any kind. Viruses of this type, for example the Rous 
sarcoma virus, were first identified as leukemogenic and sarcomagenic agents in 
chickens 84 years ago (Rous, 1911). In 1935, Rothe-Meyer and Engelbreth-Holme 
reported the identification of another infectious agent capable of inducing 
erythroleukemia in birds (reviewed in Privalsky, 1992). Several isolates of the "avian 
erythroblastosis virus" were obtained, and ultimately a stable strain, designated AEV-
ES4!R, was recovered and shown to be a retrovirus. An intensive investigation of 
the oncogenic mechanisms employed by these viruses, however, began only in 
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contemporary times, made possible by the development of assays for transformation 
of cultured cells and biochemical methods for analysis of viral genomes and proteins. 
Consequently, four decades elapsed before the study of AEV -ES4IR was resumed 
(Graf et al., 1976~ Graf and Beug, 1978), with a subsequent focus on the cooperative 
action of the two AEV-associated oncogenes, v-erbA and v-erbB (Graf and Beug, 
1983; Frykberg et al., 1983; Venn strom and Bishop, 1982). 
Highly oncogenic retroviruses, including AEV, are the most rapid and efficient 
oncogenic agents known (reviewed in Teich et al., 1985). Viral oncogenes therefore 
provide a good experimental model system to study oncogenesis. Furthermore, the 
widespread presence of activated oncogenes in human tumours suggests that there are 
common mechanisms governing transformation by oncogenic retroviruses and 
oncogenesis by other carcinogenic agents (reviewed in Varmus, 1989). The rates of 
base substitutions for retroviral genes is roughly 106 times higher than that for their 
cellular counterparts (Gojobori and Yokoyama, 1985). The high rate for the retroviral 
genes can be attributed to a high mutation rate caused in the process of reverse 
transcription (Temin, 1989), and potentially allows retroviruses to undergo multiple 
mutations and recombinations before they are subject to selection. These 
observations have given rise to the hypothesis that the evolution of oncogenic 
retroviruses is a mutation-driven process, whose stages are analogous to the 
spontaneous mutations leading to the activation of cellular proto-oncogenes (Temin, 
1988; reviewed in Weinberg, 1989b). In nonretroviral cancers, genetic instability and 
the concomitant accumulation of mutations results in tumour cell heterogeneity. This 
process provides malignant tumours with great biological diversity, which enables 
them to succeed in a competitive environment. Consequently, cancer cells not only 
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develop aggressive proliferation and metastasizing potential, but also resistance to 
natural and synthetic drugs (reviewed in Pienta et al., 1989). The explanatory power 
of the "oncogene hypothesis" has provided a strong impetus to efforts aimed at 
understanding the precise role of mutations found in retroviral and cellular 
oncogenes. 
(3) Contributions of vlc-erbA research to an understanding of human cancer 
It was recently reported that male mice transgenic for v-erbA develop 
hepatocellular carcinoma, demonstrating that v-erbA can promote neoplasia in 
mammals (Barlow et al., 1994). Based on the fact that v-ErbA contributes to 
oncogenic transformation by dominantly repressing TR and the closely related 
retinoic acid receptor (RAR) (Schroeder et al., 1992a, 1992b), dominant negative 
forms of TR and RAR could reasonably be expected to be involved in human 
cancers. Dominant negative forms of TR, with several genetic lesions resembling 
those present in v-ErbA, have been identified in the rare syndrome of generalized 
thyroid hormone resistance (GTHR) (reviewed in Privalsky, 1992). In TRs from 
individuals suffering from GTHR, point mutations in the ligand binding domain 
result in ligand binding-deficient receptors that act as dominant negative inhibitors 
when coexpressed with the wild-type TR. Elevated rates of cancer development have 
not been observed in affected individuals, suggesting that the expression of at least 
these particular dominant negative TR alleles does not result in cancer in humans. 
However, the possibility that a link between other dominant negative forms of TR 
and human cancer might be found in the future cannot yet be excluded. 
Interestingly, a dominant negative RAR has been implicated in promyelocytic 
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leukemia (PML) in humans (reviewed in Damm, 1993; Privalsky, 1992). The 
unliganded PML-RARa fusion product, consisting of a truncated RARa gene 
translocated to the PML locus on chromosome 15, is thought to act through a 
dominant negative mechanism to interfere with promyelocytic differentiation. This 
indicates that inhibition of cellular differentiation by dominant negative nuclear 
receptors of cellular origin does indeed occur in human cancers. 
An understanding of the processes which help to prevent cancer is one of the 
primary aims of cancer research. In this regard, perhaps the most important outcome 
of studies of v/c-erbA to date has been the characterization of c-erbA as a tumour 
suppressor gene (reviewed in Damm, 1993). Not only does TRlc-ErbA mediate 
differentiation of erythroid progenitor cells, but it also is involved in: (i) repression of 
mitogenic signalling components, such as repression of the AP-l transcription factor 
complex in chicken embryo fibroblasts (Desbois et aI., 1991a, 1991b; Zhang et al., 
1991), and inhibition of platelet-derived growth factor B/c-sis gene expression in glial 
cells (Iglesias et al., 1995); (ii) inhibition of proliferation (Gandrillon et al., 1994); 
and (iii) induction of programmed cell death (apoptosis) (Gandrillon et al., 1994). 
Finally, the study of v-ErbA has been invaluable in the molecular dissection of 
functional domains of nuclear receptors, and has greatly contributed to our 
understanding of the action of dominant negative oncogenes. These aspects of v-
ErbA are discussed in detail in Chapters II and III. 
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(4) Tire Xenopuf lael,is oocyte is a model system/or studies o/transcriptional 
regulation and oncogene action 
Oocytes of Xenopus laevis, the African clawed frog, can be used as an 
exceptionally efficient assay system to characterize the function of both cis- and 
trons-acting factors in gene expression (Fig. 1) (Gurdon and Melton, 1981; Heikkila, 
1990; Wang et al., 1991). For example, Xenopus oocytes have recently been 
employed in studies of transcriptional regulation by oestrogen receptors (Theulaz et 
al., 1988; McKenzie et al., 1990; Watson, 1991), and by a recombinant trans-
activator protein, which consisted of the potent activation domain of the herpes 
simplex virus virion protein VP16 and the DNA binding domain of the yeast 
activator GAL4 (GAL4-VP16) (Xu et al., 1993). Unlike expression studies in 
transfected cultured cells, oocyte microinjection offers the possibility to directly 
introduce cell components, such as nuclear proteins, as well as gene templates, and 
thereby allows the in vivo reconstitution of cell-specific nuclear environments. This 
advantage of the X enop"s oocyte expression system is illustrated by studies of 
f3-globin promoter activation in the presence of nuclear extracts from erythroid tissues 
(Rungger et al., 1990); silencing and activation of the mouse interleukin-2 gene 
promoter by protein extracts from resting and mitogen-induced primary 
T-Iymphocytes (Mouzaki et al., 1991); and stimulation of sea urchin early and late 
H2B histone gene expression by a gastrula nuclear extract (Maxson et al., 1988). 
Oncogene involvement in the signal transduction events mediating control of the 
cell cycle can be studied by maturation assays carried out in X enop"s oocytes 
(reviewed in Smith, 1989). For example, the oncogenic p21 1l1S product (Birchmeier et 
al., 1985; Pomerance et al., 1992), the v-mos protein (Freeman et al., 1990), the 
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Figure 1. Stage V (Dumont, 1972) Xenopus laevis oocytes. The dark pigmented 
animal pole and the unpigmented vegetal hemisphere are shown. Bar: 1 mm. 
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pp60V-SIlZ product (Spivack et al., 1984), and the oncogenic form of nell tyrosine 
kinase (Narasimhan et al., 1992) have been studied in oocytes. Unlike most 
vertebrate somatic cells, which are arrested in Go, X enop"s oocytes are arrested in 
prophase at the G/M border of meiosis. Progesterone stimulation of oocytes leads to 
the activation of pre-existing mitogen-activated protein kinase (MAPK) and a cyclin 
B/CDC2 complex, known as maturation-promoting factor (MPF), and subsequent 
resumption of the cell cycle (reviewed in Kosako et al., 1994a; Maller, 1990~ Smith, 
1989). Since expression of oncogenes, or microinjection of oncogenic proteins, can 
also lead to cell cycle reentry, oocytes offer a useful system in which the pathways 
mediating oncogene action can be analyzed. 
2. Natun~ and Scope of this Investigation 
(1) Aim 1: How do tlte trans-activation and repression domains of TR and 
v-ErbA function in Xenopus oocytes? 
A central issue arising from the discovery of retroviral oncogenes is how a viral 
oncogene differs functionally from its normal progenitor. To address this question, 
the potential for differential cell-specific modes of action distinguishing TR from its 
retroviral homolog v-ErbA was tested in X enop"s oocytes. For the characterization 
of TR and v-ErbA function, regulatory networks, involving TRs, mammalian and 
avian thyroid hormone response elements (TREs), and cell-specific nuclear protein 
extracts, were reconstituted in oocytes. The findings of this study are described and 
discussed in Chapter II. 
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(2) Aim 2: Does l'-ErbA initiate cell cycle reentry in Xenopus oocytes? 
The growth-promoting properties of the v-erbA oncogene have so far exclusively 
been linked to dominant repression of the anti-mitogenic roles of TR and RAR 
(Desbois et al., 1991a, 1991b; Gandrillon et al., 1994; Schroeder et al., 1992a, 1992b; 
Sharif and Privalsky, 1991; Zhang et aI., 1991). Chapter III describes the results of 
meiotic induction assays and ultrastructural studies in Xenopus oocytes, which 
showed that the v-erbA product induces early to intermediate meiotic events by 
activating de novo gene expression. The findings of this study suggest that v-ErbA 
does not initiate cell cycle reentry by antagonizing endogenous TR in oocytes. 
II. 
Constitutive Trans-activation by the Thyroid Honnone Receptor and a 
Novel Pattern of Activity of i1s Oncogenic Homolog v-EmA in Xenopus 
Oocytes 
1. Introduction 
This chapter describes how transcriptional control by the a. and B isoforms of thyroid 
hormone receptor (TR) is modulated by (i) the nuclear environment of Xenopus 
oocytes, (ii) the structure of the DNA control elements, termed thyroid hormone 
response elements (TREs), at which TRs are bound, and (iii) heterodimerization with 
the retinoid X receptor (RXR). The oncogenic counterpart of TR, v-ErbA, was tested 
for its ability to dominantly repress TR at a range of TREs in the context of Xenopus 
oocytes. v-ErbA was shown to be converted to a transcriptional activator by binding 
to certain TREs and by the presence of injected tissue-specific factors from anterior 
pituitary cells. In the introduction, the structural and functional differences between 
TRa., TRB, and v-ErbA, and the mechanisms of transcriptional control by these 
nuclear receptors are reviewed. 
A bbreviations used in this chapter: ELISA, enzyme linked immunosorbant assay; 
lysTRE, TRE from the chicken lysozyme gene; maITRE, TRE from the rat malic 
enzyme gene; rOH, rat growth hormone; rOH3 TRE, TRE from the third intron of the 
rat growth hormone gene; RXR, retinoid X receptor; T3, 3,5,3'-L-triiodothyronine, 
thyroid hormone; TR, thyroid hormone receptor; TRE, thyroid hormone response 
element; TREp, palindromic TRE. 
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(1) Evolutionary relationslups and diversity of thyroid IlOrmone receptor genes 
TRs are members of the steroid/thyroid hormone receptor gene family of sequence~ 
specific transcription factors, inducible by their cognate ligands (Detera~Wadleigh and 
Fanning, 1994; Laudet et al., 1992). In addition to receptors for thyroid hormone 
(T3)' members of this family include the receptors which mediate the effects of 
glucocorticoids, androgens, oestrogens, progestins, mineralocorticoids, 1,25-
dihydroxyvitamin D3, all-trans retinoic acid, and 9~cis retinoic acid, as well as a 
number of related orphan receptors without known ligands (Detera~Wadleigh and 
Fanning, 1994; Laudet et al., 1992; reviewed in Beato, 1989; Evans, 1988). Nuclear 
hormone receptors are key regulators of metabolism, reproduction, development and 
tissue~specific differentiation (reviewed in Beato, 1989; Chatterjee and Tata, 1992; 
Evans, 1988). Recently, a nuclear receptor, named farnesoid X-activated receptor, 
was characterized which is activated by the intracellular metabolite farnesol, a 
component of the mevalonate pathway in mammalian cells (Forman et al., 1995a). 
Interestingly, the isolation of this receptor suggests the existence of a potentially 
novel metabolite-controlled intracellular signalling system in vertebrates. 
TRs, like other transcription factors, are composed of modular functional domains 
whose action is dependent on cellular context (domains A to F; Fig. 2A) (reviewed in 
Glass and Rosenfeld, 1991; Green and Chambon, 1986).TRs are encoded by two 
distinct but closely related genes, c-erbA a and c-erbA n, which map to chromosomes 
17 and 3 respectively in humans (reviewed in Brent et al., 1991). Both genes 
express several alternatively spliced isoforms. The TRa genes in rats and humans 
express the T3-binding isoform TRal along with c-ErbAa2, which does not 
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Figure 2. Modular composition and amino acid sequence similarity of TR isoforms 
and v-ErbA. (A) Schematic of a generalized TR represented as a rectangle; indicated 
within are the AlB, C, D, E and F subregions. Below are shown the various receptor 
domains thought to be involved in transcriptional activation, dimerization or 
interaction with other proteins, DNA recognition and binding (including the P- and 
D-box elements), and the regions thought to mediate nuclear localization (adapted 
from Privalsky, 1992). (B) Comparison of primary structures of human TRIll (hTR 
betal), rat TRa.1 (rTR alpha1) and v-ErbA, the proteins used in this study. v-erbA is 
expressed as a fusion protein made up of the retroviral gag protein and the v-erbA 
product. Numbers within regions corresponding to the C and E domains represent 
percent amino acid identity with hTRB1 (adapted from Glass and Rosenfeld, 1991). 
Little or no significant homology is observed when comparing other regions of the 
receptors. 
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bind T3 because of alternative splicing at the C terminus (reviewed in Brent et al., 
1991; Glass and Rosenfeld, 1991). The closely related chicken a gene expresses 
only chicken TRa which is over 90% identical at the amino acid level to rat TRal 
(rTRal) and human TRa1 (hTRal) (Brent et al., 1991). The TR13 gene expresses 
TR131 and TR132 that differ only in their N-terminal AlB regions, which are distinct 
from the AlB region of TRal (Brent et al., 1991; Glass and Rosenfeld, 1991). 
rTRal and hTR131, employed in this study, are over 85% identical at the amino acid 
level in their DNA binding and ligand binding domains (Fig. 2B). 
(2) Tire role of t/lJ'roid hormone receptors in tire regulation of eukaryotic gene 
transcription by RNA polymerase H 
Cells regulate the transcription of virtually all their genes; for example, in order to 
establish a differentiated phenotype during development, or in response to 
extracellular signals, such as T3• Transcription of eukaryotic protein-encoding genes 
by RNA polymerase II involves the assembly of multiprotein complexes on distal 
control DNA elements, called enhancers, and proximal promoters (reviewed in 
Maldonado and Reinberg, 1995). The highly regulated nature of transcription 
complex assembly provides a finely tuned mechanism for controlling gene 
expression. Transcription is mediated by two distinct classes of transcription factors. 
The first class comprises general transcription factors which are necessary for 
accurate ~nitiation of transcription. These factors include TFIIA, TFIIB, TFIID, 
TFIIE, TFIIF, TFIIG/J, and TFIIH (reviewed in Maldonado and Reinberg, 1995; 
Buratowski and Sharp, 1992). TFIID is a multiprotein complex consisting of the 
TATA box-binding protein (TBP) complexed with a number of TBP-associated 
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factors (TAFs) (Maldonado and Reinberg, 1995). The binding of TFIID is thought to 
be the first step in transcriptional initiation, which is followed by the stepwise 
recruitment of the additional transcription factors and RNA polymerase II, and 
ultimately results in the initiation of transcription (Pugh and Tjian, 1992). 
The magnitude of transcriptional activation is greatly affected by the second class 
of sequence-specific transcription factors, transcriptional activators and repressors, 
which act to either promote or inhibit the formation of an active transcriptional 
initiation complex (reviewed in Johnson, 1995; Ptashne, 1988; Ptashne and Gann, 
1990; Tjian and. Maniatis, 1994). Transcriptional activators bind to enhancers, and 
thereby select genes to be activated, and orchestrate the assembly of the general 
transcription "machinery" at the start site of mRNA synthesis by RNA polymerase II 
(Fig. 3) (Maldonado and Reinberg, 1995; Tjian and Maniatis, 1994). Enhancer 
elements, which include DNA binding sites for TR, can be located at great distances 
from the start site of transcription, either upstream, downstream or within a 
transcribed gene (Banerji et al., 1981; Moreau et al., 1981). Transcription factors 
bound to enhancers activate transcription by forming direct protein-protein contacts 
with proximal promoter factors through DNA looping (Dunn et al., 1984; reviewed in 
Sertling et al., 1985). 
Recent in vitro transcription studies suggest that the binding of TFIIB may be the 
rate-limiting step for the initiation of transcription, and that several transcriptional 
activators act to recruit or stabilize the interaction of TFIIB within the initiation 
complex (Hori etaT., 1995; Maldonado and Reinberg, 1995; Ptashne and Gann, 
1990). Protein-protein interactions with the general transcription factor TFIIB have 
been implicated both in transcriptional repression by unliganded TR and 
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transcriptional activation in response to ligand (Fig. 3) (Fondell et al., 1993; 
Baniahmad et al., 1993). A short sequence in the N-terminal AlB region of DNA-
bound TRa is required for efficient binding to TFIffi and acts to recruit andlor 
stabilize the binding of TFIIB to the transcription complex (Hadzic et al., 1995). For 
transcriptional repression, however, inhibitory interactions with TFIIB are not 
sufficient; the recently identified corepressor N-CoR is also required (Baniahmad et 
al., 1992; Horlein et al., 1995). 
A central question in understanding transcriptional regulation is how a relatively 
small number of different transcription factors can be used to achieve the high level 
of specificity required to regulate the complex patterns of gene expression in higher 
eukaryotes. At least part of the answer is that transcription factors and enhancers are 
composed of modular components (reviewed in Beato, 1989; Dynan, 1989; Chatterjee 
and Tata, 1992; Tjian and Maniatis, 1994; Gronemeyer and Moras, 1995). As 
exemplified by TR (Fig. 2A), a typical transcription factor contains a specific DNA-
binding domain, a multimerization domain that allows the formation of homodimers 
or heterodimers, and a transcriptional trans-activation domain. Similarly, enhancers 
contain distinct sets of transcription factor-binding sites, and variations in the 
arrangement of the binding sites provide the potential to create unique DNA-protein 
complexes by forming heterodimers within and among families of transcription 
factors (reviewed in Karin et al., 1993; Mangelsdorf and Evans, 1992). Synergistic 
interactions between the proteins within the complex result in specificity, a potential 
for multiple regulatory controls, and a high level of transcription. Importantly, cell-
specific cofactors modulate the effects of transcriptional activators and repressors in a 
highly tissue-specific manner. 
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Figure 3. Schematic of a multistep model of trans-activation by TR The multistep 
model of trons-activation is derived mainly from in vitro studies of mammalian 
systems (adapted from Maldonado and Reinberg, 1995). Multiple cooperative 
interactions (symbolized by arrows) between TR, RXR, other activators (A), 
coactivators (CA), corepressors (CR), accessory factors (AF), and general 
transcription factors (TFIIA-H, TBP, TAFs), mediate activation of transcription by 
RNA polymerase II (RNAPII) at the initiation start site (start) of TR-regulated genes. 
The multiprotein complex made up of TATA-binding protein (TBP) and TBP-
associated factors (TAFs) constitutes the general transcription factor TFIID. In 
mammalian cells, TR, associated with CR, represses transcription by inhibitory 
interactions with TFIIB in the absence of T3 (-T3). T3 induces both the dissociation 
of CR and the recruitment of CA (+T3). As a result, the TRiCA complex activates 
transcription by enhancing binding of TFIIB to the general transcription complex 
(refer to text for further details). 
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These mechanisms are well illustrated by the multi-level control of the rat growth 
hormone (rGH) gene, which offers an interesting system for studying the interactions 
between factors that mediate cell-type specificity and the factors that mediate 
hormone responsiveness. The promoter of the rGH gene, which is exclusively 
expressed in the somatotrophic cells of the anterior pituitary gland (reviewed in 
Frawley, 1989), contains DNA binding sites for TR (Ye et al., 1988; Flug et al., 
1987; Norman et al., 1989; Brent et al., 1989) and for the general transcription 
factors Spl (Schaufele et al., 1990a) and GHF-3 (Schaufele et al., 1990b), as well as 
two sites for the pituitary-specific factor Pit-l/GHF-l, belonging to the homeobox 
POU domain-containing family of transcription factors (Bodner et al., 1988; Lefevre 
et al., 1987; Schaufele et al., 1990c; West et al., 1987). An additional binding site 
for TR, which was employed in this present study, is located in the third intron of 
the rGH gene (Sap et a1., 1990). TR and Pit-l act synergistically in the activation of 
the rGH promoter (Schaufele et al., 1992; Ye et al., 1988), which helps to explain 
how the widely distributed TR can activate the expression of certain genes only in 
selected cell types. 
(3) Specific recognition of thyroid Iwrmone response elements by t!tyroid 
Iwrmone receptors 
The DNA binding domain of TR possesses two zinc finger motifs (Freedman et 
al., 1988; Luisi et al., 1991). Adjacent to each zinc finger is an amphipathic a-helix, 
involved in the folding of the zinc finger domains into a compact globular structure 
(Hard et aI., 1990a and 1990b; Luisi et a1., 1991; Remerowski et al., 1991; Schwabe 
et al., 1990). The P-box of the first a-helix, mediating TRE recognition, contains 
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three discriminating amino acids thought to interact directly with specific bases of the 
consensus motifs within TREs (Danielsen et al., 1989; Luisi et al., 1991; Mader et 
al., 1989; Umesono et al., 1989). Further dissection of the P-box revealed that the 
amino acids act independently at the level of DNA binding (Nelson et al., 1993). 
The D-box, adjacent to the second a-helix, provides phosphate contacts to the DNA 
backbone and participates in receptor-receptor dimerization (Danielsen et aI., 1989; 
Lee et al., 1993; Luisi et al., 1991; Umesono and Evans, 1989; Umesono et al., 1991; 
Zechel et al., 1994a, 1994b). 
TRs control expression of T3-responsive genes at cis-acting TREs (reviewed in 
ChatteIjee and Tata, 1992). TREs are made up of six base pair consensus sequences, 
termed half sites, consisting of the canonical 5'-PuGGTCA recognition motif. These 
half-sites can be oriented as imperfect inverted, direct or divergent repeats, separated 
by different sized nucleotide gaps (reviewed in Gronemeyer and Moras, 1995; 
Privalsky, 1992). Naturally occurring promoters often show mixtures of half sites in 
differing orientations (Chatterjee and Tata, 1992). Specific recognition of a TRE by 
the receptor appears to require the appropriate orientation and spacing of the half-
sites, as well as the correct sequence within each half-site (Baniahmad et al., 1990; 
Desai-Yajnik and Samuels, 1993; Forman et al., 1992; Glass et al., 1988; Lazar et aI., 
1991; Naar et al., 1991; Umesono et al., 1991). TR homodimers specifically 
recognize a palindromic arrangement of half-site motifs with no spacer nucleotide 
(reviewed in Gronemeyer and Moras, 1995), as exemplified by a synthetic response 
element, termed TREp (Damm et al., 1989) used in this study (Fig. 4). This 
requirement for a distinct number of spacer nucleotides results from the 
characteristics of the D-box within the DNA binding domain, which represents a 
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Figure 4. Thyroid hormone response elements employed in this study. Nucleotide 
sequences of the TRE from the rat malic enzyme gene (maITRE) (Petty et al., 1990). 
the TRE from the chicken lysozyme gene (Baniahmad et al., 1990). the TRE from 
the third intron of the rat growth hormone gene (rGH3TRE) (Sap et al., 1990), a 
synthetic palindromic TRE (TREp) (Damm et ai .• 1989). and the clone 122 TREs 
(Bigler and Eisenman, 1994) are shown. The orientation of individual half sites is 
indicated by arrows. Intervening nucleotides between half~sites are indicated by 
numbers. A putative half site within rGH3 TRE is depicted by a broken arrow. 
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weak DNA-induced dimerization interface (Luisi et al., 1991; Schwabe et al., 1990; 
Umesono and Evans, 1989). TRs can bind TREs as monomers and homodimers 
(Forman et al., 1992; Ikeda et al., 1994; Lazar et al., 1991; Katz and Koenig, 1993). 
However, heterodimerization with mammalian auxiliary factors, most notably the 
nuclear receptors for 9-cis retinoic acid (RXRs), results in increased affinity for the 
response element in vitro and enhanced activation of gene expression in vivo (Bugge 
et al., 1992; Burnside et al., 1990; Heyman et al., 1992; Kliewer et al., 1992; Murray 
and Towle, 1989; Yu et al., 1991; Zhang et al., 1992; for a review, see Mangelsdorf 
and Evans, 1992). 
Many naturally occurring TREs are composed of two directly repeated half-sites 
separated by four nucleotides (DR4), such as the TRE from the rat malic enzyme 
gene (maITRE) (Petty et al., 1990) employed in this study (Fig. 4). 
Heterodimerization of TR with RXR at DR4, which is due to a strong interaction 
between the dimerization surfaces located in the ligand binding domains and weaker 
interaction between the dimerization surfaces in the D-boxes of TR and RXR, results 
in cooperative DNA binding and specific recognition of DR4 TREs (Kliewer et al., 
1992; Lee et al., 1993; Leid et al., 1992a, 1992b; Mader et al., 1993; Marks et al., 
1992; Perlmann et al., 1993; Yu et al., 1991; Zechel et al., 1994a, 1994b; Zhang et 
al., 1992). Recently, the understanding of the stereochemical principles underlying 
specific recognition of DR4 TREs by TR-RXR heterodimers was greatly enhanced by 
the crystallographic characterization of the heterodimer bound to a DR4 TRE 
(Rastinejad et al., 1995). 
In addition to palindromic and DR4 TREs, inverted palindromes which are bound 
by homodimers and heterodimers (Gronemeyer and Moras, 1995), like the TRE from 
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the chicken lysozyme gene (lysTRE) (Baniahmad et al., 1990) used in this study 
(Fig. 4), are found in naturally occurring enhancer elements. Finally, complex TREs, 
consisting of more than two half-sites arranged in differing orientations, have also 
been described. Two complex TREs, the TRE from the third intron of the rat growth 
hormone gene (rGH3TRE) (Sap et al., 1990), and the clone 122 TREs of an as yet 
unidentified T3-responsive gene (Bigler and Eisenman, 1994), were employed in this 
investigation (Fig. 4). At present, it remains unknown whether TR binds to complex 
TREs in monomeric, dimeric, or multimeric form. 
(4) ConstituJil'e and ligand~induced transcriptional regulation by tllJ'roid Iwrmone 
receptors 
Induction of gene transcription by TR is achieved through autonomous trans-
activation domains (reviewed in Gronemeyer, 1992): a constitutive trans-activation 
domain located in the N-terminal region of the receptor (Hadzic et al., 1995; 
Hollenberg et al., 1995) and, in the C-terminus, three ligand-inducible trans-activation 
domains, which are all required for maximum transcriptional activatien (Baniahmad 
et al., 1995). Although transcriptional activation by TR is primarily ligand-dependent 
in mammalian cells, ligand-independent activation has also been observed (Bigler and 
Eisenman, 1994; Forman et al., 1988; Forman and Samuels, 1990; Saatcioglu etal., 
1993a). In the yeast, Saccharomyces cerevisiae, TR functions as a ligand-
independent activator with enhanced expression in the presence of T 3 (Privalsky et 
al., 1990). In mammalian cells, unliganded TRs, thought to be constitutively bound 
to hormone response elements, can suppress the basal activity of promoters 
containing TREs (Baniahmad et al., 1990, 1992; Damm et al., 1989; Fondell et al., 
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1993; Sap et al., 1989; Zenke et aI., 1990). The repressor function has been mapped 
to the hinge domain of TR, and was shown to be separable from its activator 
function (Damm and Evans, 1993). A C-terminal silencer domain has also been 
characterized (Baniahmad et al., 1992, 1995). At present, it is not well understood 
how the trans-activation and repression domains are regulated in the context of the 
full-length receptor. 
At positively regulated TREs, addition of T3 results in the activation of 
transcription, suggesting that the hormone triggers a conformational change in TR 
that induces the activator function (Allan et al., 1992; Bhat et al., 1993; Leng et al., 
1993; Toney et al., 1993). This conformational switch causes both the dissociation of 
corepressor proteins as well as the recruitment of coactivator(s) (Chen and Evans, 
1995; Horiein et al., 1995; Kurokawa et al., 1995; Lee et aI., 1995a, 1995b). At 
negatively regulated TREs, TRs act as transcriptional repressors when bound to T3 
(reviewed in Chatterjee and Tata, 1992; Glass and Rosenfeld, 1991). In addition, two 
novel TREs were recently identified. Both the clone 122 TREs (Bigler and 
Eisenman, 1994) and a TRE in the Rous sarcoma virus long terminal repeat (LTR) 
(Saatcioglu et al., 1993a), mediate strong activation by unliganded TR, while addition 
of T 3 reverses this response. 
(5) v-ErbA: Origins and mode of action 
The v-erbA gene of the avian erythroblastosis virus (AEV) constitutes a virally 
transduced, highly mutated form of the chicken TRa. gene, and is expressed as a 
fusion product with gag, the retroviral structural protein gene (for a review, see 
Privalsky, 1992). AEV belongs to a small group of avian replication-defective 
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leukemia viruses and carries two distinct oncogenes, v-erbA and v-erbB, which 
together induce erythroblastosis in young chicks (Graf et al., 1976; Graf and Beug, 
1983). This collaborative action of v-erbA and v-erbB is discussed in detail in 
Chapter III. 
The cooperative mode of v-erbA function reinforces the notion that the 
development of a transformed phenotype is most readily achieved through the actions 
of at least two oncogenes, the hypothesis known as "the multistep causation of 
carcinogenesis" (reviewed in Weinberg, 1989b). Since the v-erbA oncogene is not 
itself capable of overt transformation (Gandrillon et al., 1987), but cooperates with a 
wide variety of other oncogenes to enhance transformation (Kahn et ai., 1986), it 
provokes two intriguing questions: What is its cooperative role, and how does it exert 
its subtle effects on growth and differentiation? 
To date, the growth-inducing properties of v-erbA have been shown to involve 
interference with the function of nuclear hormone receptors, belonging to signalling 
pathways distinct from those induced by the mitogenic kinases. v-ErbA acts as a 
dominant repressor in mammalian and avian cells, blocking activation of gene 
expression by two differentiation-inducing factors, liganded TR and retinoic acid 
receptor (RAR) (Damm et al., 1989; Sap et ai., 1989; Sharif and Privalsky, 1991). 
The v-erbA protein has sustained small N- and C-terminal deletions and 13 internal 
amino acid changes relative to the TR progenitor (Fig. 5) (for a review, see 
Privalsky, 1992). Mutations within the C-terminus of the v-erbA protein appear 
primarily responsible for its conversion into a constitutive transcriptional repressor, as 
these mutations result in loss of the ability to bind thyroid hormone at high affinity 
(Damm et al., 1989; Sap et ai., 1989; Zenke et al., 1990; for a review, see Prival sky , 
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Figure 5. Comparison of the chicken TRa,l (cTR alphal) and v-ErbA. The cTRa,l 
protein is displayed schematically on top, and the v-erbA protein is presented for 
comparison below. Arrows indicate the N- and C-terminal deletions relative to 
cTRa,l, and the dashes indicate the locations of the 13 internal amino acid 
differences between cTRa,l and v-ErbA. In addition, the N-terminal fusion to 
retroviral gag sequences in v-ErbA is shown (adapted from Privalsky, 1992). 
eTR alpha 1 
v-ErbA 
26 
1992). v-ErbA has retained some binding ability, since, surprisingly, v-ErbA acts as 
a hormone-regulated activator in S. cerevisiae (Privalsky et al., 1990; Sharif and 
Privalsky, 1991). The ability of v-ErbA to respond to hormone in yeast suggests that 
its hormone binding ability can be influenced by the environment. Consequently, 
cellular factors modulating hormone-receptor interactions may be important in the 
oncogenicity of v-erbA . 
Several mechanisms have been suggested to account for transcriptional repression 
by v-ErbA, such as direct promoter silencing (Baniahmad et al., 1990, 1992), 
competition with TR and RAR for DNA binding sites (Damm et al., 1989; Selmi and 
Samuels, 1991), or formation of inactive heterodimers between v-ErbA and TR or 
RAR (Desbois et aI., 1991 a; Schroeder et al., 1992a, 1992b; for reviews, see Yen and 
Chin, 1994; Herskowitz, 1987). Of these mechanisms, direct promoter silencing is 
the least understood (reviewed in Levine and Manley, 1989; Renkawitz, 1990). That 
v-ErbA and unliganded TR are able to repress transcription through direct promoter 
silencing is shown by the fact that repression is effective on a minimal promoter 
(Baniahmad et al., 1990, Fondell et al., 1993). Moreover, both factors inhibit 
transcription independently of the position and orientation of the TRE to which they 
are bound (Baniahmad et al., 1990). The following observations suggest that 
competition for DNA binding is critical for dominant negative activity. Firstly, 
mutation of the DNA binding domain of v-ErbA abrogates its dominant negative 
activity (Damm et al., 1989). Secondly, v-ErbA homodimers, v-ErbAIRXR 
heterodimers and v-ErbArrR heterodimers can form on TREs (Hermann et al., 1993; 
Yen et al., 1994). It has .been proposed that one or all of these complexes may 
compete with normal TR complexes for binding at TREs and thereby block T3-
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mediated gene activation (Yen and Chin, 1994). Finally, these different mechanisms 
do not have to be mutually exclusive. For instance, inactive v-ErbAfTR dimers 
might form on a TRE and silence the promoter by blocking the assembly of a 
functional pre-initiation complex (Baniahmad et al., 1990, 1992; Fondell et al., 1993; 
Yen et al., 1994; Yen and Chin, 1994). By default, they would also prevent TR 
complexes from binding to that TRE (Yen and Chin, 1994). 
In addition to mutations in the hormone binding domain (Fig. 5), the v-erbA 
protein has acquired a substitution of one of the three discriminating amino acids 
within the P-box, and a second mutation in the D-box of the DNA binding domain 
(Fig. 6) (Bonde et al., 1991; Sap et al., 1986; for a review, see Privalsky, 1992). 
While the ability of the DNA binding domain of v-ErbA to bind to certain TRE 
sequences has been conserved (Bonde ·et al., 1991; Damm et al., 1989; Sap et al., 
1989; Vemeuil and Metzger, 1990), the two zinc finger domain mutations, and 
mutations in an N-terminal region outside of the DNA binding domain, alter the 
range of DNA target sequences the v-erbA protein can bind to relative to TR (Chen 
et al., 1993; Sharif and Privalsky, 1991; Smit-McBride and Privalsky, 1993; Subauste 
and Koenig, 1995; Zenke et al., 1990). To summarize, multiple mutations and two 
deletions confer an oncogenic phenotype on the v-erbA product. v-ErbA has evolved 
into a dominant repressor of TR, its cellular progenitor, and also exhibits an altered 
range of DNA binding ability relative to TR. 
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Figure 6. Schematic representation of the DNA binding domain of the v-erbA 
protein. The two zinc finger modules are shown, using the standard one letter amino 
acid code. The relationship of the conserved cysteines (C) to the coordinated zinc 
atoms (Zn), involved in stabilization and folding of the two zinc finger modules, is 
emphasized. The amino acids comprising the P- and D-boxes are indicated by 
asterisks. The two amino acid substitutions sustained by v-ErbA relative to cTRa1 
are boxed (adapted from Privalsky, 1992). 
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(6) Summary of results 
In this chapter, I show that Xenopus oocytes constitute a viable model system for 
the reconstitution of complex regulatory networks involving TR and v-ErbA. The 
nuclear environment of oocytes revealed novel functions of the constitutive trans-
activation domains present in TR and v-ErbA. The results of a detailed analysis of 
the constitutive and ligand-enhanced trons-activation functions of both a and 13 
isoforms of TR, exhibited at a range of TREs in oocytes, are presented. Furthermore, 
a constitutive trons-activator function of v-ErbA was shown to be induced by binding 
to a complex response element, clone 122 TREs, and by the presence of nuclear 
protein extract from anterior pituitary cells at rGH3 TRE. With the exception of some 
additional data, the results described in this chapter have been published and a reprint 
of the publication is included in Appendix 1. 
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2. MateIials and Methods 
(1) Plasmids 
RS-rTRa., RS-v-erbA, and tk-TREp-CAT were gifts from R. Evans (Salk Institute 
for Biological Studies, La Jolla, CA). The expression vectors contain rat TRa. eDNA 
or the gag-v-erbA oncogene under the transcriptional control of the Rous sarcoma 
virus (RSV) long terminal repeat (LTR) (Damm et al., 1989; Thompson and Evans, 
1989). tk-TREp-CAT contains a synthetic palindromic TRE linked to a herpes 
simplex virus thymidine kinase-chloramphenicol acetyltransferase fusion gene (tk-
CAT) (Damm et al., 1989). The T3-responsive CAT reporter constructs were gifts 
from P. 1. Romaniuk (University of Victoria, Victoria, BC, Canada) and contain 
TREs from the promoter regions of the rat malic enzyme gene (maITRE), the chicken 
lysozyme gene (lysTRE), the third intron of the rat growth hormone gene 
(rGH3TRE), and the synthetic palindromic TRE (TREp) linked to a mouse mammary 
tumor virus (AMTV) LTR-CAT fusion gene (AMTV-CAT) (Nelson et al., 1993). 
The pTPT -CAT reporter construct was a gift from R. N. Eisenman (Fred Hutchinson 
Cancer Research Center, Seattle, WA) and contains a 450 bp Sau3A-BamHI fragment 
from clone 122, spanning all three TREs, cloned into pBLCAT3 (Bigler and 
Eisenman, 1994). pRSV-Pit-l was a gift from H H Samuels (New York University 
Medical Center, New York, NY) and contains a cDNA clone of the rat Pit-l/GHF-l 
gene linked to the RSV LTR (Fox et aI., 1990). The RSh-TRB construct contains the 
wild type human TRBI gene, and the RSh-TRB C122>A expression plasmid contains 
an in vitro-generated mutant human TRB 1 gene (alanine instead of cysteine at 
position 122), both under control of the RSV LTR (Nelson et al., 1993). The RSh-
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RXRa. expression vector contains human retinoid X receptor a. eDNA linked to the 
RSV LTR. LlMTV-CAT contains a CAT reporter gene driven by the ilMTV LTR 
promoter (Thompson and Evans, 1989). RSh-TRI3, RSh-TR13 CI22>A, RSh-RXRa., 
and LlMTV -CAT were gifts from P. J. Romaniuk pRSV -lacZ was obtained from M. 
Harkey (University of Washington, Seattle, WA) and contains the E. coli 13-
galactosidase gene under control of the RSV LTR (Gorman et al., 1983). 
(2) Microinjections and ELISA 
A lobe of ovary was surgically removed from an adult female Xenopus laevis and 
processed as described (Allison et al., 1991). Microinjections were performed 
according to published methods with modifications (Allison et al., 1991, 1993; Nagl 
et al., 1995). Stage V (Dumont, 1972) oocytes were microinjected with 20 nl 
plasmid DNA in TE (10 mM Tris-HCI, pH 8.0, 1 mM EDTA) into the nucleus by 
the 'blind' injection method with the needle inserted in the center of the animal pole 
(Gurdon and Melton, 1981; Colman, 1984). After microinjection, oocytes were 
incubated in O-R2 (Appendix 2; Allison et aI., 1991) medium for 20-24 h at 18°C in 
the presence or absence of 100 nM T3 (3,5,3'-triiodo-L-thyronine, Sigma, Chemical 
Co., St Louis, MO). Healthy oocytes (uniform pigment, not mottled) were 
homogenized singly in 200 III 0.25 M Tris buffer, pH 7.5, and centrifuged at 10,000 
x g in a microfuge at 4°C for 10 min. The supernatant was then centrifuged as 
before. This extract was used in the determination of CAT and 13-galactosidase 
protein expression levels by enzyme linked immunosorbant assay (ELISA) according 
to the manufacturer's specifications (5 Prime-3 Prime, Inc., Boulder, CO). The 
concentration of total protein in extracts from single oocytes was adjusted to a 
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concentration of 175 to 200 Ilg/ml by 1: 1 dilution with Dilution Buffer. Microwells 
coated with rabbit polyclonal antibody specific to CAT protein or specific to the E. 
coli 13-galactosidase protein (13-Gal) were incubated with extracts from microinjected 
oocytes, uninjected controls, and appropriate pure CAT or 13-Gal protein standards. 
Biotinylated secondary antibody to CAT or 13-Gal was then bound to the primary 
antibody-antigen complex. After washing, bound biotinylated antibody was 
quantitated colorimetrically by incubation with streptavidin-conjugated alkaline 
phosphatase and p-nitrophenyl phosphate as substrate. The wells were read at 405 
nm against the reagent blank in a microtiter well reader (model EL 311, Bio-Tek 
Instruments, Winooski, VT). For each assay, a standard curve utilizing four pure 
protein standards was prepared, to ensure that CAT or 13-Gal concentrations of 
sample extracts fell within the linear range of the assay. All experiments were 
repeated two to three times with different animals since there can be variability in 
transcriptional activity between different batches of oocytes. The data on reporter 
gene expression levels were analyzed by nested analysis of variance (ANOV A) 
controlling for variability between females and between independent ELISA assays. 
(3) Immunoprecipitation of l'-erbA protein 
Oocytes were injected into the nucleus with 2.5 ng RS-v-erbA in 20. nl TE, pH 8.0. 
Oocytes were then incubated in a sterile microtitre plate (5 oocytes/well) in 30 III of 
O-R2 with 1 mCi/ml L_[35S] methionine (1000 Ci/mmol, Amersham Pty Ltd., 
Auckland, New Zealand) at 18°C for 20-24 h. Twenty microliters of preswollen 
protein G-Sepharose beads (Gamma Bind Plus Sepharose, Pharmacia LKB 
Biotechnology, Auckland, New Zealand) in 0.45 ml NET-2 (Appendix 2; Allison et 
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al., 1991) was aliquoted per microfuge tube, followed by the addition of 30 III of 
monoclonal antibody LA038 against v-erbA residues 58-75 (Quality Biotech, 
Camden, NJ). Antibodies were bound to protein G-Sepharose beads for 2 h at room 
temperature with end-oyer-end rotation. After incubation, the resin was pelleted for 5 
sec in a microfuge and resuspended in 1 ml of NET -2, and the wash was repeated 
three times. Nuclear and cytoplasmic fractions of 20 v-erbA -injected oocytes per 
sample were prepared manually as described (Allison et al., 1991) after fixation in 
1% ice-cold trichloroacetic acid for 5 min. 0.5 ml NET-2 with 0.1 mM 
phenylmethylsulfonyl fluoride (PMSF) was added to both fractions. Twenty 
uninjected control oocytes were pooled per sample and homogenized in 0.5 ml 
NET-2 with 0.1 mM PMSF added. Cytoplasmic fractions and control homogenates 
were precleared of yolk and pigment by microfuging for 10 min at 10,000 x g at 
4°C. The supernatants of control samples and cytoplasmic fractions, and the nuclear 
fraction samples, were added to each washed protein G-Sepharose-antibody pellet and 
incubated at 4°C for 1 h with end-oyer-end rotation. After incubation, the resin with. 
bound antigen was pelleted, and washed four times with NET-2. Forty microliters of 
2 X SDS sample buffer (4% SDS, 20% glycerol, 120 mM Tris, pH 6.8,0.01% 
bromophenol blue) were added to each pellet, the samples were heat denatured to 
release the antigen and the resin was pelleted for 5 sec in a microfuge .. The 
~upt)rnatant, with 1 mM dithiothreitol (DTT) added, was resolved by 12% SDS-
polyacrylamide gel electrophoresis followed by fluorography. 
(4) ELISA for total T] 
. Ten oocytes per sample, either incubated in 100 nM T3 for 20 h and subsequently 
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washed three times in O-R2, or cultured in O-R2 only, were homogenized in 100111 
0.25 M Tris buffer, pH 7.5, and centrifuged at 10,000 x g in a microfuge at 4°C for 
10 min. The supernatant was then centrifuged as before. This extract was used in 
the quantitative determination of total T3, both bound and free hormone, in oocytes 
by ELISA (Enzymun-Test T3, Boehringer Mannheim, Auckland, New Zealand). Test 
tubes coated with streptavidin were incubated with oocyte extracts or T3 standards, 
together with anti-T3 antibody-horseradish peroxidase (POD) conjugate. T3 standards 
were prepared in 0.25 M Tris buffer, pH 7.5, at 0, 0.1, 1, 10 and 100 nM. Binding 
of sample T3 to anti-T3 antibodies was then competed by addition of biotinylated T3 
polyhapten, which anchors previously unbound anti-T3 antibodies to the streptavidin-
coated test tube wall. After washing, bound anti-T3 antibody-POD conjugate was 
quantitated colorimetrically by incubation with 2, 2' -azino-di-[3-ethyl-benzthiazoline 
sulfonate (6)] (ABTS)1H20 2• The samples were transferred to micro-cuvettes and 
read against buffer at 420 nm in a spectrophotometer. For each assay, a standard 
curve utilizing the five T 3 standards was prepared. Two independent determinations 
were carried out with oocytes from two different animals, and four replicates (10 
oocytes/replicate) were assayed in each determination. 
(5) Preparation of nuclear protein extracts from ovine allterior pituitary cells and 
cytoplasmic injection 
Nuclear protein extracts were prepared essentially as described by Maxson et al. 
(1988). All procedures were carried out at 4°C. Ten milliliters of sheep anterior 
pituitary cells maintained in primary cell culture (4.8 x 106 viable cells/ml) were 
concentrated by centrifugation, washed in phosphate-buffered saline, and then washed 
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once in 1.5 M glucose. The resultant partially lysed cells were homogenized gently 
in 10 volumes of low-salt buffer (4 mM magnesium acetate, 50 mM Tris, pH 7.4, 
0.5% Nonidet P-40, 10 mM 2-mercaptoethanol, 0.1 mM phenylmethylsulfonyl 
fluoride [PMSF]). Two to five strokes in a Dounce glass homogenizer were 
sufficient to complete lysis. The homogenate was overlaid (15 ml per tube) on step 
sucrose gradients consisting of 5 mlof 1.7 M sucrose on 5 ml of 2.2 M sucrose in 
30-rol Nalgene tubes; The gradients were centrifuged at 5,000 x g for 15 min, and 
the gray nuclei were collected from the interface between the two sucrose solutions. 
The nuclei were diluted twofold with a buffer containing 75 mM NaCI, 25 mM 
EDTA, 5 mM Tris, pH 7.5, 20 mM 2-mercaptoethanol, and 0.1 mM PMSF. Partially 
lysed nuclei and chromatin were collected by centrifugation at 10,000 x g for 30 min. 
The chromatin-nuclei pellet was suspended in extraction buffer (0.45 M NaCI, 20 
mM Tris, pH 7.0, 1 mM EDTA, 1 mM EGTA, 0.5 mM dithiothreitol [DTT], 0.1 mM 
PMSF), and vortexed for several minutes, and the insoluble material was collected by 
centrifugation at 10,000 x g for 30 min. The supernatant was set aside, and the 
extraction and centrifugation were repeated on the residual nuclear material with 
extraction buffer containing 1 M NaCI and then 2 M NaCI. The extracts of all three 
salt washes were pooled and concentrated by precipitation with ammonium sulfate 
(0.35 g/ml), dialyzed for 24 h against several changes of injection buffer (100 mM 
NaCI, 20 mM Tris, pH 7.0,5 mM MgCI2, 1 mM EDTA, 0.1 mM EGTA, 5% 
glycerol, 0.5 mM DTT, 0.1 mM PMSF), and concentrated severalfold by 
centrifugation in centricon 10 micro concentrators (Amicon, Beverly, MA). Extracts 
were stored frozen at -80°C. Five hours before microinjection of gene templates, 
oocytes were microinjected with 20 nl of extract into the cytoplasm. 
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3. Results 
(1) Bot". constitutive and Ts-mediated gene activation functions of TRa and TRjI 
were induced in Xenopus oocytes and en/lanced by RXR 
I was interested to establish whether Xenopus oocytes can be used for the 
reconstitution of nuclear receptor networks in vivo. In this context, I wished to 
ascertain whether oocytes provide a cellular background for nuclear hormone receptor 
action similar to either yeast or mammalian cells, or whether they constitute a unique 
context. TR mRNA is present at all stages of oogenesis (Kawahara et al., 1991) and 
in fertilized eggs (Banker et al., 1991); however, at the onset of my study, TR protein 
had not been detected by immunoprecipitation or Western immunoblotting (Banker et 
al., 1991), suggesting that maternal transcripts are stored for use later in 
embryogenesis. Results obtained by enzyme linked immunosorbant assay (ELISA) 
showed that oocytes contain no detectable endogenous T3 « 0.1 nM). After 
incubation in 100 nM T3, oocytes exhibited an intracellular hormone concentration of 
~ 5 nM (Fig. 7), which falls within the physiological range for T 3 action. Thus, I 
presumed that X enop"s oocytes would be suitable for experiments investigating 
transcriptional regulation by exogenous TR and v-erbA protein at a range of diverse 
TREs, both with and without added T3• 
I sought to reflect the natural diversity of TREs by employing four positively 
regulated response elements possessing different half-site characteristics; i. e., the 
direct repeat TRE in the rat malic enzyme gene promoter (maITRE) (Petty et al., 
1990), the inverted palindromic TRE in the promoter region of the chicken lysozyme 
gene (lysTRE) (Baniahmad et al., 1990), the tripartite TRE in the third intron of the 
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Figure 7. Determination of endogenous and exogenous T3 in Xenopus oocytes by 
ELISA. A standard curve from ELISA of T3 standards at the indicated 
concentrations was plotted against absorbance at 420 nm. The absorbance readings 
from ELISA of 10 pooled oocytes, cultured in O-R2 (endogenous) or incubated in 
100 nM T3 (exogenous) for 20 h were plotted on the standard curve to determine the 
T3 content. The error bars indicate the SEMs of two independent determinations with 
oocytes from different females (4 replicates/treatment/determination). 
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rat growth hormone gene (rGH3TRE) (Sap et al., 1990) and a synthetic palindromic 
TRE (TREp) (Damm et al., 1989); and one complex response element which is 
strongly induced by unliganded TR and repressed by T 3 in mammalian cells (clone 
122 TREs) (Bigler and Eisenman, 1994). A rat TRa. (rTRa.) expression plasmid and 
a CAT reporter gene under the control of one of five different TREs were 
microinjected into the oocyte nucleus. Unliganded rTRa. induced transcription of all 
five TRE-regulated CAT reporter genes (Fig. 8). Constitutive reporter gene induction 
by rTRa. was strongest when under the control of lysTRE, TREp, or the clone 122 
TREs. CAT reporter gene transcription under control of three positively regulated 
TREs (maITRE, lysTRE, TREp) was further enhanced by the addition of T3, but was 
unresponsive to hormone with rGH3TRE (Fig. 8). In contrast to results obtained in 
CV1 (monkey kidney) cells (Bigler and Eisenman, 1994), addition of T3 did not 
significantly repress TR-mediated transcription regulated by the clone 122 TREs (Fig. 
8). Reporter gene induction by TR was shown to be dependent on the presence of a 
TRE in oocytes, as expression levels of the AMTV -CAT reporter gene lacking a TRE 
sequence were not induced by coinjection of rTRa., in the presence or absence of T3 
(Fig. 8). 
Unexpectedly, there was a weak T3-dependent induction of the tk-TREp-CAT and 
TREp-AMTV -CAT reporter constructs in the absence of exogenous TR, while the 
AMTV promoter alone was not responsive to T3 (Fig. 8). Significant induction from 
TREp in response to T3 was observed in samples analyzed 4 h after microinjection of 
the reporter gene into the nucleus and persisted over a 36 h period of hormone 
incubation (Fig. 9). Contrary to my original assumptions, these results suggested the 
presence of low levels of an endogenous TR-like activity in oocytes. A recent study 
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Figure 8. TR-mediated TRE-CAT reporter gene transcription in Xenopus oocytes. 
Two ng AMTV -CAT or tk-CAT reporter gene construct linked to one of five 
different TREs as indicated, or 2 ng AMTV-CAT lacking a TRE, was microinjected 
into the oocyte nucleus together with 0.5 ng of the rTRa. expression vector. Oocytes 
were cultured in the presence or absence of 100 nM T3 (TRI+T3 and TRI-T3) for 24 
h. Alternatively, oocytes were microinjected with reporter constructs alone, and 
incubated with and without hormone (+T3/-T3). t\MTV-TREp-CAT was tested with 
and without T3 only. Activation of the reporter gene was measured in terms of the 
levels of CAT protein present in oocytes, analyzed individually by ELISA. Basal 
transcription levels of the reporter constructs in the absence of exogenous TR and T3 
were arbitrarily assigned the value 1. For each CAT reporter construct 2 or 3 
independent experiments (5 oocytes per treatment) were performed and the mean fold 
induction over basal transcription was calculated. The error bars indicate the SEMs. 
Differences in levels of reporter gene transcription were significant at p < 0.0001. 
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Figure 9. Time course of transcriptional activation of the tk-TREp-CAT reporter 
construct by endogenous TR in the presence of T3• Two ng tk-TREp-CAT reporter 
construct was microinjected into the oocyte nucleus. Oocytes were then cultured 
with and without 100 nM T3• Activation of the reporter gene was measured in terms 
of the levels of CAT protein present in single oocytes at the indicated times after 
microinjection, and expressed in arbitrary units based on the measurement of CAT 
levels by ELISA. Five oocytes per time point were assayed and the time course was 
repeated 4 times. The error bars indicate the SEMs. 
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has now reported that X enoplis oocytes contain both lRa and TR13 protein (Eliceiri 
and Brown, 1994). The observed T3-mediated induction of a CAT reporter gene 
under control of TREp in the absence of exogenous TR indicates that these 
endogenous TRs can function as T 3-regulated activators. 
The J3 isoform of the receptor, human TRI3 (hTRI3) , also constitutively induced 
transcription at TREp, albeit to a lesser degree than rlRa (Fig. 10). Gene activation 
by hTR13 was not significantly enhanced in the presence of hormone at TREp. 
Moreover, to achieve detectable levels of reporter gene induction by hTRI3, a five 
times greater amount of the expression vector (RSh-TRI3) had to be microinjected 
compared to RS-rTRa. This increased requirement might have been due to 
differences in the expression of the two constructs in oocytes, or to the decreased 
binding affinity of TR13 for palindromic TREs (Privalsky et al., 1990; Holloway et 
al., 1990). 
RXRs have recently been shown to heterodimerize with lRs, enhancing lR 
binding to TRE elements, and augmenting T3-mediated transcriptional activation 
(reviewed in Mangelsdorf and Evans, 1992). Therefore, it was of interest to test how 
heterodimerization with RXR affects the action of lR in oocytes. In this series of 
experiments, equimolar amounts of expression plasmids for human RXRa (hRXRa) 
and rTRa, or hTRI3, were microinjected into the oocyte nucleus, together with the tk-
TREp-CAT reporter construct. Employing TREp in this experiment allowed a direct 
comparison between activation by both TR and RXR with induction by TR alone, 
because TREp binds both TR monomers and homodimers, as well as RXRITR 
heterodimers (Forman et al., 1992, 1995b). As shown in Fig. 10, hRXRa enhanced 
constitutive reporter gene activation by both rlRa and hTRl3. 
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Figure 10. tk-TREp-CAT reporter gene transcription in the presence of hRXRa and 
rTRa or hTRB. Oocytes were microinjected with 2 ng tk-TREp-CAT only (reporter 
only), or together with varying amounts of hRXRa (RXR), rTRa (TRalpha) and 
hTRB (TRbeta) expression plasmids as indicated. Oocytes were incubated with and 
without hormone (+T3, -T3) for 24 h. and then analyzed individually by ELISA as 
described in Figure 8. 
reporter only 
2.5ng RXR 
0.5ng TRalpha 
o .5ng T RaJphalO .5ng RX R 
0.5ng TRbeta 
0.5ng TRbeta/0.5ng RXR 
2.5ng TRbeta 
2.5ng TRbeta/2.5ng RXR 
fold induction 
o ~ N 00 ~ ~ ~ ~ ~ ~ 
~ IlII 
+ I 
-1-1 
(0)(0) 
43 
Co expression of hRXRa. increased T3-independent and T3-mediated reporter gene 
activation by rTRa. to the same level. The presence of hRXRa. enhanced the 
constitutive activator function of hTRI3 (2.5 ng expression vector microinjected) to 
levels seen with unliganded rTRa. alone (0.5 ng expression vector). In addition, with 
hRXRa. present, hTRB activated the reporter gene in a T3-responsive manner to the 
same level as rTRa.. 
To summarize, both rTRa. and hTRf3 constitutively activated reporter gene 
transcription at five different TREs, while activation was further inducible by T 3 at a 
subset of TREs. Furthermore, co expression of hRXRa. enhanced both ligand-
independent and ligand-dependent activation by rTRa. and hTRf3 at TREp. An 
endogenous TR activity mediated weak T3-induction of TREp. 
(2) Only certain naturally occurring TREJ acted as control elements for repression 
by v-ErbA in tile presence or absence of Ts 
In mammalian and avian cells, TR activities are blocked by v-ErbA acting as a 
dominant repressor at the level of the TRE. However, this function of v-ErbA is not 
universal, but depends on cellular context (Privalsky et al., 1990; Smit-McBride and 
Privalsky, 1993). Potent suppression of basal transcription of T3-regulated genes in 
the absence of TR and T3 has also been shown in mammalian cells (Damm et al., 
1989; Damm and Evans, 1993), and has been implicated in v-erbA oncogenesis 
(Fuerstenberg et al., 1992; Privalsky, 1992; Sharif and Privalsky, 1991; Zenke et al., 
1990). I sought to establish the action of v-ErbA in Xenopus oocytes in two ways. 
The first series of experiments tested the competitive interaction between v-ErbA and 
rTRa. at naturally occurring TREs, by determining the extent to which v-ErbA was 
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able to dominantly repress TR-induced activation of the reporter gene constructs. 
The second set of experiments tested the ability of v-ErbA to suppress basal promoter 
activity of the reporter genes in the absence of TR and T3• 
Prior to experiments, I determined whether the v-erbA product is transcribed and 
translated in X enoplis oocytes, and whether it is targeted to the nucleus. Nuclear and 
cytoplasmic fractions were prepared manually for immunoprecipitation assays. The 
v-erbA expression plasmid was shown to direct the synthesis of a 75 kDa polypeptide 
which was predominantly recovered from the nuclear fraction using a monoclonal 
anti-v-erbA antibody (Fig. 11). This polypeptide is identical in size to that expected 
for the gag-v-erbA protein (Privalsky, 1992). This indicates that a full-length v-erbA 
product is synthesized in oocytes. Furthermore, the immunoprecipitation assays 
showed that the v-erbA product is correctly targeted to the nucleus in oocytes. 
Having determined that v-erbA is expressed in X enoplis oocytes, I then carried 
out a series of coinjection experiments to test the dominant repressor function of v-
ErbA. In both the presence and absence of T3, v-ErbA acted as a dominant repressor· 
of rTRa.-mediated CAT reporter gene transcription from IysTRE, maITRE, and TREp 
(Fig. 12A). Repression was most complete at TREp. The dominant action of v-
ErbA was dose-dependent, as a 5-fold excess of the v-erbA expression plasmid 
produced an even greater repression of TR-mediated induction of the reporter genes 
than an equal ratio of v-erbA and TR templates (data not shown). In contrast, v-
ErbA did not repress rTRa.-mediated transcription under the control of rGH3TRE 
(Fig. 12A). However, coexpression of the cofactor hRXRa. reduced transcription in 
the presence of rTRa. and v-ErbA at this TRE (Fig. 12A). 
In mammalian cells, v-erbA represses basal transcription of T3-responsive genes in 
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Figure 11. Immunoprecipitation of v-erbA protein from cytoplasmic and nuclear 
fractions. Oocytes microinjected with 2.5 ng v-erbA expression vector, and 
uninjected control oocytes, were cultured in O-R2 medium with 1 mCi/ml L_[35S] 
methionine for 20 to 24 h. Nuclei of v-erbA -injected oocytes were then manually 
isolated. Cytoplasmic (Cy) and nuclear (N) fractions of 20 v-erbA -injected oocytes, 
and homogenates of 20 uninjected whole oocytes (C), were incubated with protein G-
Sepharose-antibody complexes in an immunoprecipitation assay. Labelled 
polypeptides were recovered and separated electophoretically on 12% SDS-
polyacrylamide gels followed by fluorography. The 75 kDa gag-v-erbA protein 
(Privalsky, 1992) was predominantly immunoprecipitated from the nuclear fraction. 
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the absence of T3 (Damm et al., 1989; Damm and Evans, 1993). In the present 
study, v-ErbA did not act as a repressor of basal gene transcription under control of 
four different positively regulated TREs in oocytes (Fig. 12A). Repression of basal 
transcription by v-ErbA would have been detectable by the CAT ELISA employed, 
since the linear range of the assay (tested down to A405 -0.15) extended below the 
CAT protein levels observed due to basal promoter activity (A405 -0.23-0.3) (data not 
shown). The loss of this function by v-ErbA parallels the lack of repression of basal 
transcription by unliganded exogenous TR in oocytes. Importantly, expression of v-
erbA in oocytes abolishes its function as a repressor of basal promoter activity, but 
does not interfere with its dominant repressor potential. 
I showed that dominant repression by v-ErbA in the oocyte is a specific effect in 
the following ways. First, transcription levels of the AMTV -CAT reporter plasmid 
were unaffected by the presence of rTRa andlor v-ErbA with and without T3, 
showing that gene regulation by rTRa and v-ErbA is dependent on the presence of a 
TRE (Fig. 12A). Second, T3-dependent induction by rTRa of the AMTV-IysTRE-
CAT reporter gene was unaffected by the coinjection of the lacZ expression vector in 
place of the v-erbA construct (Fig. 12B). Both in the presence and absence of the 
lacZ vector, T3 enhanced reporter gene expression 1.5 fold over levels induced by 
unliganded rTRa. This control was performed at a 2-fold greater concentration of 
the lacZ vector (5 ng) compared with experiments using v-erbA construct (2.5 ng). 
Dominant repression by v-ErbA was thereby shown not to be caused by 'non-specific 
squelching' (Ptashne, 1988); i.e., essential transcription factors are not simply being 
titrated by the presence of an excess of v-erbA expression template. 
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Figure 12. Effects of v-ErbA on TRE-CAT reporter gene transcription. (A) 
Dominant repression of TR-mediated TRE-CAT reporter gene transcription by v-
ErbA in Xenopus oocytes. Oocytes were cultured in the presence or absence of 100 
nM T3 after microinjection with 2 ng ~TV-CAT or tk-CAT reporter gene construct 
linked to four different TREs as indicated, or 2 ng ~TV-CAT without a TRE, and 
0.5 ng rTRa. expression vector alone (TR/+T3, TRI-T3), or together with a 5-fold 
excess of v-erbA (2.5 ng) (v-erbAfIRI+T3, v-erbAfIRI-T3). Two ng rGH3TRE 
reporter construct plus 0.5 ng rTRa., 2.5 ng v-erbA, and 2.5 ng hRXRa. expression 
plasmids were also tested (v-erbA/TRlRXRI-T3, v-erbAfIRlRXRI+T3). In addition, 
2 ng TRE-CAT reporter gene construct was microinjected into the oocyte nucleus 
with 2.5 ng v-erbA expression plasmid, and oocytes were cultured without T3 (v-
erbAI-T3). Alternatively, oocytes were microinjected with reporter constructs alone, 
and incubated in the absence of T3 (-T3). After 24 h, oocytes were assayed 
individually for CAT protein by ELISA. Basal transcription rates of the CAT 
reporter constructs in the absence of exogenous TR, v-ErbA and T3 (-T3) were 
arbitrarily assigned the value 1. Two or 3 independent experiments (5 oocytes per 
treatment) were performed for each TRE-CAT reporter gene construct and the mean 
fold induction over basal transcription was calculated. The error bars indicate the 
SEMs. Differences in levels of reporter gene transcription were significant at p < 
0.0001. (B) T3-induction of lysTRE-CAT reporter gene transcription in the presence 
of rTRa. and lacZ expression plasmids. Oocytes were microinjected with 2 ng 
~TV-IysTRE-CAT reporter gene construct plus 0.5 ng rTRa. with or without 5 ng 
lacZ expression vector, as indicated, and incubated in the presence or absence of 100 
nM T3 (-T3/+T3). A single experiment with 5 oocytes per treatment was performed 
and analyzed as described for (A). (C) Constitutive trans-activation by v-ErbA at the 
clone 122 TREs. Oocytes were cultured with and without T3 after microinjection of 
2 ng pTPT-CAT plasmid, containing the clone 122 TREs linked to a tk-CAT reporter 
construct (tk-clone 122), or 2 ng ~TV-IysTRE-CAT plasmid, and 0.5 ng v-erbA 
expression vector (v-erbAI+T3, v-erbAI-T3). Alternatively, oocytes were 
microinj ected with reporter constructs alone, and incubated in the absence of T 3 
(-T3). Three independent experiments with 5 oocytes per treatment were performed 
and analyzed as described for (A). 
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The v-erbA protein binds T 3 only at very low affinity, due to several mutations in 
the C-terminal domain (Damm et al., 1989; Forrest et al., 1990; Privalsky et al., 
1988; Sap et al., 1989). Presumably, this lack of hormone binding would render v-
ErbA highly resistant to undergoing a ligand-induced conformational change. For 
this reason, I was interested to ascertain how v-ErbA acts at the clone 122 TREs in 
oocytes. In mammalian cells, T 3 inhibits the activator function and induces the 
repressor function of TR at this TRE (Bigler and Eisenman, 1994). I showed in the 
previous section that, in oocytes, TR· constitutively activated transcription at the clone 
122 TREs. I also observed constitutive trans-activation of the reporter gene construct 
by v-ErbA (Fig. 12C). This induction by v-ErbA was not significantly affected by 
T3• The v-erbA protein was also unresponsive to T3 at lysTRE in oocytes (Fig. 12C). 
In the previous section I reported that there was a weak T 3-dependent induction of 
the TREp-CAT reporter gene in the absence of exogenous TR, suggesting the 
presence of low levels of T3-regulated endogenous TR in oocytes. The T3-dependent 
reporter gene induction by endogenous TR was dominantly repressed to the same 
level by v-ErbA and a dominant negative in vitro-generated mutant of human TRB 
(TR CI22>A) (Fig. 13). This DNA-binding deficient mutant is thought to repress 
TR-mediated gene transcription by forming inactive dimers with TR (Nelson et al., 
1993). Therefore, dominant repression by TR C122>A suggests that endogenous TR 
was able to dimerize with the exogenous mutant TRB. The slight T3-dependence of 
transcription in the presence of TR C122>A was interpreted as not biologically 
significant, because of high sample variability. Repression of the reporter gene by v-
ErbA or TR C122>A was dependent on the presence of a TRE. The lacZ reporter 
gene, which lacks a TRE, was expressed at levels similar to those of the CAT 
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Figure 13. Dominant repression of an endogenous TR-like activity by v-ErbA or an 
in vitro-generated mutant of TR. Oocytes were microinjected with 2 ng of tk-TREp-
CAT reporter plasmid alone (none), or together with v-erbA or TR C122>A 
expression plasmids in the presence or absence of 100 nM T3 (+T3, -T3) in the 
combinations indicated. As a control, 2 ng RSV -lacZ reporter gene instead of tk-
TREp-CAT construct was coinjected with TR C122>A or injected alone (none). 
Relative reporter gene transcription was expressed in arbitrary units based on 
measurements of CAT or B-galactosidase protein levels by ELISA. Two independent 
experiments with 5 oocytes per treatment were performed. The error bars indicate 
the SEMs. Transcription levels of the RSV -lacZ construct did not differ significantly 
between treatments (p < 0.39). Transcription levels of the tk-TREp-CAT construct in 
the presence or absence of T3 were significantly different at p < 0.0001. 
RSV-lacZ 
tk-TREp-CAT 
+3ng TR C122>A 
none 
+3ng TR C122>A 
+3ng v-erbA 
none 
~ +T3 
II1II -T3 
0.0 0.1 0.2 0.3 0.4 0.5 
Relative reporter gene transcription 
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reporter gene, and was not repressed by either v-ErbA (data not shown) or TR 
C122>A (Fig. 13). 
In summary, my results show that v-ErbA displays an altered pattern of activity in 
oocytes, compared to both mammalian cells and the yeast, S. cerevisiae. v-ErbA did 
not repress basal reporter gene transcription, yet acted as a dominant repressor of TR 
action at the positively regulated TREs tested, with the exception of rGH3 TRE. At 
the clone 122 TREs, v-ErbA acted as a constitutive activator. 
(3) Pituitary-specific transcriptional regulation of rGHjTRE by rTRa and 
v-ErbA 
In a previous section, I showed that the T3-dependent activator function of rTRa 
was not induced at rGH3TRE in the presence of hormone (Fig. 8). Previous studies 
have shown that optimal transcription of the rat growth hormone gene (rGH) under 
control of TRE sequences in the promoter region is dependent on a cell-specific 
factor, Pit-lIGHF-l, binding at upstream elements (Lefevre et 01., 1987). Since the 
rGH gene is expressed only in somatotrophic cells of the anterior pituitary gland, 
gene regulation at rGH3TRE, the TRE from the third intron, presumably also requires 
cell-specific auxiliary factors, of known or unknown origin. For this reason, I sought 
to reconstitute the nuclear environment of anterior pituitary cells in oocytes. 
X enop"s oocytes possess the experimentally attractive feature of correctly targeting 
nuclear proteins, injected into the oocyte cytoplasm, to the nucleus (see, for example, 
Maxson et 01., 1988). In this experiment, nuclear protein extract from ovine anterior 
pituitary cells was injected into the oocyte cytoplasm five hours before nuclear 
microinjection of gene templates. 
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When oocytes were microinjected with nuclear protein extract, both the hormone-
independent and hormone-dependent activator functions of rTRa were induced at 
rGH3TRE (Fig. 14A). Surprisingly, under the same conditions, v-ErbA acted as a 
constitutive activator at rGH3 TRE, whose strength of activation exceeded that of 
rTRa (Fig. 14A). Increasing the amount of v-erbA expression template injected did 
not enhance this response further (data not shown). In contrast, v-ErbA did not 
affect basal promoter activity of this TRE-reporter construct in the absence of nuclear 
protein extract (Fig. 14A). 
These findings suggested that auxiliary factor(s), present in the injected nuclear 
protein extract from anterior pituitary cells, significantly altered the effect of both 
rTRa and v-ErbA on reporter gene regulation at rGH3TRE in oocytes. Two plausible 
candidates for this auxiliary role are the pituitary-specific transcription factor 
Pitl/GHF-l and RXR. To test this possibility, expression vectors for either Pit-II 
GHF-l or hRXRa were coinjected with rTRa or v-erbA constructs, and reporter gene 
transcription regulated by rGH3 TRE was assayed. Transcription was weakly induced 
by hRXRa alone, while Pit-IIGHF-l had no significant effect on basal promoter 
activity (Fig. 14B). The activity patterns of rTRa and v-ErbA observed in the 
presence of nuclear protein extract of anterior pituitary cells were not replicated in 
the presence of hRXRa or Pit-IIGHF-l (Fig. 14B). Instead, co expression of hRXRa 
or Pit-I, together with rTRa, reduced trans-activation of rGH3TRE (Fig. 14B) 
compared to levels of trans-activation by rTRa alone (cf. Figs. 12A and I4B). Pit-l 
repressed induction of rGH3 TRE by liganded rTRa below basal transcription (Fig. 
14B). Compared to levels in the presence of v-ErbA only (Fig. 14A), coexpression 
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Figure 14. Pituitary-specific transcriptional regulation of rGH3 TRE by rTRct and v-
ErbA. (A) Action of rTRct and v-ErbA at rGH3TRE in the presence of pituitary 
nuclear extract from ovine anterior pituitary cells. Oocytes were either microinjected 
with 20 nl of nuclear protein extract into the cytoplasm five hours before nuclear 
injection of gene templates (+PNE) or microinjected with the gene templates in the 
absence of nuclear protein extract (-PNE). Oocytes were then cultured in the absence 
or presence of 100 nM T3 (-T3, +T3) after microinjection with 2 ng AMTV-
rGH3TRE-CAT reporter gene construct alone (reporter only), or together with 0.5 ng 
rTRct (plus TR) or v~erbA expression vector (plus v-erbA). After 24 h, oocytes were 
assayed individually for CAT protein by ELISA. Basal transcription rates of the 
CAT reporter construct in the absence of nuclear protein extract, exogenous TR, v-
ErbA and T3 (reporter only, -PNE, -T3) were arbitrarily assigned the value 1. (B) 
Action of rTRct and v-ErbA at rGH3TRE in the presence of hRXRct or Pit-IIGHF-l. 
Oocytes were microinjected with 2 ng AMTV-rGH3TRE-CAT reporter gene construct 
only (reporter only, no co-factor), or together with 2.5 ng expression vector for either 
hRXRct (+RXR) or Pit-IIGHF-l (+Pit-l). Alternatively, 0.5 ng expression plasmid 
for rTRct (plus TR) or v-erbA (plus v-erbA) were microinjected with AMTV-
rGH3TRE-CAT, and 2.5 ng expression vector for hRXRct (+RXR) or Pit-IIGHF-l 
(+Pit-l) was added. Oocytes were cultured with and without T3 (+T3, -T3). After 24 
h, oocytes were assayed individually for CAT protein by ELISA. Basal transcription 
rates of the CAT reporter construct in the absence of co-factors and T3 (reporter only, 
no co-factor, -T3) were arbitrarily assigned the value 1. (A) and (B) Three 
independent experiments (5 oocytes per treatment) were performed and the mean fold 
induction over basal transcription was calculated. The error bars indicate the SEMs. 
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of hRXRa with v-ErbA induced transcription slightly, while Pit-1 had no effect (Fig. 
14B). With hRXRa present, transcription was induced equally by rTRa or v-ErbA. 
These effects were not further investigated, since this series of experiments was 
carried out to test hRXRa and Pit-1 as potential candidates for conferring positive 
T3-responsiveness on rTRa, and strong constitutive activator function on v-ErbA, at 
rGH3TRE. Taken together, these results suggest that auxiliary factor(s), other than 
RXR and Pit-l/GHF-1, present in nuclear protein extracts of anterior pituitary cells, 
are necessary for T3-induction of rGH3TRE by rTRa and conversion of v-ErbA into a 
constitutive activator at this TRE. 
4. Discussion 
(1) Botll a and.p isoforms of TR act as constitutive activators in oocytes 
In X enop"s oocytes, rTRa acted as a ligand-independent transcriptional activator at 
four positively regulated TREs (lysTRE, maITRE, TREp and rGH3 TRE). With the 
exception of rGH3TRE, addition of T3 led to a further increase in CAT reporter gene 
expression by rTRa. The 3.4 to 7-fold T3-dependent reporter gene induction 
observed in oocytes was comparable to activation in mammalian· cells (Baniahmad et 
al., 1992; Damm et al., 1989; Hermann et al., 1993). hTRll also acted as a weak 
hormone-independent activator at TREp, but was not further inducible by hormone. 
The observed differences in ligand-independent activation function between rTRa and 
hTRll are most likely due to structural divergence in the N-terminal domain (Glass 
and Rosenfeld, 1991). 
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Both ligand-independent and ligand-induced activation functions (Barettino et al., 
1994; Bigler and Eisenman, 1994; Forman et al., 1988; Forman and Samuels, 1990; 
Saatcioglu et al., 1993a) exhibit distinct cell type and promoter context specificity in 
TR and other receptors belonging to the steroid/thyroid hormone receptor gene 
superfamily (Privalsky et al., 1990; reviewed in Gronemeyer, 1992). Constitutive 
trons-activation by TR has also been shown in the yeast, S. cerevisiae (Privalsky et 
al., 1990; Smit-McBride and Privalsky, 1993), and in in vitro transcription assays 
using extracts from NT2 embryonal carcinoma cells or Namalwa B cells (Lee et al. 
1994a). Taken together with these results, the ligand-independent activation function 
of mammalian TRs in oocytes points to a possible requirement of inhibitory auxiliary 
factor(s) for transcriptional repression. The finding that gene activation by 
unliganded TR at the clone 122 TREs was not reversed by T 3 in oocytes, while being 
suppressed by ligand in CVl cells (Bigler and Eisenman, 1994), also points to a 
requirement for an inhibitory auxiliary factor for the suppression of trons-activation 
by TR. 
I have shown that hRXRa. enhances both ligand-independent and ligand-induced 
activation functions of rTRa. and hTRJ3 at TREp, in analogy to the enhancement of 
both activation functions of hTRJ3 by hRXRa. seen in the yeast (Lee et aI., 1994b). 
Thus, RXRa. is not the inhibitory factor in question. My results are in close 
agreement with recent evidence which suggests that an inhibitory factor suppresses 
trans-activation by unliganded TR in mammalian cells (Baniahmad et al., 1995;· 
Casanova et aI., 1994), and which also showed that RXR was not the major 
inhibitory factor in two cell lines tested (Casanova et al., 1994). More recently, two 
mammalian corepressors of TR and v-ErbA, N-CoR and SMRT, were identified by 
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two-hybrid screening in yeast (Chen and Evans, 1995; Horlein et al., 1995; 
Kurokawa et al., 1995). N-CoR and SMRT interact with the hinge domain of 
unliganded TR and v-ErbA to mediate transcriptional silencing, and are released from 
TR upon ligand binding. However, corepressor release by ligand occurred only at 
positive TREs, and it is presently unknown whether N-CoR and SMRT are involved 
in transcriptional repression by liganded TR at negative TREs. Thus, either N-CoR, 
SMRT, or a related corepressor, most likely constitutes the component missing in 
oocytes that is required for transcriptional repression by unliganded rTRa., hTRB and 
v-ErbA at positive TREs, and possibly also for repression by liganded rTRa. at the 
clone 122 TREs. 
The present study demonstrated that mammalian rTRa.lhRXRa. and hTRBIhRXRa. 
heterodimers constitutively activate transcription from a palindromic TRE linked to 
the viral tk promoter in Xenopus oocytes. Interestingly, heterodimers of X enop"s 
specific TRs (xTRs) and RXRs (xRXRs), expressed from microinjected mRNAs in 
Xenopus oocytes, strongly repress the T 3-inducible promoter of the Xenopus TRBA 
(xTRBA) gene in the absence of T3, and efficiently induce transcription in response to 
T3 (Wong and Shi, 1995; Wong et al., 1995). The 1.6 kb xTRBA promoter sequence 
contains a DR4 TRE which is located within the transcribed region, several other 
TREs with diverse half-site characteristics in the 5' region, and extensive flanking 
regions (Machuca et al., 1995; Ranjan et al., 1994; Wong et al., 1995). These 
elements might act in concert to mediate repression and activation by xTRlxRXR. 
The differential mode of action of mammalian and Xenopus TRJRXR heterodimers, 
at the TREp-tk and xTRBA promoters respectively, serves to highlight the importance 
of the chromatin environment around TRE binding sites for transcriptional regulation 
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by TR (Almouzni and Wolffe, 1993a~ Wong and Shi, 1995; Wong et al., 1995). In 
addition, and presumably unlike their mammalian counterparts, unliganded 
xTRlxRXR heterodimers might be able to directly inhibit the oocyte transcription 
machinery without requiring a corepressor(s). 
(2) Tire v-erbA protein displays a n0l1el pattem of acti11ity in oocytes 
Conversion of TR and v-ErbA into ligand-independent transcriptional activators 
has been shown to be mediated either by cell-specific protein-protein interactions 
(Forman et al., 1988; Privalsky et al., 1990), or by direct DNA binding (Saatcioglu et 
al., 1993a; Bigler and Eisenman, 1994). A constitutive activation function has also 
been identified in the N-terminal region of v-ErbA (Saatcioglu et al., 1993a). Under 
conditions that induce the constitutive activation function of TR, v-ErbA also acts as 
a constitutive activator in yeast (Privalsky et al., 1990), and in mammalian cells 
(Saatcioglu et al., 1993a). In contrast, I show here that the oocyte-specific cellular 
background induces the ligand-independent activation function of rTRa., but not of v- . 
ErbA, at four positive TREs, suggesting that induction of this function can be 
differentially controlled in TRa. and v-ErbA within the same cellular context. On the 
other hand, both rTRa. and v-ErbA constitutively activated reporter gene transcription 
at the complex clone 122 TREs (Fig. 15). This TRE belongs to the same class of 
response elements as the TRE found in the Rous sarcoma virus-long terminal repeat, 
which mediates strong T3-independent activation by TR and v-ErbA in BeLa cells 
(Saatcioglu et al., 1993a). Binding to this type of TRE induces a conformational 
change and renders the constitutive N-terminal activation domain accessible to the 
transcription machinery (Saatcioglu et al., 1993a). In summary, expression of TR 
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Figure 15. TRE-modulated action of v-ErbA in oocytes. The identity of the 
nucleotide residue at the fourth position of the two primary half-sites in rGH3 TRE is 
indicated (boxed italicized letter) (Chen et al., 1993). Intervening nucleotides 
between half-sites are indicated by numbers. Arrows indicate orientation of half-
sites. Differential levels of dominant repression are expressed in relative terms; 
(+++) indicates complete repression, (++) indicates moderate repression, and (+) 
indicates weak repression by v-ErbA. 
TRE·modulated action of v·ErbA in oocytes: 
1. Dominant repression 
TREp 
maiTRE 
Iy.TRE 
AGGTCA 0 TGACCT 
.......... ~~
GGGTT A 4 AGGACA 
-7 
TGACCC 6 AGGTCA 
:> 
2. No repression of TR function by v·ErbA alone 
IOH TRE AGG[!JAA 6 AGTCCC 6 AGG[[CA 
<E----- :> 
3. Activation 
.1 ••• 121 TRE. 
Strength or repre,,'on 
+++ 
++ 
.. 
(++; RXR corequlrement) 
TRE! TAAGCCCCCAGCCCCCCGACATCCAGGACGCCCCAAA 
TRE2 ATACCTTATTACCTCATCATGTGAAATAG 
~ 
TRE3 TCCGAGTGGACTCGGCTCGGTCATTGGGTG 
~ -------;7 
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and v-ErbA in oocytes induced the constitutive activation function only in TR at 
positive TREs, whereas this function was activated in both TR and v-ErbA at the 
clone 122 TREs in the same cellular context. It follows that the responses of the 
ligand-independent activation domains of TR and v-ErbA to cell-specific and TRE-
mediated induction are not equivalent. 
In oocytes, v-ErbA did not repress basal promoter activity under control of all four 
positive TREs tested (TREp, lysTRE, maITRE, and rGH3TRE). Like TR, the v-erbA 
protein possesses a repressor function located in the hinge domain (Damm and 
Evans, 1993). Transcriptional repression by TR is observed on minimal promoters 
containing a TATA box and TRE sequence (Baniahmad et ai., 1990, 1992), and cell-
free transcription assays have shown that unliganded TR functions as an active 
repressor of T3-responsive genes by inhibiting the formation of a functional 
preinitiation complex (Fondell et ai., 1993). Presumably, repression by TR and v-
ErbA occurs by a similar mechanism, namely, by interference with general 
transcription factors. In oocytes, protein-protein interactions between the repressor 
domain of v-ErbA and the general transcription machinery might be prevented by a 
lack of auxiliary inhibitory factor(s) or cell-specific characteristics of the general 
transcription complex. 
(3) Dominant negative repression by v-ErbA depends on tile nature of the TRE 
The action of v-ErbA at rGH3TRE has not been tested in mammalian cells to my 
knowledge. In oocytes, v-ErbA failed to repress TR-mediated induction at rGH3TRE. 
At the same time, v-ErbA dominantly repressed tllms-activation by TR at three other 
positive TREs with diverse half-site characteristics (maiTRE, lysTRE and TREp). 
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The TRE-modulated action of v-ErbA in oocytes is summarized in Fig. 15. Although 
both primary half-sites of rGH3TRE possess a favorable thymidine nucleotide at the 
fourth position (Chen et al., 1993; Sap et al., 1990), and the sequence of the major 
binding site is identical to the AGGTC/GA consensus motif (Fig. 15), it appears that 
v-ErbA does not successfully compete with rTRa for binding due to the structure of 
rGH3TRE. As shown by other workers, heterodimerization with RXR-related factors 
can be essential for the dominant negative action of v-ErbA (Chen and Privalsky, 
1993; Hermann et al., 1993). In the present study, a reduced level of trans-activation 
of rGH3TRE by rTRa and v-ErbA was observed in the presence of hRXRa. 
However, the significance of this finding is presently unclear, since hRXRa also 
reduced trons-activation by rTRa alone at this TRE. 
(4) An activity in nuclear protein extracts from anterior pituitary cells conferred 
T3-re,'ponsiveness to rTRa and converted v-ErbA into a constitutive activator 
at rGH3TRE 
My findings suggest that T3-induction of rGH3TRE is regulated in a cell-specific 
manner. In the presence of nuclear protein extract from anterior pituitary cells, the 
T3-dependent activation function of rTRa was induced at rGH3TRE in addition to T3-
independent tnms-activation by rTRa without extract. I showed that T3-
responsiveness of rTRa was not mediated by hRXRa or the pituitary-specific 
transcription factor Pit-IIGHF-1 which is required for efficient T3-induction of the 
growth hormone gene in somatotrophs (Lefevre et al., 1987). General mammalian-
type transcription factors might have been involved in conferring T 3-responsiveness 
to rTRa, since rGH3TRE is also T3-inducible in CVl cells (Sap et aI., 1990). The 
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tripartite rGH3TRE, although located in the third intron of the rat growth hormone 
gene, exhibits a markedly higher affinity for TR, as well as greater gene induction 
ability, than the TRE located in the promoter region of the gene, indicating an 
important in vivo role for this TRE sequence (Sap et al., 1990). Further indications 
of the importance of regulatory regions in introns are the presence of a 
glucocorticoid-responsive element in the first intron of the human growth hormone 
gene (Slater et al., 1985), and the requirement for the presence of introns in the rat 
growth hormone gene for efficient expression in transgenic animals (Brinster et al., 
1988). Interestingly, v-ErbA acted as an efficient constitutive activator at rGH3TRE 
in the presence of nuclear protein extract from anterior pituitary cells, whereas it had 
no effect on basal promoter activity under the control of rGH3 TRE without extract. 
Coexpression of Pit-lIGHF-l or hRXRa. did not replicate the mode of action of the 
v-erbA protein as a constitutive activator seen with the nuclear protein extract. This 
finding suggests that indirect or direct interactions with an as yet unidentified nuclear 
factor present in pituitary cells result in a conformational change in v-ErbA at 
rGH3TRE that induces its constitutive activation function. The conversion of v-ErbA 
into a constitutive activator by nuclear protein extract from anterior pituitary cells at 
rGH3 TRE suggests that the dominant negative phenotype of the v-erbA oncogene can 
be abolished by either direct or indirect interactions with other nuclear .factors. My 
experimental approach illustrates how studies of exogenous receptors in oocytes, in 
conjunction with microinjected auxiliary proteins, may contribute to the 
characterization of cell-specific and TRE-mediated mechanisms that modulate the 
action of receptor domains. 
m. 
The v-erbA Oncogene Initiates Early and Intennediate Events of Meiotic 
Maturation in Xenopus Oocytes 
1. Introduction 
This chapter presents evidence to suggest that a direct link may exist between partial 
growth factor autonomy conferred by v-ErbA and induction of gene(s) normally 
controlled by mitogenic signalling networks. I show that v-ErbA can initiate the 
release from G2 cell cycle arrest in stage VI (Dumont, 1972) Xenopus oocytes by 
activating gene expression. Ultrastructural analysis of v-erbA -expressing oocytes 
revealed transformations of the nuclear membrane indicative of early and 
intermediate stages of meiosis, while chromosome condensation and spindle 
formation did not occur. A portion of v-ErbA was localized to the cytoplasmic 
fibrils of the nuclear pore complexes, which raises the possibility that v-ErbA might 
affect the nucleocytoplasmic transport of a cell cycle regulator. 
At the beginning of the introduction, the present model of growth-promotion by v-
ErbA is reviewed. The following sections describe the regulation of meiotic 
pathways by progesterone or by introduced oncogenic proteins, and the 
Abbreviations used in this chapter: AL, annulate lamellae; AP-l, activator protein-I; 
GVM, germinal vesicle migration; GVBD, germinal vesicle breakdown; IBMX, 
isobutylmethylxanthine; MPF, maturation-promoting factor; MAPK, mitogen-
activated protein kinase; NPC, nuclear pore complex; NLS, nuclear localization 
signal; RAR, retinoic acid receptor; TR; thyroid hormone receptor. 
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accompanying structural changes in the nucleus and the nuclear membrane. In 
addition, the structure of nuclear pore complexes and their function in 
nucleocytoplasmic transport is illustrated. 
(1) Deregulation ofproliferatil'e controls by l'-ErbA 
Neoplastic transformation is mediated by the disruption of the signalling networks 
which regulate cellular proliferation and differentiation. Extensive interference with 
cellular growth control is exemplified by the cooperative action of v-erbA and its 
retroviral partner v-erbB, both carried by the avian erythroblastosis virus (AEV), 
which together induce acute erythroblastosis and fibrosarcomas in young chicks (Graf 
and Beug, 1983). The v-erbB gene, a truncated version of the chicken epidermal 
growth factor receptor, is necessary and sufficient for the transformation of chicken 
embryo fibroblasts by AEV (Sealy et al., 1983; Frykberg et al., 1983). v-ErbB 
initially induces proliferation of erythroid stem cells, but does not block their 
differentiation program (Frykberg et al., 1983). As a consequence, erythrocytic cells 
transformed by viruses carrying only the v-erbB oncogene spontaneously differentiate 
at a high rate and stop multiplying (Frykberg et al., 1983; Yamamoto et al., 1983). 
v-erbA, acting in conj unction with v-erbB, is able to block differentiation and to 
inhibit the expression of genes required for the mature phenotype (Fuerstenberg et al., 
1992; Schroeder et al., 1990; reviewed in Privalsky, 1992; Damm, 1993). v-ErbA 
arrests the stem cells transformed by v-ErbB at the CFU-E (colony-forming unit-
erythroid) stage (Samarut and Gazzolo, 1982; Beug et al., 1982) and thereby 
maintains their proliferative potential (Frykberg et al., 1983). Other oncogenes 
encoding cytoplasmic proteins, like v-src, v-jps, v-sea, and v-Ha-ras are able to 
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replace v-erbB by cooperating with v-erbA in erythroid transformation (Kahn et aI., 
1986). 
As described in detail in Chapter II, the v-erbA product dominantly represses the 
actions of normal TR and RAR While chicken embryo fibroblasts expressing only 
v-erbA do not display a fully transformed phenotype, they exhibit a greatly enhanced 
growth potential and a decreased requirement for growth factors (Gandrillon et al., 
1987). These growth-promoting properties of v-ErbA have so far exclusively been 
linked to dominant repression of the anti-mitogenic roles of TR and RAR. This 
mode of action is indicated by the fact that v-erbA is able to stimulate proliferation 
by overcoming growth inhibition by retinoic acid (Sharif and Privalsky, 1991). In 
this context, v-erbA function is strongly correlated with its action as a dominant 
negative oncogene in abrogating AP-1 repression by RAR and TR (Desbois et al., 
1991a, 1991b; Zhang et al., 1991). Furthermore, v-erbA renders erythrocytic 
progenitor cells insensitive to the induction of apoptosis, and of self-renewal 
inhibition, by retinoic acid and thyroid hormone (Gandrillon et al., 1994). 
(2) Meiotic induction of Xenopus laevis oocytes by progesterone and 
oncogene products 
Oncogene involvement in the signal transduction events of the cell cycle can be 
studied by maturation assays carried out in oocytes from Xenopus laevis. Fully 
grown oocytes are arrested at the G/M border and can be induced to enter M-phase 
by progesterone, insulin, or a range of introduced oncogene products (reviewed in 
Smith, 1989; Daar et al., 1991; Graziani et aI., 1992; Grieco et al., 1995). Within 
minutes of progesterone exposure, a decrease in levels of cyclic AMP (cAMP) 
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occurs, mediated by inhibition of adenylate cyclase, which in turn downregulates 
protein kinase A (PKA) and protein kinase C (PKC) activities (Smith, 1989; Matten 
et al., 1994). Following hormonal stimulation, de novo translation of c-mos kinase 
occurs (Sagata et al., 1988; Yew et al., 1992; Sheets et al., 1995) and a number of 
other cytoplamic kinases are activated, including Raf-l serine-threonine kinase 
(Fabian et aI., 1993; Muslin et al., 1993b), phosphatidylinositol 3-kinase (Muslin et 
al., 1993a) and MAPK kinase (Mordret, 1993; Posada et al., 1993; Kosako et al., 
1994a, 1994b). These phosphorylation cascades culminate in the activation of 
maturation-promoting factor (MPF) and mitogen-activated protein kinase (MAPK). 
MPF and MAPK trigger the events of maturation, including germinal vesicle 
breakdown (GVBD), chromosome condensation, and meiotic spindle formation, either 
directly or by activating other protein kinases (Bement and Capco, 1990; Smith, 
1989). MPF contains the Xenopus homolog of the universal M-phase inducer p34cdc2, 
a serine-threonine kinase with histone HI phosphorylating activity, which is 
complexed with B-type cyclins (Gerhart et al., 1984; Maller, 1990; Minshull et al., 
1991). 
There is growing evidence for the existence of several complementary control 
pathways which regulate partially overlapping sets of events at the G/M transition. 
In particular, early maturation events, occurring prior to chromosome condensation, 
can be induced in progesterone-treated oocytes in the absence of protein synthesis 
(Baltus et al., 1973; Drury and Schorderet-Slatkine, 1975); membrane 
vesicularization, lamin disassembly and chromosome condensation are independent 
processes (Newport and Spann, 1987; Bement and Capco, 1990); GVBD can occur in 
the absence of active CDC2 in mouse oocytes (Choi et al., 1991; Gavin et al., 1992, 
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1994); and GVBD and white spot formation in X enoplis oocytes can be 
biochemically separated (Muramatsu et al., 1989; Waldmann et al., 1990). In 
addition, GVBD in X enoplis oocytes and a pseudomitotic phenotype in HeLa cells 
are inducible by a cdc2-independent, NIMA-like pathway (Osmani et al., 1991a, 
1991b; Lu and Hunter, 1995). 
(3) Nuclear envelope dynamics during tire cell cycle 
The nuclear membrane of eukaryotic cells separates the genome from the 
cytoplasm. This separation permits additional levels of regulation which are absent 
in prokaryotic cells, and thus constitutes a major landmark in evolution (Dingwall 
and Laskey, 1992). The nuclear membrane consists of two concentric lipid bilayers, 
which are perforated by nuclear pore complexes (NPCs) that serve as channels for 
molecular exchanges between the nucleus and cytoplasm. The inner nuclear 
membrane is lined by the nuclear lamina, composed of a network of lamin proteins, a 
specialized type of intermediate filament protein (reviewed in Dingwall and Laskey, 
1992). At the beginning of M-phase in almost all eukaryotic cells, the nuclear DNA 
dissociates from the nuclear envelope and condenses to form compact chromosomes. 
In eukaryotic cells that undergo an open mitosis, the nuclear envelope vesicularizes 
and the nuclear lamins depolymerize. At the completion of mitosis, these membrane 
vesicles and lamin proteins bind to the surface of condensed DNA and reestablish an 
intact nuclear envelope (reviewed in Gerace and Foisner, 1994; Goldberg and Allen, 
1995; Dingwall and Laskey, 1992). Of all the mitotic rearrangements that occur, the 
disassembly of the nuclear lamina is the best understood, whereas almost nothing is 
known about the mechanisms of membrane vesicularization and nuclear pore 
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disassembly. 
The X enoplis oocyte nuclear membrane is an attractive model system for the 
investigation of dynamic interactions of its components during the passage through 
the cell cycle (reviewed in Gerace and Foisner, 1994). The nuclear membrane of the 
X enop"s oocyte possesses several specialized features, i.e., a high density of NPCs 
(Scheer et al., 1976), and a nuclear lamina composed of a single lamin isomer 
(Benavente et al., 1985; Stick and Hausen, 1985); moreover, the large size of the 
oocyte nuclei allows the manual isolation of nucler membranes (Krohne and Franke, 
1983). Cell-free systems, based on extracts from mature Xenopus eggs in either a 
mitotic or an interphase state, have allowed the elucidation of a number of processes 
involved in nuclear disassembly (see, for example, Lohka and Maller, 1985; 
Macaulay et al., 1995; Miake-Lye and Kirschner, 1985; Newport and Spann, 1987; 
Pfaller et al., 1991; Pfaller and Newport, 1995; reviewed in Gerace and Foisner, 
1994) and nuclear reassembly respectively (see, for example, Lohka and Masui, 
1984; Burke and Gerace, 1986; Newport, 1987; Pfaller et al., 1991; Pfaller and 
Newport, 1995; reviewed in Almouzni and Wolffe, 1993b). Importantly, employing 
cell-free nuclear disassembly systems, it has been possible to dissociate GVBn from 
chromosome condensation (Newport and Spann, 1987). Lamina disassembly appears 
to be necessary but not sufficient for GVBn (Newport and Spann, 1987), and is 
controlled by reversible phosphorylation of lamin proteins (Miake-Lye and Kirschner, 
1985; Burke and Gerace, 1986; Gerace and Blobel, 1980). MPF, the pivotal 
regulator of mitosis, is thought to playa direct role in the phosphorylation of the 
lamins at the onset of M-phase (Peter et al., 1990). Finally, nuclear reassembly can 
be studied in X enoplis egg extracts. These extracts, which contain large stockpiles of 
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disassembled nuclear components, readily reconstitute nuclei around condensed 
chromosomes in vitro; a process which occurs with astonishing spontaneity (Lohka 
and Masui, 1983; Burke and Gerace, 1986; Newport, 1987). 
Annulate lamellae (AL), an additional intracellular membrane compartment, are 
found in the cytoplasm and consist of stacks of flattened membranes perforated by 
numerous and densely packed pore complexes (Kessel, 1992). AL are especially 
numerous in rapidly growing cells, such as male and female gametes, tumour cells 
and virally infected cells. AL are believed to store excess nuclear envelope and NPC 
components for later use, but might have additional functional roles (Kessel, 1992). 
AL disassemble, along with the oocyte nucleus, during meiotic maturation (Stafstrom 
and Staehelin, 1984; Bement and Capco, 1989; Kessel and Subtelny, 1981). During 
this process, pore complexes disappear and the membrane is transformed into 
distended cisternae (Kessel and Subtelny, 1981). The significance of these structural 
alterations remains unknown. 
(4) Structure and function of nuclear pore complexes 
Nucleocytoplasmic transport plays a fundamental role in coordinating the functions 
of the nucleus and the cytoplasm (reviewed in Melchior and Gerace, 1995; Stochaj 
and Silver, 1992). Transport across the nuclear envelope is carried out by the NPCs 
which are believed to be similar in both structure and function in all eukaryotic 
organisms from yeast to mammals (reviewed in Forbes, 1992; Gerace, 1992; Hurt, 
1993; Rout and Wente, 1994). The nuclear pore is a highly selective channel 
through which macromolecules must pass to enter or exit the nucleus (reviewed in 
Hinshaw, 1994). Most proteins are too large to diffuse through the NPCs and are 
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actively transported through gated channels in the NPCs by signalwmediated 
mechanisms (reviewed in Guiochon-Mantel and Milgrom, 1993; Melchior and 
Gerace, 1995; Stochaj and Silver, 1992). Mediated import of proteins into the 
nucleus is specified by short stretches of amino acids known as nuclear localization 
sequences (NLSs). NLSs do not possess a clear consensus sequence, but most NLSs 
are highly enriched in basic amino acids, and may be continuous, as in the simian 
virus 40 (SV 40) large T antigen, or bipartite, as in nucleoplasmin (Boulikas, 1994; 
LaCasse and Lefebvre, 1995; reviewed in Dingwall and Laskey, 1991). NLS-
mediated nuclear import of proteins can be viewed as a two-step process, consisting 
of ATP-independent binding to the NPC, followed by ATP-dependent translocation 
through the pore channel (GOrlich et al., 1994; Newmeyer et al., 1986a, 1986b; 
Newmeyer and Forbes, 1988; Richardson et al., 1988). 
The NPC has dimensions of ~120 x 80 nm and a mass of ~125 x 106 D (Reichelt et 
al., 1990), and may contain up to 100 different polypeptides (Rout and Wente, 1994). 
Of these pore proteins, only a small number have been identified to date (reviewed in 
Rout and Wente, 1994; Doye and Hurt, 1995). Three-dimensional image 
reconstruction suggests that NPCs are comprised of nuclear and cytoplasmic rings, 
with eight spokes radiating toward a central transporter apparatus (Hinshaw et al., 
1992; Hinshaw, 1994) (Fig. 16). A "central channel complex" is attached to the 
inside of the spokes and contains the gated channel involved in signal-mediated 
transport of macromolecules (Forbes, 1992; Hinshaw, 1994; Hinshaw et al., 1992; 
Melchior and Gerace, 1995). In addition, sets of fibrils emanate from both the 
nucleoplasmic and cytoplasmic rings (Forbes, 1992; Richardson et al., 1988; Ris and 
Malecki, 1993). In isolated nuclear envelopes of amphibian oocytes, the 
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Figure 16. Transverse thin section of a nuclear pore complex (NPC) in an isolated 
nuclear membrane from a stage V (Dumont, 1972) Xenopus oocyte. NM, nuclear 
membrane; CR, cytoplasmic ring; T, central transporter; CF, cytoplasmic fibrils; NF, 
nucleoplasmic fibrils. Bar: 50 nm. 
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nucleoplasmic fibrils, which are ~75-100 nm long, are joined at their distal ends in a 
basket-like structure (Jarnik and Aebi, 1991; Goldberg and Allen, 1992), whereas the 
structurally distinct cytoplasmic fibrils are <25-50 nm long and have no obvious 
distal connections (Forbes, 1992) (Fig. 16). The initial binding of NLS-bearing 
proteins, complexed with cytoplasmic transport factors, is thought to occur at the 
fibrils at the cytoplasmic rings of the NPCs (reviewed in Melchior and Gerace, 
1995). 
NPCs perform a crucial role in controlling cellular processes, and mutations in 
NPC proteins can cause nuclear transport defects, extensive changes in nuclear 
membrane structure, and abnormal nuclear migration in the yeast Saccharomyces 
cerevisiae (see, for example, Bogerd et al., 1994; for a recent review, see Doye and 
Hurt, 1995). Interestingly, certain viral proteins can modulate nucleocytoplasmic 
transport of mRNA. For example, the adenoviral EIB protein, bearing a NLS and 
localized at NPCs, inhibits export of host transcripts, while promoting export of viral 
mRNA (Liang et al., 1995). Other recent studies showed that the fibrils emanating 
from the cytoplasmic face ofNPCs contain the proteins CAN/nup214 (Fomerod et 
al., 1995; Kraemer et al., 1994) and TPRlnup265 (Byrd et al., 1994), which have 
both been associated with oncogenesis in humans when fused to other genes. Thus, 
oncogenes may be capable of inducing oncogenesis by altering the functions of 
NPCs. 
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(5) Summary of results 
To assess whether v-ErbA can interfere directly with cell cycle control pathways, I 
investigated the effects of expression of v-erbA in Xenopus oocytes. This study 
showed that v-ErbA initiates early to intermediate meiotic events in Xenopus oocytes. 
v-ErbA induced a rearrangement of pigment in the animal hemisphere resembling the 
meiotic white spot and extensive ultrastructural meiotic changes in the architecture of 
the nuclear membrane, annulate lamellae, and the nucleoli, while chromosome 
condensation and spindle formation did not occur. Meiotic induction by v-ErbA was 
not mimicked by a dominant negative in vitro-generated mutant of TR, suggesting 
that release from G2 cell cycle arrest by v-ErbA was not mediated by dominant 
repression of endogenous TR. Furthermore, v-ErbA-initiated maturation was 
independent of the cAMPIMPF signal pathway, but required de novo gene 
expression. Interestingly, the v-erbA protein was partially localized to NPCs by 
immunogold labelling. A novel function is proposed for v-ErbA by which it might 
disrupt nuclear mitogenic controls. 
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2. Materials and Methods 
(1) P1asmids 
RS-v-erbA, RSh-TRl3 C122>A and pRSV-IacZ are described in Chapter II, 
Materials and Methods. The pKCR2-cea plasmid was a gift of B. Vennstrom 
(Karolinska Institute, Stockholm, Sweden), and contains the chicken c-erbA eDNA 
expressed from the SV40 promoter (Sap et al., 1989). The pGEM-4Z vector was a 
gift of M. Privalsky (University of California, Davis, CA), and contains the gag-v-
erbA eDNA under control of the SP6 promoter. The V3 clone was a gift of A. 
Munoz (Instituto de Investigaciones Biomedicas, Madrid, Spain). The chimeric v-/c-
erbA clone V3 contains the retroviral gag sequence in the SacI-DrallI fragment of v-
erbA joined to the subsequent DraIlI-ApaI fragment of c-erbA under control of the 
phage T7 promoter (Munoz et al., 1988). 
(2) Oocyte microinjections 
A lobe of ovary was surgically removed from an adult female X enoplIs laevis and 
processed as described in Chapter II. Microinjections were performed according to 
published methods with modifications (see Chapter II). Defolliculated stage VI 
(Dumont, 1972) Xenopus laevis oocytes were microinjected with 5 ng v-erbA 
expression vector alone or with 2 ng pRSV -lacZ, or with 5 ng pRSV -lacZ as a 
control, in a fixed volume of 20 nl TE (10 mM Tris-HCI, pH 8.0, 1 mM EDTA) into 
the nucleus by the 'blind' injection method with the needle inserted in the center of 
the animal pole. Alternatively, 5 ng V3 mRNA in a fixed volume of 50 nl TE, pH 
7.6, was injected into the cytoplasm. In addition, internally labelled v-erbA protein 
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was synthesized by Caroline F. Bunn from the pGEM-4Z template by in vitro 
coupled transcription/translation in rabbit reticulocyte lysate (Promega, Madison, WI) 
according to the manufacturer's specifications, using SP6 polymerase. Oocytes were 
incubated in cycloheximide (200 ~g/ml) or actinomycin D (30 ~g/ml) for 16 h, and 
subsequently microinjected into the cytoplasm with 50 nl v-erbA solution 
(approximately 100 pg v-ErbA in rabbit reticulocyte lysate). This procedure was also 
carried out by C. F. Bunn. 
(3) ELISA 
Thirty-six hours after microinjection of 2 ng pRSV-lacZ and 5 ng RS-v-erbA, 
healthy oocytes (uniform pigment, not mottled) were homogenized singly in 200 ~l 
0.25 M Tris buffer, pH 7.5, and centrifuged at 10,000 x g in a microfuge at 4°C for 
10 min. The supernatant was then centrifuged as before. This extract was used in 
the determination of I3-galactosidase protein expression levels by enzyme linked 
immunosorbant assay (ELISA) according to the manufacturer's specifications (5 
Prime-3 Prime, Boulder, CO), and as described in Chapter II. This assay was 
repeated two times with oocytes from different animals since there can be variability 
in transcriptional activity between different batches of oocytes (see Chapter II). For 
each assay, a standard curve utilizing four pure protein standards was prepared, to 
ensure that I3-Gal concentrations of sample extracts fell within the linear range of the 
assay. The data on reporter gene expression levels were analyzed by nested analysis 
of variance (ANOV A) controlling for variability between females and between 
independent ELISA assays. 
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(4) Incubation treatments and assessment of germinal vesicle movement and 
germinal vesicle breakdown 
Oocytes were incubated in (i) O-R2 medium (Allison et al. 1991) only; or (ii) 
progesterone (10 ~g/ml) (Sigma, Chemical Co., St Louis, MO); (iii) taxol (10 ~g/ml) 
(Sigma); (iv) forskolin (20 ~M) (Sigma) and isobutylmethylxanthine (IBMX; 2 mM) 
(Sigma); (v) cycloheximide (200 ~g/ml) (BDH Chemicals NZ Ltd., Palmerston 
North, New Zealand); or (vi) actinomycin D (30 ~g/ml) (actinomycin CI; Boehringer 
Mannheim NZ Ltd., Auckland, New Zealand) in O-R2. Twenty-four hours after 
microinjection with 5 ng RS-v-erbA, pRSV-IacZ, or 50 nl v-erbA protein solution, 
and/or a 24-hour incubation treatment ([i]-[viD, oocytes were scored for germinal 
vesicle movement (GVM, white spot) under a stereomicroscope. Oocytes were 
assessed for germinal vesicle breakdown (GVBD) by manual dissection after fixation 
in ice-cold 1% trichloroacetic acid (TCA) for 5 min. Oocytes were scored positive 
for GVBD when the nucleus could not be dissected intact due to nuclear instability. 
(5) Differential interference contrast microscopy 
Oocytes, incubated in progesterone, or microinjected with 5 ng RS-v-erbA, RSh-
TR13 CI22>A, or unrelated RSV-IacZ template, were fixed and embedded essentially 
as described by Hausen and Riebesell (1991). In brief, oocytes were fixed in Romeis 
fixative (25 ml saturated mercuric chloride, 20 ml 5% trichloroacetic acid, 15 ml 
37% formaldehyde) for three hours. Subsequently, oocytes were dehydrated in an 
ethanol series of 50% (15 min), 70% (30 min), 80% (15 min), 90% (15 min), 95% 
(15 min), and 100% (3 x 10 min); then infiltrated in 50% glycol methacrylate 
infiltration solution (Polaron) in ethanol for 1 hour and left in 100% infiltration 
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solution overnight. Oocytes were embedded in glycol methacrylate (Polaron) in 
gelatine capsules under nitrogen at 37°C for 5 hours. Five micron sections were 
obtained with Ralph glass knives. In order to remove mercury precipitates, the dry 
sections were treated with an alcoholic iodine potassium iodide solution (2% iodine, 
3% potassium iodide in 90% ethanol) for 2 min, washed in 0.25% sodium thiosulfate 
for 15 min, and thoroughly rinsed in distilled water. The sections were stained 
utilizing an azofuchsin/aniline blue/orange G triple staining method (Hausen and 
Riebesell, 1991). Three independent batches of oocytes were used, and 3 to 4 
oocytes per treatment/per batch were analyzed using differential interference contrast 
mIcroscopy. Oocyte sections were photographed using Agfa optima color film with a 
blue filter. 
(6) Electron microscopy for ultrastructural analysis 
In ultrastructural studies of Xenopus oocytes, long fixation times and special 
fixation procedures are necessary. Unless indicated otherwise, all procedures were 
carried out at 4°C. Oocytes were fixed in 2.5% glutaraldehyde and 0.05% low 
molecular weight tannic acid in O-R2 overnight. Oocytes were then washed in 
O-R2 three times for 30 min, and subsequently transferred to 2% OS04 (in ddH20) 
for 3 hours with one change. Oocytes were then washed in O-R2 for 30 min, and 
dehydrated in a graded ethanol series of 30% (30 min), 50% (30 min), 70% 
(overnight), 80% (20 min), 90% (20 min), 95% (15 min), and 100% (2 x 15 min). 
After the 70% ethanol step, all further procedures were carried out at room 
temperature. Oocytes were incubated in 100% acetone twice for 20 min, and then 
gradually embedded in Spurr's resin in acetone: 30% resin (1 hour), 50% resin 
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(3 hours), 70% resin (overnight), 90% resin (8 hours), and 100% resin (overnight). 
Oocytes were transferred into 100% resin in molds and cured at 70°C for 24 hours. 
Ultra-thin sections (50 nm) were stained with 5% uranyl acetate in 50% ethanol for 
20 min, washed in ddH20, stained with lead citrate for 20 min, and put through a 
final washing step in ddH20. 
(7) Histone Hl kinase assay 
Adult female X enop"s laevis were injected with 0.5 ml gonadotropin (from 
pregnant mares' serum, Sigma; 200 Vlml in sterile ddH20) subcutaneously into the 
dorsal lymph sac, to improve the synchrony of response to progesterone in oocytes. 
After four days, a lobe of ovary was surgically removed from the animal and 
processed as described above. Defolliculated stage VI (Dumont, 1972) oocytes were 
microinjected into the nucleus with 5 ng RS-v-erbA or incubated in progesterone (10 
Ilg/ml). At specified times, oocytes extracts were prepared by homogenizing groups 
of 10 oocytes in 20 III extraction buffer (20 mM Tris, pH 7.5, 80 mM 13-
glycerophosphate, 20 mM EGTA, 15 mM MgC12, 25 Ilg/ml aprotinin, 25 Ilg/ml 
leupeptin, 1 mM benzamidine, 0.5 mM phenylmethylsulfonyl fluoride [PMSF], 5 mM 
Pefabloc [Boehringer Mannheim], and 1 mM dithiothreitol [DTTD. The homogenate 
was centrifuged at 10,000 x g for 10 min at 4°C to pellet yolk and pigment. Ten 
microliters of the supernatant were mixed and incubated for 20 min at 25°C with 10 
III kinase buffer (30 mM Tris, pH 7.5, 30 mM MgC12, 1 mCi/ml yC2p] ATP 
[Amersham] , 3 mg/ml histone HI [SigmaD (Kosako et al., 1994b). The reaction was 
stopped by the addition of an equal volume of 2 X SDS sample buffer (4% SDS, 
20% glycerol, 120 mM Tris, pH 6.8, 0.01 % bromophenol blue) and boiling for 5 
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min. Samples were resolved by 12% SDS-polyacrylamide electrophoresis followed 
by autoradiography. 
(8) In vitro transcription of tire V3 construct 
The plasmid containing the chimeric v-/c-erbA gene V3 under the control of the 
phage T7 promoter was linearized with Eco RI, extracted with phenol-chloroform and 
precipitated. Transcription was carried out with 1 III T7 RNA polymerase (50 U/IlI, 
Epicentre) in 4 III 5X T7 RNA polymerase buffer (Epicentre), 2 III DDT (100 mM), 
1 III RNasin (40 U/IlI) (Promega), 0.6 III of each of the four ribonucleotide 
triphosphates (100 mM), 3 III 7mGpppG (20 mM) (New England Biolabs), and 1 III 
template DNA at a concentration of 1 Ilg/IlI, for Ih at 37°C. The mixture was then 
incubated with 1 III of RNase-free DNase (10 U/IlI) (Boehringer) in 9 III DNase 
dilution buffer for 15 min at 37°C. The reaction was stopped by heating the mixture 
to 65°C, and the mRNA was precipitated with 2 III 4 M LiCI and 60 III of 100% 
ethanol, prechilled at -20°C, for 30 min at -80°C. The RNA was pelleted by 
centrifugation at 12,000 x g for 10 min, washed with cold 70% ethanol, dried under 
vacuum, and dissolved in 5 III TE, pH 7.6. 
(9) Immunoprecipitation of oocyte fractions witlt an anti-v-erbA antibody 
Oocytes were micro injected with 5 ng RS-v-erbA, pKCR2-cea expression plasmid 
into the nucleus, or 5 ng V3 mRNA into the cytoplasm, and incubated in a sterile 
microtitre plate (5 oocytes/well) in 30 III of O-R2 with 1 mCi/ml L_[35S] methionine 
(1000 Ci/mmol, Amersham Pty Ltd., Auckland, New Zealand) at 18°C for 24 h. 
Nuclear fractions of 10 or 20 pooled v-erbA -injected oocytes were prepared manually 
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as described in Chapter II, after fixation in 1 % ice-cold TCA for 5 min. Samples 
were homogenized in 0.5 ml NET-2 (Allison et aI., 1993) containing 0.1 mM PMSF. 
For pr.eparation of nuclear membrane fractions, nuclei were manually isolated in 
nuclear isolation medium (NIM; 83 mM KCI, 17 mM NaCl, 10 mM Tris, pH 7.2, 5 
mM Pefabloc) (Krohne and Franke, 1983) in a small siliconized petri dish, using 
watchmaker's forceps. Nuclei were freed from adhering yolk by aspirating them into 
a pipette with an inner bore diameter of 0.7-0.8 mm, then washed once in fresh NIM 
and transferred into nuclear envelope isolation medium (NEM; 83 mM KCI, 17 mM 
NaCl, 10 mM MgCI2, 10 mM Tris, pH 7.2.5 mM Pefabloc). Within 30-60 s, the 
nuclear content forms an opaque and compact aggregate from which the nuclear 
membrane ( envelope) detaches. The nuclear membranes were isolated by aspirating 
nuclei into a pipette with an inner bore diameter of 0.3-0.4 mm, cleaned in fresh 
NEM by repeated aspiration into a small pipette and transferred into a microfuge 
tube. Ten or 20 nuclear envelopes were pooled per sample and collected by 
centrifugation for 4 min at 8,000 x g and resuspended by gentle aspiration in 0.5 ml 
NET -2 containing 5 mM Pefabloc. 
For total soluble protein electrophoretic separations, 20 ~l 2 X SDS sample buffer 
and 1 mM DTT were added to 20 ~l homogenate from nuclear and nuclear 
membrane fractions, which were then resolved by 12% SDS-polyacrylamide gel 
electrophoresis and stained with Bio-Rad Silver Stain (Bio-Rad Laboratories Pty Ltd., 
Auckland, New Zealand). Immunoprecipitations of the nuclear fraction and nuclear 
envelope samples were carried out as described in Chapter II, using 30 ~l of 
monoclonal antibody LA038 against v-erbA residues 58-75. 
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(10) Immunolabelling of isolated nuclear membranes 
Oocytes were microinjected with 5 ng RS-v-erbA or pKCR2-cea into the nucleus 
and incubated in O-R2 for 12 to 14 h. Nuclear membranes of 20 oocytes per sample 
were manually isolated as described above, and fixed in 2% formaldehyde, freshly 
made from paraformaldehyde in PBS (137 mM NaCI, 1.3 mM N~HP04' 2.5 mM 
NH2P04, pH 7.2), for 10 min at 4°C. Immunolabelling with colloidal gold, 
employing a biotin-streptavidin bridging technique, was carried out following 
published procedures (Cordes et al., 1993) with modifications, and according to the 
manufacturer's specifications (Amersham). Membranes were collected by 
centrifugation at 8,000 x g for 4 min and washed three times in PBS, pH 7.2, 
containing 50 mM NH4C1. Membrane samples were then resuspended in 24 III PBS, 
pH 7.2, with 6 III anti-v-erbA antibody LA038, and incubated for 2 h at room temp. 
Membranes were then centrifuged at 8,000 x g for 4 min, and washed three times in 
PBS. Subsequently, membranes were resuspended in 99 III PBS, pH 7.2, containing 
1 III biotinylated goat anti-mouse Ig antibody (Amersham), and incubated for 2 h at 
room temperature. The samples were then washed with PBS, pH 7.2, as described 
above. Next, membranes were incubated in 38 III PBS, pH 7.2, with 2 J.t! AuroProbe 
EM streptavidin 10 nm (Amersham) for 2 h at room temperature, and washed in PBS 
as before. Membranes were fixed in 2.5% glutaraldehyde in PBS, pH 7.2, for 30 min 
at 4°C, washed three times in PBS, followed by fixation in 2% aqueous OS04 for 30 
min at 4°C and several washes in ddH20. Membrane samples were dehydrated in a 
graded ethanol series, incubated in 100% acetone twice for 20 min, and embedded in 
Spurr's resin in acetone: 50% resin (1 h), 90% resin (overnight), and 100% resin 
(1 h). Membranes were then immersed in fresh resin and cured at 70°C for 14 h. 
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Ultra-thin sections (50 nm) were stained with 2% uranyl acetate in 50% ethanol for 
10 min, washed in ddH20, stained with lead citrate for 5 min, and washed in ddH20. 
3. Results 
(1) v-ErbA induced GVM and GVBD in Xenopus oocytes, but did not activate 
Ids tone Hl kinase activity 
During meiosis, oocytes undergo unequal divisions leading to polar body 
formation. For this process to occur, the oocyte nucleus (germinal vesicle) situated 
near the center of the oocyte, must migrate towards the animal hemisphere cortex and 
pigment granules in the region are rearranged, producing a whitish circular spot 
(germinal vesicle migration, GVM) (Lessman, 1987; reviewed in Smith, 1989). At 
the end of progesterone-induced GVM and GVBD, the white spot represents the area 
where the meiotic spindle has formed (Brachet et ai., 1970; reviewed in Smith, 1989; . 
Bement and Capco, 1990). Thus, the meiotically mature egg can be distinguished 
from the oocyte by the formation of this white spot which becomes delineated by a 
dark ring of rearranged pigment. 
I first tested the ability of v-ErbA to initiate maturation in Xenopus oocytes by 
comparing the rate of GVM and GVBD in progesterone-treated and v-erbA -injected 
oocytes obtained from the same females. I have shown previously that v-ErbA, 
synthesized from a microinjected gene template in Xenopus oocytes, is functional and 
acts as a dominant repressor of TR (Chapter II; Nagl et ai., 1995). In the present 
series of experiments, stage VI oocytes (Dumont, 1972) were injected into the 
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nucleus with 5 ng of v~erbA expression plasmid and cultured in O~R2 for 24 h, or 
incubated in progesterone for the same time period. Microinjection of v~erbA 
expression plasmid resulted in GVM. After 24 h, pigment granules were rearranged 
at the animal hemisphere cortex, forming a distinct, translucent circular spot with the 
nucleus visible underneath (Fig. 17 A). The v-ErbA~induced pigment rearrangement 
was highly similar to the meiotic white spot induced by progesterone (Fig. 17 A, cf. 
Panels b and c), although occasionally pigment aggregation in the center of the white 
spot in v-erbA -injected oocytes was seen (Panel d). For an assessment of whether 
GVM in v-erbA -injected oocytes is an active process or a consequence of 
degenerative changes in the cytoskeleton, I compared GYM in v~erbA -expressing 
oocytes with acrylamide-induced GVM (Lessman and Kessel, 1992). At present, the 
mechanism for positioning the oocyte nucleus is unknown, but is believed to involve 
an extensive intermediate filament network (Lessman and Kessel, 1992). 
Acrylamide, an intermediate filament inhibitor, induced GVM in 20.5% of control 
oocytes positioned with the animal pole uppermost, but only elicited GVM in 2.6% 
of controls positioned in the opposite orientation (Table I). In contrast, 56.8% of v-
erbA -injected oocytes exhibited a distinct white spot when orientated with the animal 
pole uppermost, while 27.8% of v-erbA -injected oocytes showed this feature when 
incubated with the vegetal pole uppermost. The depigmented patch at the animal 
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pole of oocytes incubated with acrylamide, resulting from the displacement of 
pigment granules by the nucleus (data not shown), was distinct from the white spot 
seen in v-erbA -expressing oocytes (Fig. 17 A). GVM occurred in 41 % of v-erbA-
injected oocytes oriented at random, while the mean frequency of GVM in 
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Figure 17. v-ErbA induces GVM and GVBD in Xenopus oocytes, but not MPF 
histone HI kinase activity or chromosome condensation. (A) v-ErbA induced 
pigment rearrangements similar to meiotic white spot formation. Stage VI (Dumont, 
1972) oocytes were injected with 5 ng lacZ expression plasmid (Panel a), incubated 
in 10 Ilg/ml progesterone (Panel b), or injected with 5 ng v~erbA template (Panels c 
and d), followed by examination of the pigment arrangement after 24 h. (B) GVM 
and GVBD induced by v~ErbA were not inhibited by forskolinlIBMX or taxo1. Stage 
VI oocytes were injected with 5 ng v-erbA template (V) or 5 ng lacZ expression 
vector (C) and incubated in O-R2 alone, or in 10 Ilg/ml progesterone (P). 
Alternatively, microinjected or progesterone-treated oocytes were incubated in 20 11M 
forskolin/2 mM ffiMX (forskolin), or 10 Ilg/ml taxol. After 24 h, the percentage of 
oocytes displaying GYM was assessed by inspection of whole oocytes, and the 
frequency of GVBD induction was scored by manual dissection of nuclei in 1% 
TCA. Three independent experiments were performed (30-40 
oocytes/treatment/experiment). The error bars indicate the SEMs. (C) Chromatin 
remained decondensed, as v-ErbA did not inhibit transcription of a lacZ reporter 
gene. Oocytes were microinjected with 2 ng lacZ reporter gene construct alone 
(reporter only), or together with 5 ng v-erbA template (plus v-ErbA), and incubated 
for 36 h. Relative lacZ gene transcription was expressed in arbitrary units based on 
measurements of 13~galactosidase protein levels by ELISA. Two independent 
experiments with 5 oocytes per treatment were performed. The error bars indicate 
the SEMs (p < 0.39). (D) v-ErbA did not induce MPF histone HI kinase activity. 
After microinjection of 5 ng v-erbA or pRSV-lacZ template as a control (C) (upper 
pane!), or incubation in progesterone or O-R2 (C) (lower pane!), oocytes were 
collected at the indicated times and MPF kinase activity was assayed using histone 
HI as a substrate and y[32p] ATP. Samples were resolved by 12% SDS-
polyacrylamide electrophoresis followed by autoradiography. MPF histone HI kinase 
activity was assayed in oocytes with (+) or without (-) a distinct white spot (GVM). 
A representative example of three independent experiments, using oocytes from 
differnt female Xenopus, is shown. 
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Table 1. GVM in stage VI (Dumont, 1972) X enop"s laevis oocytes in the presence 
of v-ErbA or acrylamide*. 
pole lip perm ost animal vegetal 
GVM GVM 
total # # % total # # % 
oocytes oocytes 
v-ErbA 44 25 56.8 43 12 27.8 
acrylamide 34 7 20.5 38 1 2.6 
• Oocytes were microinjected with 5 ng v-erbA expression template or incubated 
in acrylamide (10 mM) and cultured for 24 h in the orientation indicated, before 
scoring for GVM. 
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progesterone-stimulated oocytes was 69% (Fig. 17B). Thus, although positioning the 
animal pole uppermost facilitated nuclear migration in v-erbA -expressing oocytes, 
GVM was observed with both orientations to gravity, indicating that v-erbA -induced 
GVM is a directed process. 
Next, oocytes were assessed for GVBD, and were scored positive when the 
nucleus could not be dissected intact. In 67% of oocytes that had been injected with 
v-erbA template, nuclei were unstable and could not be dissected intact 24 h after 
microinjection (Fig. 17B). In progesterone-treated oocytes, GVBD occurred with a 
mean frequency of 94% after 24 h (Fig. 17B). It has been noted previously that 
GVM or white spot formation are not always apparent during maturation (Smith, 
1989; Bement and Capco, 1990). In the present study, GVBD could be observed in 
the absence of GVM both in progesterone-treated and v-erbA -injected oocytes. 
Taken together, these findings suggested that expression of v-erbA in oocytes caused 
nuclear changes, which strongly resembled the events associated with maturation. 
Substantial evidence exists indicating that the decrease in cAMP which follows 
progesterone treatment is both necessary and sufficient for meiotic maturation. For 
example, treatment of oocytes with forskolin, an adenyl ate cyclase activator, or 
IBMX, an inhibitor of cAMP breakdown, completely inhibits meiotic maturation 
(reviewed in Smith, 1989; Bement and Capco, 1990). To test whetherv-ErbA 
activated the cAMP-regulated CDC2IMPF pathway, I incubated v-erbA -injected 
oocytes in forskolin and IBMX. Forskolin and IBMX did not significantly affect 
GVBD in v-erbA -inj ected oocytes and decreased GVM only moderately, while 
completely inhibiting progesterone-induced GYM and GVBD (Fig. 17B). This result 
indicates that the nuclear changes induced by v-ErbA do not require inhibition of 
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adenylate cyclase and a decrease in cAMP levels. 
During meiosis, the organization of microtubules undergoes dramatic changes and 
eventually tubulin is assembled into the spindle complex. Activated MPF and 
MAPK alter microtubule dynamics by inducing the phosphorylation of microtubule-
associated proteins (MAPs) which causes a drastic decrease in microtubule length 
(Bement and Capco, 1990; Davis, 1993; Gotoh et al., 1991; Matsuda et al., 1992; 
Mordret, 1993). Formation of the meiotic spindle, as well as GVM, can be blocked 
by experimentally interfering with the cytoskeletal targets of MAPKs (reviewed in 
Davis, 1993; Jessus et al., 1987; Lessman, 1987). Taxol, a microtubule stabilizer, 
inhibited GVM and GVBD induced by progesterone, but had no significant effect on 
GVM and GVBD in v-erbA -injected oocytes (Fig. 17B). This suggests that the 
nuclear changes mediated by v-ErbA did not involve rearrangements of the 
microtubular network; however, this does not rule out a role for other components of 
the cytoskeleton, such as intermediate filaments (Lessman and Kessel, 1992). 
Another characteristic of progesterone-induced maturation is chromosome 
condensation and the cessation of transcriptional activity (Bement and Capco, 1990). 
Transcription of an unrelated lacZ gene template was unaffected by the presence of 
v-ErbA 36 h after microinjection (Fig. 17C), indicating that gene transcription was 
not shut down and chromatin remained decondensed. 
MPF kinase activation, the definitive parameter of MPF-mediated oocyte 
maturation, can be measured in vitro by means of kinase activity of oocyte extracts, 
using histone HI as a substrate (Langan et al., 1989). I assayed HI histone kinase 
activity in v-erbA -injected and progesterone-incubated oocytes in three independent 
experiments with oocytes obtained from different female X enop"s. The results of a 
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representative experiment, using oocytes from the same female, are shown in Fig. 
17D. In extracts prepared from v-erbA -microinjected oocytes, HI kinase was not 
activated over an 18 h period when compared with an extract from JacZ-injected 
controls assayed after 2 h (Fig. 17D). The slightly elevated levels of HI histone 
kinase activity in samples assayed 4 h and 14 h after microinjection were interpreted 
as not significant as they were not reproduced in repeat assays. Moreover, similar 
fluctuations in HI histone kinase activity were also observed in extracts of JacZ-
injected controls assayed over time (data not shown). Compared with a control 
extract from oocytes cultured in O-R2, extracts from oocytes incubated in 
progesterone exhibited high levels of histone HI kinase activity after 2 h (2 h, 
GVM -), approximately 6 h prior to the appearance of the white spot (8 h, GVM +) 
(Fig. 17D). Both in the presence and absence of GVM, strong HI histone kinase 
activity was present in extracts from progesterone-incubated oocytes over the entire 
time interval assayed, except for the extract from oocytes lacking a meiotic spot after 
a 10 h incubation (10 h, GVM -). The low HI histone kinase activity in this sample 
was presumably due to the failure of some of the pooled oocytes to undergo meiotic 
maturation. In summary, these experiments showed that GVM and GVBD in the 
presence of v-ErbA were not caused by the activation of the cAMP-regulated 
CDC2IMPF pathway. 
(2) v-ErbA initiated changes in the nuclear membrane characteristic of early and 
intermediate meiotic events 
Many studies have relied solely on inspection of whole oocytes and dissection of 
nuclei to assay for GVM and GVBD respectively. However, this approach does not 
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allow the distinction of complete maturation from arrested meiosis which is also 
accompanied by nuclear destabilization (Baltus et al., 1973; Steinert et al., 1974). To 
enable me to discriminate between these two outcomes in v-erbA -injected oocytes, I 
performed a detailed analysis by semi-thin sectioning and interference contrast 
microscopy. Oocytes injected with v-erlJA expression template showed pronounced 
morphological changes in the vegetal half of the nuclear membrane which were 
progressive over time (Fig. 18). It should be noted here that v-erbA-
injected oocytes appeared fully viable 24 to 36 h after microinjection, as determined 
by the presence of dark, unmottled pigmentation of the animal hemisphere 
surrounding the white spot (Fig, 17 A), and by comparison with degenerative changes 
in oocytes of low viability under interference contrast (Fig. 19). Degeneration in 
these oocytes was marked by the appearance of large vacuoles in the nucleus and 
cortex. As shown in Fig. 20A, extensive invaginations of the basal nuclear 
membrane and lamina were visible in v-erbA -expressing oocytes 16 h after 
microinjection. At 36 h, the invaginations appeared as sealed off lacunae of 
cytoplasm separated by stretches of nuclear membrane, and a yolk-free area was 
visible in the cytoplasm below (Fig. 20B). At this stage, the projections of nuclear 
membrane into the nucleoplasm were not restricted to the vegetal half of the nucleus, 
but could be seen along its circumference. In progesterone-induced maturation, the 
rupture of the nucleus always occurs in the vegetal half (Baltus et ai" 1973; Bement 
and Capco, 1990; Hausen and Riebesell, 1991). In contrast, in v-erbA -injected 
oocytes, breakdown of the vegetal half of the nuclear membrane was not observed 
over a 42 h period. Instead, the dynamic rearrangements of the nuclear membrane 
eventually resulted in membrane rupture at the apical pole after 42 h (Fig. 20C), and 
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Figure 18. Semi-thin section of a stage VI (Dumont, 1972) Xenopus oocyte 36 h after 
microinj ection of 5 ng of v-erbA expression construct, viewed under differential 
interference contrast. N, nucleus; CYT, cytoplasm. Bar: 100 11m. 
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Figure 19. Degenerative changes in a stage V (Dumont, 1972) Xenopus oocyte of 
low viability incubated in O-R2 for 20 h. N, nucleus; CYT, cytoplasm; C, cortex. 
Bar: 100 !lm. 
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subsequent cytolysis at approximately 48 h (data not shown). Apical membrane 
rupture was not observed in lacZ-injected controls, demonstrating that rupture in v-
erbA -injected oocytes was not due to damage during the process of microinjection 
(Fig. 20E). Nuclear membrane rupture at the apex, associated with arrested meiotic 
maturation, has previously been shown to be independent of the site of oocyte 
microinjection (Baltus et al., 1973; Steinert et al., 1974). 
For comparison, progesterone-treated oocytes exhibited large invaginations of the 
basal nuclear membrane during intermediate meiotic maturation (16 h incubation), 
and nucleoplasm leaked into the cytoplasmic space, thereby creating a large yolk-free 
zone (Fig. 20D). After 26 h, meiotic spindle formation had occurred (Fig. 21). 
These observations showed that the structural alterations in the nuclear membrane of 
v-erbA -expressing oocytes, present 36 h after microinjection, were comparable to the 
nuclear membrane changes taking place during the intermediate stage of meiosis (Fig. 
22). However, the transformations of nuclear membrane architecture occurred more 
slowly in v-erbA -expressing than in progesterone-induced oocytes; and the 
reorganization of the nuclear envelope was arrested at this intermediate stage in v-
erbA-expressing oocytes. 
(3) v-ErbA initiated ultrastructural transformations in the nucleus and tlte cortical 
region 
The marked changes in cell ultrastructure that occur during oocyte maturation have 
been well characterized (Bement and Capco, 1990). Thus, to further investigate the 
alterations of the nuclear membrane in v-elvA -expressing oocytes, I carried out 
ultrastructural analysis by EM. First, to ensure that any ultrastructural changes 
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Figure 20. The structural changes in semi-thin sections of nuclei of v-erbA-
expressing oocytes are indicative of meiotic induction. (A) Invaginations of the basal 
nuclear membrane and lamina in v-erbA -expressing oocytes 16 h after microinjection. 
(B) Progressive v-ErbA-mediated structural changes along the circumference of the 
nuclear membrane, and yolk-free zone below the basal nuclear membrane, 36 h after 
microinjection. (C) Rupture of the apical nuclear membrane (NM) in v-erbA-
expressing oocytes 42 h after microinjection. (D) Invaginations of the basal nuclear 
membrane and lamina, and yolk-free space, in progesterone-induced oocytes after 16 
h. (E) Absence of nuclear membrane invaginations in lacZ-injected contro1.oocytes 
36 h after microinjection. Bars: 100 ~m. 
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Figure 21. Meiotic spindle in a stage VI (Dumont, 1972) Xenopus oocyte incubated 
in progesterone for 26 h. MS, meiotic spindle. Bar: 20 flm. 
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Figure 22. Semi-thin sections of nuclear membranes of stage VI (Dumont, 1972) v-
erbA -expressing and progesterone-induced oocytes, viewed under high power. Basal 
nuclear membranes of (A) a v-erbA -expressing oocyte 36 h after microinjection, and 
(B) an oocyte after a 16 h incubation in progesterone (1 0 ~g/ml). Bars: 20 ~m. 
A 
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observed were not the result of the process of microinjection, I compared lacZ 
template-injected oocytes with v-erbA -injected oocytes. LacZ-injected oocytes were 
identical in appearance to uninjected oocytes. The vegetal half of the nucleus was 
extensively folded, forming narrow cytoplasmic channels and large lobes extending 
into the nucleoplasm (Fig. 23A). Annulate lamellae (AL) were often seen in the 
cytoplasm, in close proximity to the nuclear membrane (Fig. 23A). 
In contrast, in v-erbA -expressing oocytes, the nuclear membrane was drastically 
altered, while having maintained complete continuity, in the basal region. v-ErbA 
induced the formation of long stretches of adjoined double membranes and the 
transformation of AL into cisternae (Fig. 23B-E). Seen in cross-section, the two 
double membranes appeared tightly adjoined to each other, except for small islands 
of enclosed cytoplasmic material (Fig. 23D and E). A striking feature of this 
membrane rearrangement was the alignment of NPCs across the joined membranes 
(Fig. 23F). High magnification revealed that the cytoplasmic annuli of the NPCs 
were joined to their counterparts across membranes by electron-dense material. The 
joined nuclear membranes, when manually isolated from oocyte nuclei, were firmly 
attached to each other and resistant to separation during tissue processing (data not 
shown). Furthermore, clustering of NPCs, with adjacent portions of nuclear 
membrane depleted of NPCs, was seen in the basal regions of the nuclear envelope 
(Fig. 23G and H). In regions of NPC clustering, projections of nuclear membrane 
extended into the nucleoplasm. Concomitant with the altered nuclear membrane 
architecture, multiple layers of cisternae devoid of NPCs developed (Fig. 231), which 
typically contain fibrillar material attached to the inner side of the membrane (Kessel 
and Subtelny, 1981). In addition, the nucleoli showed signs of meiotic 
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Figure 23. Ultrastructural meiotic changes in thin sections of nuclei of v-erbA-
expressing oocytes. (A) The basal nuclear membrane (NM) of control oocytes 
injected with 5 ng lacZ template was highly folded and formed narrow channels of 
cytoplasm (CYT) and lobes extending into the nucleus (N). Annulate lamellae (AL) 
were visible close to the nuclear membrane. M, mitochondrion. (B to J) Thin 
sections of v-erbA -expressing oocytes. (B) and (C) Extensive regions of nuclear 
membrane were tightly adjoined to each other 36 h after microinjection (adjoined 
membranes, AM). AL had become transformed into cisternae (C). (D) and (E) Long 
stretches of adjoined membranes (short arrows) with aligned NPCs (arrowheads) 
separated off islands of cytoplasm (CI) containing mitochondria and other 
cytoplasmic material. (F) NPCs (arrowheads) were aligned across the adjoined 
membranes (short arrows) by electron-dense material (long arrow). (G) and (H) 
NPCs in the basal nuclear membrane were clustered (large arrowheads), with adjacent 
regions being depleted of NPCs (small arrowheads), 36 h after microinjection. (1) 
AL were transformed into cisternae (C) devoid of NPCs. (J) The nucleoli (Nu) were 
segregated into distinct fibrillar and granular regions. Bars: (A) 1 Ilm; (B) 1 Ilm; (C) 
1 Ilm; (D) 1 Ilm; (E) 1 Ilm; (F) 200 nm; (G) 200 nm; (H) 500 nm; (1) 200 nm; (J) 1 
Ilm. 
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transformation (Fig. 231), i. e., the granular and fibrillar parts had become clearly 
segregated (Steinert et al., 1974). 
The cortex of v-erbA -expressing oocytes exhibited a subset of meiotic changes, but 
did not develop the characteristics belonging to the late stage of maturation (Fig. 
24A-C). Microvilli were present 36 h after microinjection of v-erbA template (Fig. 
24A and C), while they were lacking in oocytes, undergoing hormone-induced 
maturation, after 16 h (Fig. 24D). Pigment was clustered at a distance from the 
plasma membrane in both v-erbA-expressing (Fig. 24B) and progesterone-induced 
oocytes (Fig. 24E), resulting in the formation of a discrete white spot at the animal 
pole. In contrast, the cortical granules of v-erbA -expressing oocytes remained 
predominantly localized adjacent to the plasma membrane in the area of the white 
spot (Fig. 24B), but were retracted into the oocyte interior in progesterone-treated 
oocytes (Fig. 24E and F). This finding is consistent with the observation that the 
rapid decrease in cAMP level triggered by progesterone correlates with the movement 
of cortical granules away from the plasma membrane, suggesting that cortical granule 
position is controlled by the level of intracellular cAMP (Bement and Capco, 1990). 
Since v-ErbA-induced changes occur without a decrease in cAMP, the cortical 
granules would be expected to remain at the plasma membrane. Although the 
movement of both pigment and cortical granules during maturation is thought to be 
mediated by an actin network in the oocyte cortex, cortical granules apparently do 
not become associated with the actin network until after GVBD is complete 
(reviewed in Bement and Capco, 1990). Our observations provide further evidence 
for differential control of localization and movement of the two types of granules. In 
oocytes microinjected with the lacZ plasmid, microvilli were more numerous and 
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Figure 24. The cortex of v-erbA -expressing oocytes showed a subset of meiotic 
transformations in thin and semi-thin sections. (A) In the cortex of v-erbA -
expressing oocytes microvilli (MV) and yolk-free corridors (asterisk) were visible 36 
h after microinjection. Cortical granules (CG) were localized immediately below the 
plasma membrane. EM, extracellular matrix; P, pigment granules; Y, yolk platelet. 
(B) Pigment granules were retracted and clustered in the cytoplasm, while cortical 
granules (arrowheads) were present adjacent to the apical plasma membrane, in the 
area of the white spot 36 h after microinjection of v-erbA (semi-thin section). (C) 
The microvilli of v-erbA -expressing oocytes were partially retracted and of low 
density. The cortical endoplasmic reticulum (CER) (arrowheads) had not formed an 
extensive network and did not encircle the cortical granules. (D) Progesterone-
induced maturation resulted in the complete retraction of microvilli after 16 h; yolk-
free corridors were disrupted, and mitochondria (M) were randomly dispersed 
throughout the cortex. (E) Progesterone induction caused the retraction of cortical 
granules and the clustering of pigment granules in the cytoplasm (semi-thin section). 
(F) Retraction of almost all cortical granules, pigment granules, and other vesicles, 
resulted in an area of clear cytoplasm in the meiotic white spot (MS) of 
progesterone-induced oocytes after 16 h. (G) Cortex of a lacZ-injected control 
oocyte 36 h after microinjection. (H) Continuous pigment layer adjacent to plasma 
membrane in lacZ-injected oocyte 36 h after microinjection (semi-thin section). (1) 
Numerous extended microvilli (MV) in lacZ-injected oocyte 36 h after 
microinjection. The CER (arrowheads) was comparable to that of v-erbA -injected 
oocytes. Bars: (A) 1 ~m; (B) 1 00 ~m; (C) 500 nm; (D) 1 ~m; (E) 1 00 ~m; (F) 1 
~m; (G) 1 ~m; (H) 100 ~m; (1) 500 nm. 

98 
further extended (Fig. 24G and I), than in v-erbA -injected oocytes (Fig. 24A and C). 
The layer of pigment granules was continuous in lacZ-injected oocytes and located 
directly adjacent to the plasma membrane (Fig. 24H), differing markedly from the 
clustered pigment arrangement in v-erbA -injected oocytes (Fig. 24B). Finally, two 
characteristic features of late maturation, disruption of the yolk-free corridors and 
development of an extensive cortical endoplasmic reticulum, were not seen in v-
erbA -expressing oocytes (Fig. 24A and C). The structure of the cortical endoplasmic 
reticulum in lacZ-injected controls (Fig. 241) was comparable to that of the cortical 
endoplasmic reticulum in v-erbA -expressing oocytes (Fig. 24C). In conclusion, 
structural analysis provides convincing evidence that v-ErbA induces early to 
intermediate meiotic events in X enoplis oocytes. A summary of the comparison of 
ultrastructural changes induced by progesterone and v-ErbA is presented in Table II. 
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Table II. Induction of early and intermediate meiotic events by v-ErbA in stage VI 
(Dumont, 1972) Xenopus oocytes. 
Timing of 
meiotic events3 
early 
intennediate 
late 
Inducer 
progesterone l 
AL transformation 
basal membrane changes 
cortical granule retraction 
pigment rearrangement 
NPC repositioning 
nuclear migration 
nucleolar dissolution 
microvilli retraction 
GVBD 
chromosome condensation 
mitochondrial corridor disruption 
cortical ER development 
microvilli retraction completed 
meiotic spindle 
v-ErbA2 
+ 
+ 
+ 
initiated 
+ 
initiated 
initiated 
apical breakdown 
1 Maturation events were identified according to Bement and Capco (1990); Brachet 
et al. (1970); Kessel and Subtelny (1981); Kessel (1992); and Steinert et al. (1974). 
2 The presence (+) or absence (-) of events, indicative of different stages of 
progesterone-induced maturation, in v-erbA -expressing oocytes is shown (see Figs. 23 
and 24). 
3 Meiotic events were timed as described in Bement and Capco (1990). 
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(4) v-ErbA acted at tlte level of gene activation 
Some of the growth-promoting properties of v-ErbA are mediated by dominant 
repression of TR and RAR (Desbois et al., 1991a, 1991b; Zhang et al., 1991; 
Gandrillon et al., 1994; Sharif and Privalsky, 1991). Stage VI Xenopus oocytes 
contain low levels of TRa. and TRB protein (Eliceiri and Brown, 1994), but lack 
thyroid hormone (T3) (Chapter II; Nagl et al., 1995). Conceivably, unliganded TR 
might contribute to the G2 arrest by repressing certain M-phase-inducing genes. 
Therefore, I wished to assess whether dominant negative inactivation of unliganded 
TR by v-ErbA was responsible for the induction of early meiotic events. I have 
shown in Chapter II that the action of endogenous oocyte TR can be blocked by a 
dominant negative in vitro-generated mutant of human TRB (TR C122>A) (Nagl et 
al., 1995). This DNA-binding deficient mutant is thought to block TR-mediated gene 
regulation by forming inactive dimers with TR (Nelson et al., 1993). When v-ErbA 
was replaced by the mutant TR C122>A, the morphology of the basal nuclear 
membrane in TR C122>A-injected oocytes was identical to that of untreated G2-
arrested oocytes (Fig. 25A). This finding suggested that v-ErbA did not initiate 
maturation events by acting as a dominant antagonist of endogenous TR and pointed 
to a direct role in gene activation for v-ErbA. 
Thus, to test whether release of the G2 arrest by v-ErbA required de novo gene 
expression, the frequency of GVBD was scored in oocytes that had been injected 
with in vitro-synthesized v-erbA protein and incubated in actinomycin D, an inhibitor 
of transcription, or cycloheximide, an inhibitor of protein synthesis. This experiment 
was carried out in collaboration with Caroline F. Bunn. Since v-ErbA was not 
purified from the translation reaction mixture, it was possible that the rabbit 
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Ji'igllre 25. v-ErbA acts at the level of gene activation, but not as an antagonist of 
TR (A) A dominant negative mutant of TR has no effect on nuclear structure. The 
basal nuclear membrane of a TR C122>A-injected oocyte 36 h after microinjection. 
Bar: 20 IJ.m, (B) GVBD initiation by v-ErbA required de novo gene expression. The 
frequency of GVBD was scored by dissection of nuclei from uninjected controls, or 
from oocytes injected with in vitro-synthesized v-ErbA (in rabbit reticulocyte lysate), 
after a 24 h incubation in O-R2, 30 IJ.g/ml actinomycin D (Act D), or 200 IJ.g/ml 
cycloheximide (CXD), As an additional control, oocytes were injected with the 
rabbit reticulocyte lysate transcription/translation mixture (TNT) and scored for 
GVBD, The error bars indicate the SEMs of 3 independent experiments (30-40 
oocytes/treatment/ experiment), 
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reticulocyte lysate could supply factors that would effect GVBD. Thus, oocytes were 
injected with lysate mixture as a control. As shown in Fig. 25B, the lysate alone did 
not induce GVBD. Twenty-four hours after microinjection, the mean frequency of 
GVBD in oocytes injected with v-ErbA, and incubated in the absence of inhibitors, 
was 61 % (Fig. 25B). Incubation of v-ErbA-injected oocytes in either actinomycin D 
or cycloheximide significantly reduced the frequency of GVBD to 7.5% (Fig. 25B), 
showing that meiotic induction by v-ErbA is dependent on mRNA synthesis and 
translation. Taken together, these results suggest that v-ErbA initiates meiotic events 
by activating a key regulator gene(s) in oocytes. 
(5) A portion of vNErbA was present at nuclear pore complexes 
Srp1, a Saccharomyces cerevisiae homolog of importin, the vertebrate nuclear 
localization sequence (NLS) receptor, is essential for nuclear protein import, and is 
required for mitosis (Loeb et al., 1995). Conditional S1]JJ mutants arrest in the cell 
cycle during the G/M phase, suggesting that import of cell cycle regulators into the 
nucleus is critical for cell cycle progression. Thus, it was of interest to determine 
whether v-ErbA associated with NPCs, thereby potentially modulating 
nucleocytoplasmic transport of cell cycle regulators. In immunoprecipitation assays, 
the majority of v-erbA protein, expressed from the RS-v-erbA construct, is recovered 
from manually isolated oocyte nuclei, while approximately 10% of v-ErbA partitions 
to the cytoplasmic fraction (Chapter II). As shown in Fig. 26A, a protein with a 
molecular weight of approximately 75 kD, corresponding in size to the full-length 
gag-v-erbA fusion protein encoded by the RS-v-erbA expression template (Privalsky, 
1992), was predominantly detected in total soluble protein fractions from nuclei 8 h 
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Figure 26. A portion of v-ErbA was present at NPCs. (A) Low amounts of v-ErbA 
were associated with the nuclear membrane. Panel a: Total soluble protein fractions 
were prepared from 10 manually isolated nuclei (N) or nuclear membranes (NM), 0 
or 8 h after microinjection of 5 ng v-erbA expression template, and resolved by 12% 
SDS-PAGE and silver staining. The arrowhead indicates a protein of approximately 
75 kD, corresponding in size to the full-length gag-v-erbA fusion protein. Molecular 
weights (D) are indicated by dashes: 85,200; 55,600; 39,200; 26,600; 20,100; 14,300. 
Panel b: Total soluble protein fractions from 10 nuclei or 10 nuclear membranes 24 h 
after microinjection. Symbols are as described in Panel a. Panel c: The 75 kD gag-
v-erbA protein was immunoprecipitated from the nuclear membrane and nuclear 
fractions using anti-v/c-erbA antibodies. Oocytes microinjected with 5 ng v-erbA 
expression vector were cultured in O-R2 medium with 1 mCi/ml L_[35S] methionine 
for 24 h, and nuclear membranes and nuclei were manually isolated. Nuclear 
membrane (NM) and nuclear (N) fractions of 10 v-erbA -injected oocytes were 
incubated with protein G-Sepharose-antibody complexes in an immunoprecipitation 
assay. Labelled polypeptides were recovered and separated by 12% SDS-PAGE 
followed by fluorography. Panel d: c-ErbA was exclusively immunoprecipitated from 
the nuclear fraction. Immunoprecipitation of c-erbA protein from the nuclear and 
nuclear membrane fractions of 20 oocytes injected with 5 ng c-erbA expression 
vector was carried out as described in Panel c. (B) Immunogold EM detection of v-
ErbA at NPCs. Manually isolated nuclear membranes from v-erbA -injected oocytes 
were immunolabelled with 10-nm colloidal gold, using a v-erbA -specific monoclonal 
antibody in a biotin-streptavidin bridging technique, prior to embedding and thin 
sectioning. Panel a: An en face view of the cytoplamic side of the nuclear envelope. 
Arrowheads indicate examples of colloidal gold-labelled NPCs clearly revealed by 
this plane of sectioning. Panels band c: Selected examples of transversely sectioned 
NPCs labelled by the anti-v-erbA antibody. Panels d and e: Representative examples 
of tangentially sectioned nuclear envelopes. The v-erbA -specific antibody exclusively 
labelled the cytoplasmic fibrils of NPCs. The cytoplasmic side of all cross-sectioned 
nuclear envelopes faces the top of the figure. The cytoplasmic side of the nuclear 
envelope often forms blebs (Panel e). Bars: Panel a, 200 nm; Panel b, 100 nm; 
Panels c-e, 50 nm. 
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after microinjection of the gene template (Panel a). Interestingly, low levels of a 
protein of comparable size were also detectable in total soluble protein fractions from 
nuclear membranes after 8 h (panel a). After 24 h, v-ErbA accumulation in both the 
nuclear and nuclear membrane fraction was further increased (Panel h). In addition, 
v-ErbA was immunoprecipitated from both fractions by a monoclonal antibody with 
dual specificity for both v-erhA and chicken c-erhA (Freake et al., 1988) (Panel c). 
In contrast, deliberate overexposure of the fluorograph showed that wild-type chicken 
c-ErbA, expressed from injected c-erhA templates, was exclusively 
immunoprecipitated from the nuclear fraction (Panel d). 
To identify the precise location of the v-erhA product, I performed immunogold 
labelling of manually isolated nuclear membranes (Fig. 26B). Nuclear membranes, 
isolated from v-erhA -expressing oocytes, were exclusively decorated with gold 
particles at the cytoplasmic face of NPCs (Panels a to c) and, more specifically, the 
v-erhA product was localized to the fibrils emanating from the cytoplasmic annuli 
(Panels d and e). A possible reason for the relatively low labelling density, which 
contrasted with the strong signal obtained by immunoprecipitation, is that the primary 
antibody was raised against a synthetic peptide of v-erhA (residues 58-75) within the 
DNA binding domain. Since the v/c-erhA NLS is separated from the DNA binding 
domain by only 12 amino acid residues (Fig. 27) (Dingwall and Laskey, 1991; 
Lacasse and Lefebvre, 1995), antibody accessibility might have been reduced due to 
steric hindrance between the DNA binding domain and a NPC component(s) 
interacting with the v-ErbA NLS. In summary, immunogold localization of v-ErbA 
to the cytoplasmic fibrils of NPCs points to the possibility that this oncogenic protein 
might mediate some of its effects by interfering with NPC function. 
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Figure 27. Amino acid sequence of the epitope within the DNA binding domain 
(residues 58-75) and the nuclear localization signal of v-ErbA. v-ErbA residues 58-
75 (indicated by a line), against which the monoclonal antibody LA038 was raised, 
are part of the DNA binding domain, The nuclear localization signal (NLS) (boxed) 
is separated from the DNA binding domain by only 12 amino acid residues. 
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(6) Preliminary results suggest tlud tlte association wit" NPCs might be mediated 
by tI,e gag protein 
The v-erbA oncogene is expressed as a fusion product with the viral gag sequence 
(Privalsky, 1992). The results described in the previous section pointed to a possible 
involvement of gag in mediating the association of v-ErbA with NPCs, since it was 
shown that c-ErbA alone was not localized to the nuclear membrane. Interestingly, 
in preliminary experiments, a chimeric gag-c-erbA product (V 3)' was also 
immunoprecipitated from isolated nuclear membranes (Fig. 28). This finding 
supports the notion that the gag portion of the gag-v-erbA product might be 
mediating association with NPCs. Since NLSs have been identified in the gag 
products of some retroviruses, such as human immunodeficiency virus 1 (illV -1), and 
foamy viruses (Bukrinsky et al., 1993; Schliephake and Rethwilm, 1994), I analyzed 
the gag sequence of the gag-v-erbA fusion product for sequence homologies with 
known NLS motifs (LaCasse and Lefebvre, 1995; Siomi and Dreyfuss, 1995). 
However, as shown in Fig. 29, the AEV gag sequence contains only dispersed 
hydrophobic residues, and does not exhibit any previously identified NLS motif. 
Therefore, it seems unlikely that the observed gag-mediated association of the gag-v-
erbA protein with NPCs was caused by Gag interactions with a NLS receptor. On 
the other hand, the retroviral Gag proteins have been termed "particle-making 
machinesll , since they direct the formation of virion-like particles through Gag-Gag 
interactions, even when expressed in the absence of all other virus-encoded 
components (reviewed in Wills and Craven, 1991). It is therefore possible that Gag-
Gag interactions between several gag-v-erbA proteins, simultaneously docked at the 
same NPC, caused the aggregation of these proteins and thereby blocked their 
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Figure 28. Immunoprecipitation of the gag-c-erbA product (V3) from nuclear and 
nuclear membrane fractions. Oocytes injected with 5 ng V3 mRNA into the 
cytoplasm (V 3), or uninjected control oocytes (C), were incubated in O-R2 medium 
with 1 mCi/ml L_[35S] methionine for 24 h, and nuclear membranes and nuclei were 
manually isolated. Nuclear membrane (NM) and nuclear (N) fractions of 20 oocytes 
per sample were prepared and processed as described in Fig. 26. 
NM NI NM N 
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5'-REEQVTSEQAKFWLGLGGGRVSPPGPECIEKPATERRIDKGEMGETTVQRDA 
KMAPEKMATPKTVGTSCYQCGTATGCNCVTASAPPPPYVGSGLTPSLAGAGEQ 
GQGGDTPRGAEQPRAEPGHAGQAPGPALTDW ARlREELASTGPPVV AMPVVIL 
TEGP A WTPLEP-3' 
Figure 29. AEV gag amino acid sequence sequence (GeneBank Accession Number 
M32090 Y00044). Single letter amino acid code is used and hydrophobic amino 
acids (lysine, K; arginine, R) are underlined. Nucleotide sequence conversion was 
carried out by DNASIS open reading frame display. 
nuclear import. The putative gag-dependence of v-ErbA association with NPCs was 
not investigated further, since it lies outside the scope of this investigation. It does, 
however, raise the interesting question of whether the Gag portion of the gag-v-erbA 
fusion protein, although it is not involved in transcriptional regulation by v-ErbA 
(Sap et ai., 1989), might nevertheless contribute to the function of this oncogenic 
protein by affecting its subcellular localization. 
4. Discussion 
A detailed understanding of the role of oncogenes in meiotic induction, and in cell 
cycle control in general, requires the dissection of the complex processes through 
which subsets of biochemical signal cascades result in distinct structural 
reorganizations of the cell. My study identified a new role for the retroviral v-erbA 
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protein in partially lifting the cell cycle arrest at the G/M transition in Xenopus 
oocytes, and, moreover, characterized the distinct subset of structural transformations 
induced by v-ErbA. 
(1) v-ErbA induces a subset of meiotic events in Xenopus oocytes independently 
of CDC2IMPF kinase 
The progressive changes in nuclear structure during oocyte maturation can serve as 
markers for temporal subsets of meiotic transformations. In the present study, I 
showed that v-erbA -expressing X enoplis oocytes exhibited structural changes 
associated with a subset of meiotic events occurring prior to chromatin condensation. 
These changes showed remarkable similarity to progesterone-induced events, despite 
key differences in the mode of induction. Early and intermediate meiotic events 
were induced by v-ErbA independently of the cAMP-regulated CDC2/MPF pathway, 
and required gene transcription. In contrast, the induction of Xenopus oocyte 
maturation by progesterone does not require gene transcription, but is absolutely 
dependent on polyadenylation and translation of stored mRNA coding for the serine-
threonine kinase Mos (Sagata et al., 1988~ Yew et al., 1992~ Sheets et al., 1995). 
The identification of a distinct subset of meiotic characteristics induced by v-ErbA 
is in agreement with other studies, reviewed in the introduction to this chapter, which 
have shown that meiotic events can be biochemically separated (Baltus et al., 1973; 
Drury and Schorderet-Slatkine, 1975; Newport and Spann, 1987; Bement and Capco, 
1990; Choi et al., 1991; Gavin et al., 1992, 1994; Muramatsu et al., 1989; 
Waldmann et aI., 1990). In addition, NIMA kinase induces nuclear breakdown, 
pigment rearrangement and chromatin condensation in X enoplIs oocytes, but not 
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spindle formation or nuclear migration, and does not activate CDC2IMPF or MAPK 
(Lu and Hunter, 1995). Furthermore, the membrane-bound guanine nucleotide-
binding protein Ras can induce maturation and activation of MAPK by both Mos-
dependent and Mos-independent pathways, and can bypass changes in intracellular 
cAMP levels (Smith, 1989, and refs. therein; Hattori et al., 1992; Pomerance et al., 
1992; Shibuya et al., 1992; Nebreda et al., 1993). Recently, it has been shown that 
cAMP-dependent protein kinase A inhibition of meiosis acts at more than one site, 
demonstrating that MAPK and MPF activation are not necessarily interdependent 
events during maturation (Matt en et al., 1994). Thus, the changes associated with M-
phase induction can be grouped into partially overlapping sets of events which ar~ 
regulated by several complementary control pathways. 
(2) v-ErbA releases tlte G2 arrest in oocytes, but meiosis is blocked at an 
intennediate stage 
The rearrangements of the basal nuclear membrane, NPC clustering, AL 
transformation into cisternae, and segregration of the granular and fibrillar 
components of nucleoli, which were all observed in v-erbA -expressing oocytes, 
represent the initiation of events leading to the dissassembly of the nuclear membrane 
and NPCs during meiosis (Bement and Capco, 1990; Kessel and Subtelny, 1981; 
Brachet et al., 1970; Steinert et aI., 1974). However, the reorganization of the 
nuclear membrane in v-erbA -injected oocytes did not proceed past this intermediate 
stage, chromosomes remained decondensed, and eventually the nuclear membrane 
ruptured at the apical pole. Thus, although nuclear breakdown occurred, the endpoint 
of the v-erbA -induced pathway was cytolysis, rather than meiotic spindle formation. 
111 
CDC2IMPF, either directly or through activation of other protein kinases, induces 
the disassembly of the nuclear lamina filaments and NPCs, and the vesicularization 
of the nuclear membrane (reviewed in Bement and Capco, 1990; Smith, 1989); and 
chromosome condensation and meiotic spindle formation are mediated by the 
reorganization of microtubules by CDC2IMPF and MAPK (Gotoh et al., 1991; 
Bement and Capco, 1990). The failure of these progressive events to occur in v-
erbA -expressing oocytes was correlated with the fact that CDC2IMPF kinase was not 
activated, and that v-ErbA-mediated nuclear changes were not inhibited by taxol. 
This suggests that the nuclear changes did not involve rearrangements of the 
microtubular network and, by implication, occurred independently of a MPFIMAPK 
requirement. NIMA-related kinases, which are thought to be substrates of CDC2, are 
also involved in the regulation of chromosome condensation (Osmani et al., 1991a, 
1991b; O'Connell et al., 1994; Lu and Hunter, 1995; Ye et al., 1995; reviewed in Fry 
and Nigg, 1995). Interestingly, lack of nimA during mitosis causes the proliferation 
of endomembranes in and around nuclei and fragmentation of the nuclear membrane 
in Aspergillus nidulans (Osmani et al., 1991a). My findings suggest that release of 
the G2 arrest by v-ErbA allows meiotic reinitiation up to a point where signal 
transmission by activated MPF, MAPK, and possibly NIMA-related protein kinases, 
becomes essential for M-phase progression. 
There was a striking match between the v-erbA -induced events and the 
characteristic features seen in the induction of early maturation by the simultaneous 
treatment of oocytes with progesterone and cycloheximide, or by injection of extract 
prepared from progesterone-treated oocytes (Baltus et al., 1973; Steinert et al., 1974; 
Smith, 1989). This subset of structural changes, termed pseudomaturation, is induced 
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in the absence of de novo synthesis of c-mos protein and MPF activation (Drury and 
Schorderet-Slatkine, 1975; Wasserman and Masui, 1975; Kobayashi et al., 1991), and 
includes adjoined nuclear membranes, mottling of the pigment layer, and 
condensation of the fibrillar core of the nucleoli (Baltus et al., 1973; Steinert et al., 
1974). Moreover, chromosome condensation is never observed in pseudomaturation, 
and the eventual apical rupture of the nuclear membrane results in cytolysis (Brachet 
et al., 1970; Steinert et al., 1974; Drury and Schorderet-Slatkine, 1975). Induction of 
early maturation by microinjected, in vitro-synthesized v-ErbA, which required 
mRNA synthesis and translation, and induction of pseudomaturation in the absence of 
protein synthesis, appear to constitute two alternate pathways capable of initiating an 
overlapping set of events. 
In oocytes, M-phase induction by v-ErbA, like pseudomaturation, is ultimately a 
destructive process. The reason for this most likely lies in the absence of additional 
signals from activated protein kinases, essential for the completion of maturation. 
Once the G/M restriction point is passed, the maturing oocyte is committed to 
undergo events leading to GVBD and lacks the ability to reverse the meiotic 
pathway. Consequently, the initiated structural transformations eventually lead to the 
disintegration of the oocyte. This situation is wholly different from the context in 
which v-ErbA functions in somatic cells. Somatic cells constantly receive a wide 
range of extracellular signals conveyed by growth factors, which activate mitogenic 
kinases (reviewed in Weinberg, 1989a). Abnormal activation of a gene(s), encoding 
a cell cycle inducer, by v-ErbA can be expected to act in a complementary manner to 
these events and enhance certain mitogenic signals. As a result, v-ErbA apparently 
does not cause nuclear dissolution in somatic cells, but confers a reduced requirement 
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for growth factors and an enhanced growth potential (Gandrillon et al., 1987). These 
effects of v-ErbA are further discussed in Chapter IV. 
(3) Growtlt-promoting properties of v-ErbA 
The question of whether the growth-promoting properties of v-ErbA can be 
exclusively attributed to dominant repression of TR and RAR, or whether it also 
requires the activation of specific v-ErbA-responsive genes, remains unanswered to 
date. My study showed that the release of the cell cycle arrest at the G/M transition 
point by v-ErbA required de novo gene expression, and occurred independently of 
cAMP regulation and CDC2IMPF kinase activation. Furthermore, v-ErbA apparently 
does not act by dominantly inhibiting endogenous TR, since a dominant negative 
mutant of TR had no effect on cell ultrastructure. Therefore, the putative target 
gene(s) is unlikely to be regulated by TR in oocytes. 
Importantly, the cellular forms of several viral oncogenes are found as signalling 
components of the MAPK cascade, which suggests that this pathway mediates 
somatic cell transformation (reviewed in Davis, 1993; Mordret, 1993; Mansour et al., 
1994). Within the nucleus, signal transduction by MAPK activates a range of 
transcription factors by phosphorylation, including the products of the c-jun and c-fos 
proto-oncogenes which form the so-called AP-1 complex (Mordret, 1993; Davis, 
1993; Avruch et al., 1994). Conceivably, v-ErbA action might mimic the function of 
a MAPK-activated transcription factor in oocytes. It is interesting to note in this 
context that another member of the steroid/thyroid receptor superfamily, the 
oestrogen receptor, was recently shown to be phosphorylated by MAPK in vitro 
(Kato et al., 1995). Thus, v-ErbA might initiate maturation events by activating a 
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key gene target(s) not normally expressed in the oocyte, which is capable of 
triggering the release from G2 arrest and inducing a specific subset of structural 
transformations. 
The ability of a cell to overcome dependence on growth factors, either partially or 
completely, and to grow in an autonomous fashion, forms the basis of oncogenic 
transformation. Previously, v-ErbA was shown to confer partial growth factor 
autonomy by, firstly, rendering cells unresponsive to a range of anti-mitogenic 
controls; i. e., v-ErbA abolishes AP-l repression, induction of apoptosis, and self-
renewal inhibition mediated by TR and RAR in erythroid precursors (Desbois et al., 
1991a and 1991b; Zhang et al., 1991; Sharif and Privalsky, 1991; Saatcioglu et al., 
1993b; Gandrillon et al., 1994). Secondly, v-ErbA can activate an indirect autocrine 
pathway by inducing the platelet-derived growth factor B/c-sis gene in glial cells, 
again by exerting a regulatory role opposite to that of TR (Iglesias et al., 1995). My 
study suggests that v-ErbA, acting as an activator, can contribute to the attainment of 
growth factor autonomy by interference with mitogenic pathways distinct from those 
involving TR. 
(4) A potential role for v-ErbA at nuclear pore complexes 
A portion of v-ErbA expressed in oocytes was present at the nuclear membrane at 
the cytoplasmic face of NPC complexes, near the cytoplasmic annuli. Specifically, 
colloidal gold-labelled v-ErbA was seen at the cytoplasmic fibrils of the NPCs, 
possibly at fibril components involved in NLS-mediated ligand docking (Forbes, 
1992; Gerlich et al., 1994). NPCs perform a crucial role in controlling cellular 
processes. In the yeast S. cerevisiae, mutations in NPC proteins can cause nuclear 
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transport defects, extensive changes in nuclear membrane structure, and abnormal 
nuclear migration (reviewed in Doye and Hurt, 1995). That components of the 
import machinery can also interfere with cell cycle regulation is demonstrated by the 
effects of a mutation in the S. cerev;s;ae NLS receptor, Srp1, that targets proteins to 
the NPC (Loeb et al., 1995). A conditional srp1 mutant arrests cells at the G/M 
border, and was suggested to act by blocking the import of a critical cell cycle 
regulator. Similarly, Pendulin (or OH031), a Drosphila tumour suppressor gene 
product with sequence homology to Srp1, exhibits cell-cycle dependent nuclear 
localization and is required for normal cell proliferation (Kiissel and Frasch, 1995; 
Torok et al., 1995). In the release from G2 arrest in oocytes, potential effects of v-
ErbA at NPCs would be expected to play an early inductive role, as the association 
of v-ErbA with NPCs occurs well in advance of meiotic events. An isolated local 
effect of v-ErbA on nuclear membrane structure appears unlikely, since the set of 
ultrastructural changes induced by v-ErbA, including the observed nuclear membrane 
alterations, was fully consistent with the pleiomorphic effects of meiotic induction. 
While the significance of the presence of v-ErbA at NPCs remains to be determined, 
it is interesting to consider the possibility that, in addition to its intranuclear function 
in gene activation, v-ErbA might modulate nucleocytoplasmic transport of a key cell 
cycle regulator(s). 
IV. 
Conclusion 
Until recently, an almost exclusive emphasis on the mutational aspects of 
oncogenesis, based on retroviral model systems, has tended to relegate the cell as a 
whole to a secondary background role. Contrasting with this approach, expression of 
TR and v-ErbA in Xenopus oocytes has highlighted the importance of cell-specific 
molecular interactions in defining the properties of both transcription factors. In 
Chapter II, it was shown that both the cell-specific nuclear environment and protein-
DNA interactions at enhancers determine whether these nuclear factors act as 
repressors or activators of gene transcription. Importantly, the dominant negative 
phenotype of v-ErbA was shown not to be universal, but to be dependent on 
interactions with other nuclear factors and the nature of a given DNA binding site. 
The importance of these findings for an understanding of growth-promotion by v-
ErbA is demonstrated in Chapter III, where it was shown that v-ErbA is able to 
partially lift the G/M cell cycle arrest in fully grown oocytes. v-ErbA induced a 
subset of early to intermediate meiotic events by activating de novo gene expression, 
suggesting that v-ErbA is able to interfere with mitogenic signalling pathways. 
A bbreviations used in this chapter: DR4, direct repeat of TRE half sites separated 
by 4 nucleotides; LTR, long terminal repeat; NF-KB, nuclear factor-KB; RXR, 
retinoid X receptor; Sp1, specificity protein 1; TR, thyroid hormone receptor; TRE, 
thyroid hormone response element. 
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(1) The action of nuclear hormone receptors is dependent on molecular 
interactions 
The function of nuclear hormone receptors is still understood predominantly in a 
context-independent way, as being determined by their three-dimensional structures, 
which are implicit in their primary amino acid sequences; and, at a more reductive 
level, the functional domains within receptors are seen as autonomous modules. 
However, recent studies characterizing the modulating roles of protein-protein (Chen 
and Evans, 1995; Forman et al., 1995b; Horlein et al., 1995; Kurokawa et al., 1995; 
Lee et al., 1995a and 1995b) and protein-nucleic acid interactions (Kurokawa et aI., 
1995; Rastinejad et al., 1995; Sjoberg and Venn strom, 1995; Toney et al., 1993), as 
well as reports on interdomain allosteric regulation (Durand et al., 1994; Kurokawa et 
al., 1994), indicate that this view inadequately reflects nuclear receptor action. The 
findings on TR and v-ErbA function reported in my dissertation, together with these 
studies, demonstrate a pressing need for an expanded conceptual framework on which 
to base nuclear receptor research. Hence, I propose a context-sensitive model of 
nuclear receptor action, which views receptor protein functions as plastic properties, 
requiring definition by molecular interactions. 
To allow responsiveness to the complex requirements of development, 
differentiation and the cell cycle, eukaryotic genes are coupled via cellular signal 
transduction networks to their extra- and intra-cellular environments. Cancer 
represents a range of disorders in cellular signal processing, mediated by the 
abnormal function of regulatory network components. In both healthy and neoplastic 
cells, the information transmitted to the genome via multiple signal pathways is 
combined at DNA control sequences by complex assemblages of transcription factors, 
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and then transmitted to the general transcription machinery. Many different types of 
signals are processed in this way; for example, information about a cell's lineage, its 
interactions with other cells, the stage of the cell division cycle, and hormonal 
signals. Individual regulatory elements function as multifactorial switches, each 
being responsible for only a certain aspect of the regulation of a given gene. 
Consequently, the full regulatory scope of a gene is only achieved by the integrated 
action of all, or of changing sub-sets, of its regulatory elements. This is well 
illustrated by the action of TR at TR-regulated genes which are commonly controlled 
by complex patterns of different control elements. The chicken lysozyme gene, for 
example, is regulated by the combined activity of thyroid and steroid response 
elements, enhancer sequences and silencer elements, to the effect that an entire 
chromatin loop with extensive flanking parts on both sides of the transcribed region 
acts as a regulatory unit (Sippel and Renkawitz, 1989). 
Another consequence of the modular composition of complex enhancers is that 
different combinations of binding sites generate different transcriptional patterns. 
Modulation of the mode of action of TRlRXR heterodimers by different TREs 
provides an interesting example. My study showed that mammalian TRiRXR 
heterodimers constitutively activated transcription from a palindromic TRE linked to 
a viral promoter in X enop"s oocytes. In contrast, X enop"s TRIRXR heterodimers act 
as efficient activators and repressors of the 1.6 kb promoter of the X enop"s TRJ3A 
gene, containing several TREs within extensive flanking regions (Machuca et ai:, 
1995), in the presence or absence of T3 respectively (Wong and Shi, 1995). While 
species-specific interactions between the nuclear receptors and general transcription 
factors might have contributed to these differences, this comparison underscores the 
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importance of enhancer composition for the action of TR and RXR. The effects of 
allosteric interactions between RXR and TR, or RXR and the orphan receptor Nurrl, 
serve to further illustrate this point (Forman et al., 1995). Heterodimerization 
between TR and RXR, bound at two consensus half-sites in a DR4 or palindromic 
arrangement, results in the suppression of ligand-induced transcriptional activities of 
RXR. Interestingly, without binding directly to DNA, RXR can heterodimerize with 
a Nurrl monomer bound to a single half-site. As a result of this interaction, the 
constitutive activity of Nurrl is suppressed, and the complex becomes 9-cis retinoic 
acid dependent. As an additional example of binding site complexity, the human 
immunodeficiency virus type 1 (HIV-l) LTR is activated by TR binding to TREs 
contained within the viral NF-ICB and Spl DNA motifs (Desai-Yajnik and Samuels, 
1993). At the Spl element, the binding of TR and Sp1 is mutually exclusive, and 
direct interaction between the retroviral tat protein and TR is required for TR binding 
and transcriptional induction of the TRE within the Sp1 motif. 
Where oligomeric protein complexes bind to the same control sequence, different 
combinations of proteins can have different functional activities, including DNA 
binding specificities (Diamond et aI., 1990; Glass, 1994). The consequences can 
range from efficient activation to complete inhibition, and can change in response to 
environmental and differentiation signals. Thus, the diversity provided by 
dimerization, between nuclear hormone receptors (Mangelsdorf and Evans, 1992) and 
among different nuclear factor families (Karin et al., 1993), offers enormous scope 
for regulation. In addition, interactions with tissue-specific factors can have profound 
effects on receptor action. My investigation demonstrated that the v-erbA protein, 
which is generally classified as a dominant negative transcription factor in animal 
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cells, is converted into a transcriptional activator by factors present in nuclear 
extracts from anterior pituitary cells. It follows that, if a factor can act as an 
activator or repressor depending upon its interactions with other proteins, it is the 
balance of these proteins in the cell and their relative strengths of interaction that is 
of paramount iinportance. In conclusion, the combinatorial nature of the transcription 
process strongly supports a context-sensitive model of nuclear receptor action. 
Understanding the complexities of how molecular interactions, involving normal and 
oncogenic nuclear receptors, change in response to environmental, proliferation and 
differentiation signals will be an exciting focus of future research. 
(2) Signalling nehvorks and cellular architecture are interdependent 
v-ErbA initiated early to intermediate meiotic events in Xenopus oocytes by 
activating de novo gene expression. The finding that v-ErbA initiated the release 
from Gz arrest in oocytes, but did not induce advanced meiotic events, highlights the 
strictly cooperative nature of the v-erbA oncogene. In somatic cells, v-ErbA depends 
on the presence of an oncogenic protein kinase, such as v-erbB or v-src, for the 
achievement of a fully transformed phenotype (Kahn et al., 1986; Frykberg et al., 
1983). These observations emphasize that the effects of the v-erbA oncogene are 
embedded within a complex cellular signalling network made up of mutually 
interdependent components. Mitogenic signalling cascades constitute sequences of 
biochemical reactions that directly link signals initiated by receptors at the plasma 
membrane to specific cytoskeletal and transcriptional targets for control of the cell 
cycle and differentiation (Davis, 1993; Mordret, 1993). In the nucleus, cytoplasmic 
signalling cascades are integrated with the hormonal signals conveyed by steroid and 
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thyroid hormone receptors by complex cross-talk mechanisms (Desbois et al., 1991a, 
1991 b; Diamond et al., 1990; Jonat et al., 1990; Karin et al., 1993; SchOle et al., 
1990a, 1990b; Zhang et al., 1991). Signal amplification along the branching structure 
of network cascades leads to the activation of increasing numbers of targets at 
successive levels of signal transduction. Through this mechanism, the action of a 
single oncogenic receptor kinase at the cell surface, such as v-ErbB, can be sufficient 
to induce complete cellular transformation; and expression of tyrosine kinase 
oncogenes, such as tpr-met and RET, efficiently induces maturation in oocytes (Daar 
et al., 1991; Grieco et al., 1995). In contrast, the oncogenic transcription factor v-
ErbA, acting at the most distal level of mitogenic cascades, may only be able to 
activate a subset of genes essential for cellular growth-promotion, and, in oocytes, 
only induces a subset of meiotic events. 
The transformation of an oocyte into an egg provides a valuable example for the 
general requirement of a combination of intracellular signals for the induction of an 
integrated structural and functional response. Meiosis is orchestrated by subsets of 
biochemical signal cascades, which independently regulate distinct structural 
reorganizations, with the ultimate outcome of dramatically altering cell function 
(Bement and Capco, 1990). Thus, intracellular signalling could be seen as a system 
which processes the information transmitted by all pathways in a parallel distributed 
network. Similar models of biological information processing have been proposed to 
explain such diverse processes as brain function (revewed in Rowe, 1995) and 
differentiation and development (Atlan and Koppel, 1990). Possibly, these models 
reflect certain universal principles of signal processing, operating at all organizational 
levels in biological systems. A cell receives a constant stream of signals both from 
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within the cell itself and from the surrounding environment, and information is most 
likely carried by the changing patterns and intensities of all signalling events 
combined. These patterns are created by the substrate specificity of regulatory 
kinases in mitogenic cascades, and the binding strengths of protein-protein and 
protein-nucleic acid interactions in nuclear receptor signalling. Importantly, the cell-
specific expression of numerous network components can greatly alter the response to 
upstream and cross-talk signals. 
Cells interpret biological information within three-dimensional networks in which 
structure and function are mutually dependent. Unfortunately, studies of cell 
structure have often been judged to be of only observational interest and of lesser 
scientific value than biochemical approaches. However, the study of nuclear 
architecture is now moving to the forefront of molecular biology, as its crucial role in 
gene regulation (see, for example, Blobel, 1985; Nigg, 1988; Bidwell et al., 1993; 
Cremer et al., 1993; Dworetzky et aI., 1992), differentiation, growth control and 
neoplastic transformation has been recognized (reviewed in Brasch and Dchs, 1995; 
Penman, 1995; Pienta et al., 1989). It has also been proposed that structural 
information, derived from cell-cell contacts or cell shape, can be transmitted to the 
nuclear matrix by the cytoskeleton, and might influence gene transcription (Cook, 
1989; Pienta et al., 1989). 
Genetic instability, activation of oncogenes and deregulated signal transduction are 
direct causes of cellular transformation. It is important to remember that virtually 
every component of the cytoskeleton and the nuclear matrix can also be altered in 
cancer cells; and that alteration of cell structure is in fact the morphological hallmark 
of cancer diagnosis (Pienta et al., 1989, and refs. therein). It is therefore necessary to 
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define the relationship between abnormal signalling events induced by oncogene 
products, cell structure and genetic changes. The products of oncogenes and their 
targets can be pictured as sensitive nodes within integrated regulatory-structural 
networks, whose activity is capable of profoundly altering the global state of the cell. 
These considerations motivated me to take a combined biochemical and 
ultrastructural approach in my investigation of v-ErbA-initiated maturation events in 
X enop"s oocytes. M-phase initiation by v-ErbA through gene activation, shown by 
my study, exemplifies oncogene action through interference with mitogenic signalling 
networks. In addition, I identified an abnormal subcellular localization for v-ErbA, 
which was partially found associated with the pore complexes at the cytoplasmic face 
of the nuclear envelope. This finding poses the intriguing question of whether v-
ErbA can also disrupt regulatory networks by interfering with cellular architecture, in 
particular, components of NPCs. In conclusion, my study as a whole contributes a 
range of new perspectives on the v-erbA oncogene and its action within the 
regulatory-structural networks of cells. 
(3) Nehvork models of neoplastic cells will open up new avenues in cancer 
research 
Biological models change with time (Keller, 1995). In the 1950s and 1960s, 
cellular processes were explained in terms of biochemical pathways and the 
thermodynamic principles of reaction kinetics. The ability of a cell to establish 
metabolic pathways was believed to depend solely on the execution of a fixed 
genetic program (reviewed in Keller, 1995). During this period, studies of two DNA 
tumour viruses, polyomavirus and simian virus 40, belonging to the papovavirus 
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group, suggested that the addition of one or a few genes could dramatically alter cell 
behaviour (reviewed in Eckhart, 1989). This led to the realization that neoplastic 
changes could be analyzed genetically and biochemically, and marked the beginning 
of experimental oncology (reviewed in Varmus, 1989). Cancer came to be seen as a 
genetic disease. Starting from this premise, experimental oncology has succeeded in 
identifying viral and cellular oncogenes as well as tumour suppressor genes, and has 
established models of neoplastic transformation possessing extraordinary explanatory 
power (reviewed in Chapter I). Importantly, models of collaborating viral oncogenes, 
such as v~erbA and v-erbB, have led to the multistep hypothesis of carinogenesis 
(reviewed in Weinberg, 1989b); 
In the 1990s, through the discovery of allosteric control, the intricacies of 
transcriptional regulation and the complexities of the cell cycle, cells are increasingly 
coming to be seen as intricate networks of structures and information. We now 
know that genomes do not function as fixed programs, and that cells actively regulate 
their genes in response to their own internal state (reviewed in McKnight and 
Yamamoto, 1992) and a wide range of signals from their environment, including 
those conveyed by hormones (reviewed in Hill and Treisman, 1995). Steroid and 
thyroid hormones comprise the broadest class of gene regulatory agents known 
(Brasch and Ochs, 1995; Detera-Wadleigh and Fanning, 1994; Laudet et al., 1992). 
Their receptors, belonging to the diverse superfamily of nuclear receptors, playa 
central role in the regulatory networks that transmit signals, originating from the 
extracellular environment, to the genome through a complex sequence of molecular 
interactions. Together, these insights have important implications for cancer research. 
In the United. States, for example, hormone-related cancers account for more than 
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20% of all newly diagnosed male and more than 40% of all newly diagnosed female 
malignancies (Henderson et al., 1993). Hormonal signals contribute to the causation 
and progression of several human cancers, including cancer of the breast, 
endometrium, prostate and ovaries. The interplay between hormonal signals, normal 
and oncogenic nuclear receptors, and additional activated oncogenes therefore 
constitutes an area of primary importance in cancer research. Furthermore, oncogene 
function needs to be understood within the context of the global state of structural 
and regulatory networks of neoplastic cell types. In the future, the development of 
network models of neoplastic cells, reflecting these complexities, will expand our 
understanding of the role of oncogenes in human cancer. 
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Appendix 1 
The results of the investigation described in Chapter II were published and a reprint 
of the publication is included.in Appendix 1. 
In consultation with my supervisor, Dr. Lizabeth A. Allison, I designed and carried 
out the study described in this publication. Colleen C. Nelson prepared the TR 
C122>A clone and some of the reporter gene constructs while she was a postdoctoral 
fellow in the laboratory of Paul J. Romaniuk. 
Constitutive Transactivation by the 
Thyroid Hormone Receptor and a 
Novel Pattern of Activity of its 
Oncogenic Homolog v-ErbA in 
Xenopus Oocytes 
Sylvia B. Nagl*, Colleen C. Nelsont, Paul J. Romaniuk, 
and Lizabeth A. Allison 
Department of Zoology (S.B.N., L.A.A.) 
University of Canterbury 
Christchurch, New Zealand 
Department of Biochemistry and Microbiology (C.C.N., P.J.R.) 
University of Victoria 
Victoria, British Columbia, Canada V8W 3P6 
In Xenopus oocytes, the rat thyroid hormone re-
ceptor a (rTRa), but not its oncogenic homolog 
v-ErbA, constitutively activated thyroid hormone 
(T a}-responsive reporter genes at four positive thy-
roid hormone-responsive elements (TREs). At a 
subset of the positive TREs tested, the addition of 
T a resulted in a further enhancement of reporter 
gene activation. In contrast, both rTRa and v-ErbA 
functioned as constitutive activators when bound 
to the clone 122 TREs, which are induced by unli-
ganded TR in mammalian cells. Therefore, the re-
sponses of the ligand-independent activation do-
mains of TR and v-ErbA to cell-specific and TRE-
mediated induction are not equivalent. 
Coexpression of the human retinoid X receptor a 
(hRXRa) enhanced both ligand-dependent and li-
gand-independent activation functions of rTRa 
and human TRIJ (hTRIJ) at a palindromic TRE 
(TREp). An endogenous TR activity mediated T a 
induction of TREp, while being repressed by an in 
vitro-generated dominant negative mutant of TR. 
T a-mediated gene activation, by exogenous or en-
dogenous TR, was repressed by v-ErbA at three 
positive TREs, but not at the TRE from the third 
intron of the rat GH gene (rGHa TRE). Interestingly, 
preinjection of nuclear protein extract from ante-
rior pituitary cells converted v-ErbA into a consti-
tutive activator at rGHa TRE. The pituitary-specific 
factor Pit-1/GHF-1 or hRXRa did not induce acti-
vation by v-ErbA at rGHa TRE, suggesting that the 
dominant negative phenotype of v-ErbA can be 
abolished by direct or indirect interactions with 
other nuclear factors. (Molecular Endocrinology 9: 
1522-1532, 1995) 
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INTRODUCTION 
Thyroid hormone receptors (rRs) belong to the super-
family of nuclear hormone receptors, which includes 
receptors for steroids, retinoids, and vitamin D3, and 
act as ligand-inducible transcription factors (1). TRs 
are encoded by two genes, c-erbAa and c-erbAp, 
which are cellular homologs of the retroviral v-erbA 
oncogene involved in avian erythroblastosis (Refs. 2 
and 3; for reviews, see Refs. 4 and 5). TRs, like other 
transcription factors, are composed of modular func-
tional domains whose action is dependent on cellular 
context. TRs control expression of T 3-responsive 
genes at cis-acting DNA control sequences termed 
thyroid hormone-responsive elements (IREs) which 
possess diverse sequence characteristics (for a re-
view, see Ref. 4). Induction of gene transcription is 
achieved through autonomous activation domains: a 
constitutive activation domain located in the N-termi-
nal region of the receptor and a ligand-dependent 
activation domain located in the C-terminal part (for a 
review and references, see Ref. 6). Although transcrip-
tional activation by TR is primarily ligand-dependent in 
mammalian cells, ligand-independent activation has 
also been observed (7-10). In the yeast, Saccharomy-
ces cerevisiae, TR functions as a ligand-independent 
activator with enhanced expression in the presence of 
T 3 (11). In mammalian cells, unliganded TRs, thought 
to be constitutively bound to hormone response ele-
ments, can suppress the basal activity of promoters 
containing TREs (12-17). The repressor function has 
been mapped to the hinge domain of TR and was 
shown to be separable from its activator function (18). 
A C-terminal silencer domain has also been charac-
terized (12, 19); however, how the activation and re-
pression domains are regulated in the context of the 
full-length receptor is presently not well understood. 
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Oocytes Constitute a Novel Context for v-ErbA and TR 
At positively regulated TREs, addition of thyroid hor-
mone (T 3) results in the activation of transcription, 
suggesting that the hormone triggers a conformational 
change in TR that induces the activator function (for a 
review, see Ref. 5). At negatively regulated TREs, TRs 
act as transcriptional repressors when bound to T 3 (for 
reviews, see Refs. 4 and 5). In addition, two novel 
TREs that mediate strong activation by unliganded TR 
were recently identified, whereas addition of T 3 re-
verses this response (9, 10). Although TRs are able to 
bind TREs as monomers and homodimers, het-
erodimerization with auxiliary nuclear factors, notably 
retinoid X receptors (RXRs), results in increased affinity 
for the response element in vitro and enhanced acti-
vation of gene expression in vivo (Ref. 20; for a review, 
see Ref. 21). 
The retroviral v-erbA oncogene, a highly mutated 
version of chicken TRa, acts as a dominant repressor 
in mammalian and avian cells, blocking activation of 
gene expression by liganded TRs (Refs. 14 and 16; for 
a review, see Ref. 22). Mutations within the C terminus 
of the v-erbA protein appear primarily responsible for 
its conversion into a constitutive transcriptional re-
pressor, as these mutations result in loss of the ability 
to bind thyroid hormone at high affinity (Refs. 14, 16, 
and 17; for a review, see Ref. 22). v-ErbA has retained 
some binding ability, since, surprisingly, v-ErbA acts 
as a hormone-regulated activator in S. cerevisiae (11, 
23). Two mutations within the DNA- binding domain, 
and mutations in an N-terminal region outside of the 
DNA binding domain, aiter the range of DNA target 
sequences the v-erbA protein can bind to relative to 
TR (Refs. 17, and 24-26; for a review, see Ref. 22). 
Oocytes of the frog Xenopus laevis are an excep-
tionally efficient assay system to characterize the func-
tion of both cis- and trans-acting factors in gene ex-
pression (27). Unlike expression studies in transfected 
cultured cells, oocyte microinjection offers the possi-
bility to directly introduce cell components, such as 
nuclear proteins, as well as gene templates. Here, we 
show that oocytes constitute a viable environment for 
the reconstitution of complex regulatory networks, in-
volving nuclear hormone receptors. TR, expressed 
from cloned genes microinjected into oocytes, func-
tioned as a ligand-independent activator of reporter 
genes under the control of five different TREs. At a 
subset of the positive TREs tested, the addition of T3 
led to a further increase in reporter gene expression. 
Both the a- and (3-isoform of TR acted as constitutive 
activators at a palindromic TRE in oocytes, while co-
expression of RXRa enhanced both ligand-indepen-
dent and ligand-dependent activation. Moreover, T s 
did not inhibit the ligand-independent activation func-
tion of TR at a recently identified TRE, which is strongly 
induced by TR without Ts and repressed with Ts in 
mammalian cells (clone 122 TREs). In addition, the 
v-erbA protein acted as a constitutive activator at the 
clone 122 TREs. In the absence of exogenous TR, a 
reporter gene regulated by a palindromic TRE was 
weakly induced by endogenous TR. Induction by en-
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dogenous TR was dominantly repressed by v-ErbA or 
a dominant negative in Vitro-generated mutant of hu-
man TR(3 (hTR(3). At three positive TREs, v-ErbA acted 
as a dominant repressor of TR action; however, v-ErbA 
did not repress basal gene transcription of T3-respon-
sive genes. The v-erbA protein dominantly repressed 
TR function at a direct repeat, a palindromic and an 
inverted palindromic TRE, but did not affect TR regu-
lation of the tripartite TRE from the third intron of the 
rat GH gene (rGHs TRE). After preinjection of nuclear 
protein extract from anterior pituitary celis, v-ErbA 
fUnctioned as a constitutive activator at rGHs TRE. 
RXR or the pituitary-specific transcription factor, Pit-
1/GHF-1, when expressed from coinjected templates, 
did not convert the v-erbA protein to an activator at 
this TRE. This suggests that other factors, which can 
induce the constitutive activator function of v-ErbA at 
rGH3 TRE, are present in nuclear protein extracts from 
anterior pituitary celis. These findings exemplify the 
utility of Xenopus oocytes for the characterization of 
cell-specific actions of nuclear receptor domains. 
RESULTS 
Both Constitutive and T a-Mediated Gene 
Activation Functions of TRa and TRP Are 
Induced in Xenopus Oocytes and Enhanced by 
RXR 
We sought to establish whether Xenopus oocytes can 
be used for the reconstitution of nuclear receptor net-
works in vivo. In this context, we wished to ascertain 
whether oocytes provide a cellular background for 
nuclear hormone receptor action similar to either yeast 
or mammalian cells or whether they constitute a 
unique context. TR mRNA is present at all stages of 
oogenesis (28) and in fertilized eggs (29); however, at 
the onset of our study, TR protein had not been de-
tected by immunoprecipitation or Westem immunob-
lotting (29), suggesting that maternal transcripts are 
stored for use later in embryogenesis. Results ob-
tained by enzyme-linked immunosorbent assay 
(ELISA) showed that oocytes contain no detectable 
endogenous T 3 «0.1 nM). After incubation in 100 nM 
Ts, oocytes exhibited an intracellular hormone con-
centration of ~5 nM (data not shown), which falls 
within the physiological range for Ts action. Thus, we 
presumed that Xenopus oocytes would be suitable for 
experiments investigating transcriptional regulation by 
exogenous TR and v-erbA protein at a range of diverse 
TREs, both with and without added T s' 
TREs consist of six-base pair consensus se-
quences, terml?d half-sites. These half-sites can be 
oriented as imperfect inverted, direct, or divergent re-
peats, separated by nucleotide gaps of variable size 
(for a review, see Ref. 4). Naturally occurring promot-
ers often show mixtures of half-sites in differing orien-
tations. We sought to reflect the natural diversity of 
TREs by employing four positively regulated response 
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elements possessing different half-site characteristics; 
i.e. the direct repeat TRE in the rat malic enzyme gene 
promoter (maiTRE) (30), the inverted palindromic TRE 
in the promoter region of the chicken lysozyme gene 
(lysTRE) (13), rGH3TRE (31), a synthetic palindromic 
TRE (fREp) (14), and one complex response element 
which is strongly induced by unliganded TR and re-
pressed by T 3 in mammalian cells (clone 122 TREs) 
(10). 
A rat TRa (rTRa) expression plasmid and a chlor-
amphenicol acetyltransferase (CAT) reporter gene un-
der the control of one of five different TREs were 
microinjected into the oocyte nucleus. Unliganded 
rTRa induced transcription of all five TRE-regulated 
CAT reporter genes (Fig. 1). Constitutive reporter gene 
induction by rTRa was strongest when under the con-
trol of lysTRE, TREp, or the clone 122 TREs. CAT 
reporter gene transcription under control of three pos-
itively regulated TREs (maiTRE, lysTRE, TREp) was 
further enhanced by the addition of T 3 but was unre-
sponsive to hormone with rGH3 TRE (Fig. 1). In contrast 
to results obtained in CV1 (monkey kidney) cells (10), 
addition of T 3 did not significantly repress TR-medi-
ated transcription regulated by the clone 122 TREs 
(Fig. 1). Reporter gene induction by TR was shown to 
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Fig. 1. TR-Mediated TRE-CAT Reporter Gene Transcription 
in Xenopus Oocytes 
Two nanograms of LlMTV-CAT or tk-CAT reporter gene 
construct linked to one of five different TREs as indicated or 
2 ng LlMTV-CAT lacking a TRE were microinjected into the 
oocyte nucleus together with 0.5 ng of the rTRa expression 
vector. Oocytes were cultured in the presence or absence of 
100 nM Ts (TRI+Ta and TRI-Ts) for 24 h. Alternatively, 00-
cytes were microinjected. with reporter constructs alone and 
incubated with and without hormone (+TJ-Ta). LlMTV-
TREp-CAT was tested with and without T3 only. Activation of 
the reporter gene was measured in terms of the levels of CAT 
protein present in oocytes, analyzed individually by ELISA. 
Basal transcription levels of the reporter constructs in the 
absence of exogenous TR and T3 were arbitrarily assigned 
the value 1. For each CAT reporter construct two or three 
independent experiments (five oocytes per treatment) were 
performed, and the mean fold induction over basal transcrip-
tion was calculated. The error bars indicate the SEMS. 
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be dependent on the presence of a TRE in oocytes, as 
expression levels of the mouse mammary tumor virus 
(liMTV)-CAT reporter gene lacking a TRE sequence 
were not induced by cOinjection of rTRa, in the pres-
ence or absence of T3 (Fig. 1). 
Unexpectedly, there was a weak T3-dependent in-
duction of the thymidine kinase (tk)-TREp-CAT and 
TREp-liMTV-CAT reporter constructs in the absence 
of exogenous TR, while the liMTV promoter alone was 
not responsive to T3 (Fig. 1). Contrary to our original 
assumptions, these results suggested the presence of 
low levels of an endogenous TR-like activity in 00-
cytes. A recent study has now reported that Xenopus 
oocytes contain both TRa and TRt3 protein (32). The 
observed T3-mediated induction of a CAT reporter 
gene under control of TREp in the absence of exoge-
nous TR indicates that these endogenous TRs can 
function as T3-regulated activators. 
The t3-isoform of the receptor, hTRt3, also constitu-
tively induced transcription at TREp, albeit to a lesser 
degree than rTRa (Fig. 2). Gene activation by hTRt3 
was not significantly enhanced in the presence of hor-
mone at TREp. Moreover, to achieve detectable levels 
of reporter gene induction by hTRt3, a 5 times greater 
amount of the expression vector (RSh-TRt3) had to be 
microinjected compared with RS-rTRa. This increased 
requirement might have been due to differences in the 
expression of the two constructs in oocytes or to the 
decreased binding affinity ofTRt3 for palindromic TREs 
(11, 33). 
RXRs have recently been shown to heterodimerize 
with TRs, enhancing TR binding to TRE elements and 
augmenting T 3-mediated transcriptional activation (for 
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Fig. 2. tk-TREp-CAT Reporter Gene Transcription 
Presence of hRXRa and rTRa or hTRt3 
II ·T3 
ffil +T3 
in the 
Oocytes were microinjected with 2 ng tk-TREp-CAT only 
(reporter only), or together with varying amounts of hRXRa 
(RXR), rTRa (TRalpha) and hTRt3 (TRbeta) expression plas-
mids as indicated. Oocytes were incubated with and without 
hormone (+ T 3' - T:J for 24 h and then analyzed individually 
by ELISA as described in Fig. 1. 
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Fig. 3. Effects of v-ErbA on TRE-CAT Reporter Gene Tran-
scription 
A, Dominant repression of TR-mediated TRE-CAT reporter 
gene transcription by v-ErbA in Xenopus oocytes. Oocytes 
were cultured in the presence or absence of 100 nM T3 after 
microinjection with 2 ng LlMTV-CAT or tk-CAT reporter gene 
construct linked to four different TREs as indicated, or 2 ng 
LlMTV-CAT without a TRE, and 0.5 ng rTRa expression vector 
alone (TR/+ T3, TRI-T3)' or together with a 5-fold excess of 
v-erbA (2.5 ng) (v-erbAITRI + T 3, v-erbAITRI - T 3)' Two nano-
grams of rGH3TRE reporter construct plus 0.5 ng rTRa, 2.5 
ng v-erbA, and 2.5 ng hRXRa expression plasmids were also 
tested (v-erbAITRlRXRI-Ts, v-erbAITRlRXRI+ T3)' In addi-
tion, 2 ng TRE-CAT reporter gene construct were mlcroin-
jected into the oocyte nucleus with 2.5 ng v-erbA expression 
plasmid, and oocytes were cultured without T 3 (v-erbN - T 3)' 
Alternatively, oocytes were microinjected with reporter con-
structs alone and incubated in the absence of T 3 (--TS). After 
24 h, oocytes were assayed individually for CAT protein by 
ELISA. Basal transcription rates of the CAT reporter con-
structs in the absence of exogenous TR, v-ErbA, and T 3 (-T 3) 
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a reView, see Ref. 21). Therefore, it was of interest to 
test how heterodimerization with RXR affects the ac-
tion of TR in oocytes. In this series of experiments, 
equimolar amounts of expression plasmids for human 
RXRa: (hRXRa:) and rTRa:, or hTRJ3, were microinjected 
into the oocyte nucleus, together with the TREp-tk-
CAT reporter construct. As shown in Fig. 2, hRXRa: 
enhanced constitutive reporter gene activation by 
both rTRa: and hTRJ3. Coexpression of hRXRa: in-
creased T 3-independent and T 3-mediated reporter 
gene activation by rTRa: to the same level. The pres-
ence of hRXRa: enhanced the constitutive activator 
function of hTRJ3 (2.5 ng expression vector microin-
jected) to levels seen with unliganded rTRa: alone (0.5 
ng expression vector). In addition, with hRXRa 
present, hTRJ3 activated the reporter gene in a T3-
_ responsive manner to the same level as rTRa:. 
To summarize, both rTRa: and hTRJ3 constitutively 
activated reporter gene transcription at five different 
TREs, while activation was further inducible by T 3 at a 
subset of TREs. Furthermore, coexpression of hRXRa: 
enhanced both ligand-independent and ligand-depen-
dent activation by rTRa: and hTRJ3 at TREp. An endo-
genous TR activity mediated weak T3 induction of 
TREp. 
Only Certain Naturally Occurring TREs Act as 
Control Elements for Repression by v-erbA in the 
presence or absence of T 3 
In mammalian and avian cells, TR activities are 
blocked by v-ErbA acting as a dominant repressor at 
the level of the TRE. However, this function of v-ErbA 
is not universal but depends on cellular context (11, 
26). Potent suppression of basal transcription of T3-
regulated genes in the absence of TR and T 3 has also 
been shown in mammalian cells (14, 18) and has been 
implicated in v-ErbA oncogenesis (17, 22, 23,34)_ We 
were arbitrarily assigned the value 1. Two or three indepen-
dent experiments (five oocytes per treatment) were per-
formed for each TRE-CAT reporter gene construct, and the 
mean fold induction over basal transcription was calculated. 
The error bars indicate the SEMS. B, Ts induction of lysTRE-
CAT reporter gene transcription in the presence of rTRa and 
lacZ expression plasmids. Oocytes were microinjected with 2 
ng LlMTV-lysTRE-CAT reporter gene construct plus 0.5 ng 
rTRa with or without 5 ng lacZ expression vector, as indi-
cated, and incubated in the presence or absence of 100 nM 
Ts (-T J+ Ts). Asingle experiment with five oocytes per treat-
ment was performed and analyzed as described for panel A. 
C, Constitutive trans-activation by v-ErbA at the clone 122 
TREs. Oocytes were cultured with and without T 3 after mi-
crolnjection of 2 ng pTPT-CAT plasmid, containing the clone 
122 TREs linked to a tk-CAT reporter construct (tk-clone 
122), or 2 ng LlMTV-lysTRE-CAT plasmid, and 0.5 ng v-erbA 
expression vector (v-erbN + T s, v-erbN-T J. Alternatively, 00-
cytes were mlcroinjected with reporter constructs alone and 
incubated in the absence of T 3 (-T 3)' Three independent 
experiments with five oocytes per treatment were performed 
and analyzed as described for panel A. 
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sought to establish the action of v-ErbA in Xenopus 
oocytes in two ways. The first series of experiments 
tested the competitive interaction between v-ErbA and 
rTRu at naturally occurring TREs, by determining the 
extent to which v-ErbA was able to dominantly repress 
TR-induced activation of the reporter gene constructs. 
The second set of experiments tested the ability of 
v-ErbA to suppress basal promoter activity of the re-
porter genes in the absence of TR and 
We carried out a series of coinjection experiments to 
test the dominant repressor function of v-ErbA. In both 
the presence and absence of T3, v-ErbA acted as a 
dominant repressor of rTRu-mediated CAT reporter 
gene transcription from lysTRE, maiTRE, and TREp 
(Fig. 3A). Repression was most complete at TREp. The 
dominant action of v-ErbA was dose-dependent, as a 
5-fold excess of the v-erbA expression plasmid (Fig. 
3A) produced an even greater repression of TR-medi-
ated induction of the reporter genes than an equal 
ratio of v-erbA and TR templates (data not shown). In 
contrast, v-ErbA did not repress rTRu-mediated tran-
scription under the control of rGH3TRE (Fig. 3A). How-
ever, coexpression of the cofactor hRXRu reduced 
transcription in the presence of rTRu and v-ErbA at 
this TRE (Fig. 3A). 
In mammalian cells, v-ErbA represses basal tran-
scription of T 3-responsive genes in the absence of T 3 
(14, 18). In the present study, v-ErbA did not act as a 
repressor of basal gene transcription under control of 
four different positively regulated TREs in oocytes (Fig. 
3A). Repression of basal transcription by v-ErbA would 
have been detectable by the CAT ELISA employed, 
since the linear range of the assay (tested down to 
A405 ~0.15) extended below the CAT protein levels 
observed due to basal promoter activity (A405 -0.23-
0.3) (data not shown). The loss of this function by 
v-ErbA parallels the lack of repression of basal tran-
scription by unliganded exogenous TR in oocytes. Im-
portantly, expression of v-erbA in oocytes abolishes 
its function as a repressor of basal promoter activity 
but does not interfere with its dominant repressor 
potential. 
We showed that dominant repression by v-ErbA in 
the oocyte is a specific effect in the following ways. 
First, transcription levels of the ,1MTV-CAT reporter 
plasmid were unaffected by the presence of rTRu 
and-or v-ErbA with and without showing that gene 
regulation by rTRu and v-ErbA [s dependent on the 
presence of a TRE (Fig. 3A). Second, T 3-dependent 
induction by rTRu of the ,1MTV-lysTRE-CAT reporter 
gene was unaffected by the coinjection of the lacZ 
expression vector in place of the v-erbA construct (Fig. 
38). 80th in the presence and absence of the lacZ 
vector, T 3 enhanced reporter gene expression 1.5-fold 
over levels induced by unliganded rTRu (Fig. 38). This 
control was performed at a 2-fold greater concentra-
tion of the lacZ vector (5 ng) compared with experi-
ments using v-erbA construct (2.5 ng). Dominant re-
pression by v-ErbA was thereby shown not to be 
caused by 'nonspecific squelching' (35); i.e. essential 
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transcription factors are not simply being titrated by 
the presence of an excess of v-erbA expression 
template. 
The v-erbA protein binds T 3 only at very low affinity, 
due to several mutations in the C-terminal domain (14, 
16, 36, 37). Presumably, this lack of hormone binding 
would render v-ErbA highly resistant to undergo a 
ligand-induced conformational change. For this rea-
son, we were interested to ascertain how v-ErbA acts 
at the clone 122 TREs in oocytes. In mammalian cells, 
T 3 inhibits the activator function and induces the re-
pressor function of TR at this TRE (10). In Fig. 1 we 
showed that, in oocytes, TR constitutively activated 
transcription at the clone 122 TREs. We also observed 
constitutive trans-activation of the reporter gene con-
struct by v-ErbA (Fig. 3G). This induction by v-ErbA 
was not significantly affected by T 3' The v-erbA protein 
was also unresponsive to T3 at lysTRE in oocytes 
(Fig.3C). 
In the previous section we reported that there was a 
weak T 3-dependent induction of the TREp-CAT re-
porter gene in the absence of exogenous TR, suggest-
ing the presence of low levels of T 3-regulated endog-
enous TR in oocytes. The T3-dependent reporter gene 
induction by endogenous TR was dominantly re-
pressed to the same level by v-ErbA and a dominant 
negative in vitro-generated mutant of hTRJj (TR C122 
> A) (Fig. 4). This DNA-binding deficient mutant is 
thought to repress TR-mediated gene transcription by 
forming inactive dimers with TR (24). Therefore, dom-
inant repression by TR C122 > A suggests that endo-
genous TR was able to dimerize with the exogenous 
mutant TRJj. The slight T3 dependence of transcription 
in the presence of TR C122 > A was interpreted as not 
biologically significant because of high sample vari-
ability. Repression of the reporter gene by v-ErbA or 
TR C122 > A was dependent on the presence of a 
TRE. The lacZ reporter gene, which lacks a TRE se-
quence, was expressed at levels similar to those of the 
CAT reporter gene and was not repressed by either 
v-ErbA or TR C122 > A (Fig. 4). In summary, our 
results show that v-ErbA displays an altered pattem of 
activity in oocytes, compared with both mammalian 
cells and the yeast, S. cerevisiae. v-ErbA did not re-
press basal reporter gene transcription yet acted as a 
dominant repressor of TR action at the positively reg-
ulated TREs tested, with the exception of rGH3 TRE. At 
the clone 122 TREs, v-ErbA acted as a constitutive 
activator. 
Pituitary-Specific Transcriptional Regulation of 
rGHs TRE by rTRa and v-ErbA 
In Fig. 1 we showed that the T3-dependent activator 
function of rTRu was not induced at rGH3TRE in the 
presence of hormone. Previous studies have shown 
that optimal transcription of the rat GH gene (rGH) 
under control of TRE sequences in the promoter re-
gion is dependent on a cell-specific factor, Pit-1/ 
GHF-1, binding at upstream elements (38). Since the 
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Fig. 4. Dominant Repression of an Endogenous TR-Like' Activity by v-ErbA or an in Vitro-Generated Mutant of TR 
Oocytes were microinJected with 2 ng tk-TREp-CAT reporter plaj>mid alone (none), or together with v-erbA or TR C122 > A 
expression plasmids in the presence or absence of 100 nM T3 (+ T3,-Tal in the combinations indicated. As a control, 2 ng 
RSV-lacZ reporter gene instead of tk-TREp-CAT construct were coinjected with TR C122 > A or injected alone (none). Relative 
reporter gene transcription was expressed in arbitrary units based on measurements of CAT or {3-galactosidase protein levels by 
ELISA. Two independent experiments with five oocytes per treatment were performed. The error bars indicate the SEMS. 
rGH gene is expressed only in somatotrophic cells of 
the anterior pituitary gland, gene regulation at 
rGH3 TRE, the TRE from the third intron, presumably 
also requires cell-specific auxiliary factors of known or 
unknown origin. For this reason, we sought to recon-
stitute the nuclear environment of anterior pituitary 
cells in oocytes, Xenopus oocytes possess the exper-
imentally attractive feature of correctly targeting nu-
clear proteins, injected into the oocyte cytoplasm, to 
the nucleus (see, for example, Ref. 39). In this exper-
iment, nuclear protein extract from ovine anterior pi-
tuitary cells was injected into the oocyte cytoplasm 5 
h 'before nuclear microinjection of gene templates. 
When oocytes were microinjected with nuclear pro-
tein extract, both the hormone-independent and hor-
mone-dependent activator functions of rTRa were in-
duced at rGH3 TRE (Fig. 5A). Surprisingly, under the 
same conditions, v-ErbA acted as a constitutive acti-
vator at rGH3 TRE, whose strength of activation ex-
ceeded that of rTRa (Fig. 5A). Increasing the amount of 
v-erbA expression template injected did not enhance 
this response further (data not shown). In contrast, 
v-ErbA did not affect basal promoter activity of this 
TRE-reporter construct in the absence of nuclear pro-
tein extract (Fig. 5A). 
These findings suggested that auxiliary factor(s), 
present in the injected nuclear protein extract from 
anterior pituitary cells, significantly altered the effect of 
both rTRa and v-ErbA on reporter gene regulation at 
rGHs TRE in oocytes. Two plausible candidates for this 
auxiliary role are, the pituitary-specific transcription 
factor Pit-1/GHF-1 and RXA. To test this possibility, 
expression vectors for either Pit-1/GHF-1 or hRXRa 
were coinjected with rTRa or v-erbA constructs, and 
reporter gene transcription regulated by rGH3 TRE was 
assayed. Transcription was weakly induced by hRXRa 
alone, while Pit-lIGHF-1 had no significant effect on 
basal promoter activity (Fig. 58). The activity patterns 
of rTRa and v-ErbA observed in the presence of nu-
clear protein extract of anterior pituitary cells were not 
replicated in the presence of hRXRa or Pit-1/GHF-1 
(Fig. 58). Instead, coexpression of hRXRa or Pit-1, 
together with rTRa, reduced trans-activation of 
rGH3 TRE (Fig. 58) compared with levels of trans-acti-
vation by rTRa alone (Figs. 3A and 5A). Pit-1 repressed 
induction of rGH3 TRE by Iiganded rTRa below basal 
transcription (Fig. 58). Compared with levels in the 
presence of v-ErbA only (Fig. 5A), coexpression of 
hRXRa with v-ErbA induced transcription slightly, 
while Pit-1 had no effect (Fig. 58). In the presence of 
hRXRa, transcription was induced equally by rTRa or 
v-ErbA. These effects were not further investigated, 
since this series of experiments was carried out to test 
hRXRa and Pit-1 as potential candidates for conferring 
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Fig. 5. Pituitary-Specific Transcriptional Regulation of 
rGH3 TRE by rTRa and v-ErbA 
A, Action of rTRa and v-ErbA at rGH3TRE in the presence 
of pituitary nuclear extract from ovine anterior pituitary cells. 
Oocytes were either microinjected with 20 nl nuclear protein 
extract into the cytoplasm 5 h before nuclear injection of gene 
templates (+PNE) or microinjected with the gene templates 
in the absence of nuclear protein extract (-PNE). Oocytes 
were then cultured in the absence or presence of 100 nM Ts 
(-T s, + T sl after microinjection with 2 ng ilM1V-rGHs TRE-
CAT reporter gene construct alone (reporter only), or together 
with 0.5 ng rTRa (plus TR) or v-erbA expression vector (plus 
v-erbA). After 24 h, oocytes were assayed individually for CAT 
protein by ELISA. Basal transcription rates of the CAT re-
porter construct in the absence of nuclear protein extract, 
exogenous TR, v-ErbA, and Ts (reporter only, -PNE, 
were arbitrarily assigned the value 1. B, Action of rTRa and 
v-ErbA at rGH3 TRE in the presence of hRXRa or Pit-1/GHF-1. 
Oocytes were microinjected with 2 ng ilM1V-rGHsTRE-CAT 
reporter gene construct only (reporter only, no cofactor), or 
together with 2.5 ng expression vector for either hRXRa 
(+RXR) or Pit-1/GHF-1 (+Pit-1). Alternatively, 0.5 ng expres-
sion plasmid for rTRa (plus TR) or v-erbA (plus v-erbA) was 
microinjected with ilM1V-rGH3TRE-CAT, and 2.5 ng expres-
sion vector for hRXRa (+RXR) or Pit-1/GHF-1 (+Pit-1) were 
added. Oocytes were cultured with and without T 3 (+ T 3, 
-T3)' After 24 h, oocytes were assayed individually for CAT 
protein by ELISA. Basal transcription rates of the CAT re-
porter construct in the absence of cofactors and T3 (reporter 
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positive T s-responsiveness on rTRa, and strong con-
stitutive activator function on v-ErbA, at rGHs TRE. 
Taken together, these results suggest that auxiliary 
factor(s), other than RXR and Pit-1/GHF-1, present in 
nuclear protein extracts of anterior pituitary cells, are 
necessary for T s induction of rGHs TRE by rTRa and 
conversion of v-ErbA into a constitutive activator at 
this TRE. 
DISCUSSION 
Both a;- and P-Isoforms of TR Act as Constitutive 
Activators in Oocytes 
In Xenopus oocytes, rTRa acted as a ligand-indepen-
dent transcriptional activator at four positively regu-
lated TREs (lysTRE, maiTRE, TREp, and rGHsTRE). 
With the exception of rGHs TRE, addition of T s led to a 
further increase in CAT reporter gene expression by 
rTRa. The 3.4- to 7 -fold T s-dependent reporter gene 
induction observed in oocytes was comparable to ac-
tivation in mammalian cells (13, 14, 40). Human TRf3 
also acted as a weak hormone-independent activator 
at TREp but was not further inducible by hormone. The 
observed differences in ligand-independent activation 
function between rTRa and hTRP are most likely due 
to structural divergence in the N-terminal domain (5). 
Both ligand-independent and ligand-induced acti-
vation functions (7-10, 41) exhibit distinct cell type and 
promoter context specificity in TR and other receptors 
belonging to the steroid/thyroid hormone receptor 
gene superfamily (Ref. 11; for further references, see 
Ref. 6). Constitutive trans-activation by TR has also 
been shown in the yeast, S. cerevisiae (11, 26), and in 
in vitro transcription assays using extracts from NT2 
embryonal carcinoma cells or Namalwa B cells (42). 
Taken together with these results, the ligand-indepen-
dent activation function of TR in oocytes points to a 
possible requirement of inhibitory auxiliary factor(s) for 
transcriptional repression. The finding that gene acti-
vation by unliganded TR at the clone 122 TREs was 
not reversed by Ts in oocytes, while being suppressed 
by ligand in CV1 cells (1 0), also points to a requirement 
for an inhibitory auxiliary factor for the suppression of 
trans-activation by TR. We have shown that hRXRa 
enhances both ligand-independent and ligand-
induced activation functions of rTRa and hTRf:! at 
TREp, in analogy to the enhancement of both activa-
tion functions of hTRf3 by hRXRa seen in the yeast 
(43). Thus, RXRa is not the inhibitory factor in ques-
tion. Our results are in close agreement with recent 
evidence suggesting that an inhibitory factor sup-
only, no cofactor, - T 3) were arbitrarily assigned the value 1. 
In both panels A and B, three independent experiments (five 
oocytes per treatment) were performed, and the mean fold 
induction over basal transcription was calculated. The error 
bars indicate the SEMS. 
Oocytes Constitute a Novel Context for v-ErbA and TR 
presses trans-activation by unliganded TR in mamma-
lian cells (19, 44) and which also showed that RXR was 
not the major inhibitory factor in two cell lines tested 
(44). 
The v-erbA Protein Displays a Novel Pattern of 
Activity in Oocytes 
Conversion of TR and v-ErbA into ligand-independent 
transcriptional activators has been shown to be me-
diated either by cell-specific protein-protein interac-
tions (8,11) or by direct DNA binding (9,10). A con-
stitutive activation function has also been identified in 
the N-terminal region of v-ErbA (9). Under conditions 
that induce the constitutive activation function of TR, 
v-ErbA also acts as a constitutive actlvator in yeast 
(11) and in mammalian cells (9). In contrast, we show 
here that the oocyte-specific cellular background in-
duces the ligand-independent activation function of 
rTRo::, but not of v-ErbA, at four positive TREs, sug-
gesting that induction of this function can be differen-
tially controlled in TRo:: and v-ErbA within the same 
cellular context. On the other hand, both rTRo:: and 
v-ErbA constitutively activated reporter gene tran-
scription at the complex clone 122 TREs (Fig. 6). This 
TRE belongs to the same class of response elements 
as the TRE found in the Rous sarcoma virus (RSV)-
long terminal repeat (LTR), which mediates strong T3-
independent activation by TR and v-ErbA in HeLa cells 
(9). Binding to this type of TRE induces a conforma-
tional change and renders the constitutive N-terminal 
activation domain accessible to the transcription ma-
chinery (9). In summary, expression of TR and v-erbA 
in oocytes induced the constitutive activation function 
only in TR at positive TREs, whereas this function was 
activated in both TR and v-ErbA at the clone 122 TREs 
TRe~moQufllted IlcHon of v·ErbA In cce-ytes: 
1. DomInant repreulon SHenul1! III '*l!rfuhtn 
rilE, AGGTCA I) TGACCT 
~~.~ <C-------
1!urr«1 GGGTTA 4 AGGACA 
-_ .. --,,> _ ... --+ 
IrtTfiI! TGACCC 6 AGGTCA 
<E----. -~ 
2. No reprf'uion of TR function by v·ErbA alone 
H?H,TIIE AGG[!]AA 8 AOTCCe 6 AGG[!JCA (Hj AXR oorequlrement) 
~ ... -------? <. .. - - .. --;.. 
3. Aotivo.lloR 
"" T AAGCCCCCAGCCCCCCGACATCCAGGACGCCCCAAA 
1'" ATACCTTATTACCTCATCATGTGAAATAG 
~<-
1"" TCCGAGTGGACTCGGCTCGGTCA TTGGGTG 
<C------- - . .",. 
Fig. 6. Half~Site Sequences of TREs 
The identity of the nucleotide residue at the fourth position 
of the two primary half-sites in rGHs TRE is indicated (boxed 
italicized letter) (25). Intervening nucleotides between half-
site's are indicated by numbers. Arrows indicate orientation of 
half-sites. Differential levels of dominant repression are ex-
pressed in relative terms; (+++) indicates complete repres-
sion, (++) indicates moderate repression, and (+) indicates 
weak repression by v-ErbA. 
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in the same cellular context. It follows that the re-
sponses of the ligand-independent activation domains 
of TR and v-ErbA to cell-specific and TRE-mediated 
induction are not equivalent. 
In oocytes, v-ErbA did not repress basal promoter 
activity under control of all four positive TREs tested 
(TREp, lysTRE, maiTRE, and rGH3 TRE). Like TR, the 
v-erbA protein possesses a repressor function located 
in the hinge domain (18). Transcriptional repression by 
TR is observed on minimal promoters containing a 
TATA box and TRE sequence (12, 13), and cell-free 
transcription assays have shown that unliganded TR 
functions as an active repressor of T 3-responsive 
genes by inhibiting the formation of a functional preini-
tiation complex (15). Presumably, repression by TR 
and v-ErbA occurs by a similar mechanism, namely, by 
interference with general transcription factors. In 
oocytes, protein-protein interactions between the re-
pressor domain of v-ErbA and the general transcrip-
tion machinery might be prevented by a lack of auxil-
iary inhibitory factor(s) or cell-specific characteristics 
of the general transcription complex. 
Dominant Negative Repression by v-ErbA 
Depends on the Nature of the TRE 
The action of v-ErbA at rGH3 TRE has not been tested 
in mammalian cells to our knowledge. In oocytes, 
v-ErbA failed to repress TR-mediated induction at 
rGH3 TRE. At the same time, v-ErbA dominantly re-
pressed trans-activation by TR at three other positive 
TREs with diverse half-site characteristics (maiTRE, 
lysTRE, and TREp). The TRE-modulated action of v-
ErbA in oocytes is summarized in Fig. 6. Although both 
primary half-sites of rGH3 TRE possess a favorable 
thymidine nucleotide at the fourth position (25, 31), 
and the sequence of the major binding site is identical 
to the AGGTC/GA consensus motif (Fig. 6), it appears 
that v-ErbA does not successfully compete with rTRo:: 
for binding due to the structure of rGH3 TRE. As shown 
by other workers, heterodimerization with RXR-related 
factors can be essential for the dominant negative 
action of v-ErbA (40, 45). In the present study, a re-
duced level of trans-activation of rGH3TRE by rTRo: 
and v-ErbA was observed in the presence of hRXRo::. 
However, the significance of this finding is presently 
unclear, since hRXRo: also reduced trans-activation by 
(rRo:: alone at this TRE. 
An Activity in Nuclear Protein Extracts from 
Anterior Pituitary Cells Conferred T 3-
Responsiveness to rTRa and Converted v-ErbA 
into a Constitutive Activator at rGH3 TRE 
Our findings suggest that T3 induction of rGH3TRE is 
regulated in a cell-specific manner. In the presence of 
nuclear protein extract from anterior pituitary cells, the 
T3-dependent activation function of rTRo:: was induced 
at rGH3TRE in addition to T3-independent trans-acti-
vation by rTRo:: without extract. We showed that T 3 
responsiveness of (rRo:: was not mediated by hRXRo:: 
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or the pituitary-specific transcription factor Pit-1i 
GHF-1, which is required for efficient T s-induction of 
the GH gene in somatotrophs (38). General mamma-
lian-type transcription factors might have been in-
volved in conferring T s responsiveness to rTRa, since 
rGHs TRE is also Ts-inducible in CV1 cells (31). The 
tripartite rGHs TRE, although located in the third intron 
of the rGH gene, exhibits a markedly higher affinity for 
TR, as well as greater gene induction ability, than the 
TRE located in the promoter region of the gene, indi-
cating an important in vivo role for this TRE sequence 
(31). Further indications of the importance of regula-
tory regions in introns are the presence of a glucocor-
ticoid-responsive element in the first intron of the hu-
man GH gene (46) and the requirement for the 
presence of introns in the rat GH gene for efficient 
expression in transgenic animals (47). 
Interestingly, v-ErbA acted as an efficient constitu-
tive activator at rGHs TRE in the presence of nuclear 
protein extract from anterior pituitary cells, whereas it 
had no effect on basal promoter activity under the 
control of rGHs TRE without extract. Coexpression of 
Pit-1/GHF-1 or hRXRa did not replicate the mode of 
action of the v-erbA protein as a constitutive activator 
seen with the nuclear protein extract. This finding sug-
gests that indirect or direct interactions with an as yet 
unidentified nuclear factor present in pituitary cells 
result in a conformational change in v-ErbA at ' 
rGHs TRE that induces its constitutive activation func-
tion. The conversion of v-ErbA into a constitutive ac-
tivator by nuclear protein extract from anterior pituitary 
cells at rGHsTRE suggests that the dominant negative 
phenotype of the v-erbA oncogene can be abolished 
by either direct or indirect interactions with other nu-
clear factors. 
Our experimental approach illustrates how studies 
of exogenous receptors in oocytes, in conjunction with 
microinjected auxiliary proteins, may contribute to the 
characterization of cell-specific and TRE-mediated 
mechanisms that modulate the action of receptor 
domains. 
MATERIALS AND METHODS 
Plasm ids 
RS-rTRa, RS-v-erbA, and tk-TREp-CAT were gifts from R. 
Evans (Salk Institute for Biological Studies, La Jolla, CAl. The 
expression vectors contain rTRa cDNA or the gag-v-erbA 
oncogene under the transcriptional control of the RSV-L TR 
(14,48). tk-TREp-CAT contains a synthetic palindromic TRE 
linked to a herpes simplex virus tk-CAT fusion gene (14). The 
T3-responsive CAT reporter constructs contain maiTRE, 
lysTRE, rGH3 TRE, or TREp linked to a MTV (AMTV) L TR-CAT 
fusion gene (AMTV-CAT)(24). The pTPT-CAT reporter con-
struct was a gift from R. N. Eisenman (Fred Hutchinson 
Cancer Research Center, Seattle, WA) and contains a 450-
base pair Sau3A-BamHI fragment from clone 122, spanning 
all three TREs, cloned into pBLCAT3 (10). pRSV-Pit-1 was a 
gift from H. H. Samuels (New York University Medical Center, 
New York, NY) and contains a cDNA clone of the rat Pit-if 
GHF-1 gene linked to the RSV LTR (49). The RSh-TRf3 con-
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struct contains the wild type hTRf3 gene, and the RSh-TRf3 
C122 > A expression plasmid contains an in vitro-generated 
mutant hTRf3 gene (alanine instead of cysteine at position 
122), both under control of the RSV L TR (24). The RSh-RXRa 
expression vector contains hRXRa cDNA linked to the RSV 
LTR. AMTV-CAT contains a CAT reporter gene driven by the 
AMTV L TR promoter (48). pRSV-lacZ was obtained from M. 
Harkey (University of Washington, Seattle, WA) and contains 
the Escherichia coli f3-galactosidase gene under control of 
the RSV L TR (50). 
Microinjections and ELlSAs 
A lobe of ovary was surgically removed from an adult female 
Xenopus laevis and processed as described (51). Microinjec-
tions were performed according to pUblished methods with 
modifications (51, 52). Stage V oocytes were micro injected 
with 20 nl plasmid DNA in TE (10 mM Tris-HCI, 1 mM EDTA) , 
pH 8.0, into the nucleus by the 'blind' injection method with 
the needle inserted in the center of the animal pole (27, 53). 
After microinjectlon, oocytes were incubated in OR-2 (51) 
medium for 20-24 h at 18 C in the presence or absence of 
100 nM T3 (Sigma Chemical Co., St Louis, MO). Healthy 
oocytes (uniform pigment, not mottled) were homogenized 
singly in 200 ILl 0.25 M Tris buffer, pH 7.5, and centrifuged at 
10,000 x 9 in a microfuge at 4 C for 10 min. The supernatant 
was then centrifuged as before. This extract was used in the 
determination of CAT and f3-galactosidase protein expres-
sion levels by ELISA according to the manufacturer's spec-
ifications (5 Prime-3 Prime, Inc., Boulder, CO). The concen-
tration of total protein in extracts from single oocytes was 
adjusted to a concentration of 175-200 ILgfml by 1:1 dilution 
with dilution buffer. Microwells coated with rabbit polyclonal 
antibody specific to CAT protein or specific to the E. coli 
f3-galactosidase protein (f3-Gal) were incubated with extracts 
from microinjected oocytes, uninjected controls, and appro-
priate pure CAT or f3-Gal protein standards. Biotinylated sec-
ondary antibody to CAT or f3-Gal was then bound to the 
primary antibody-antigen complex. After washing, bound bi-
otinylated antibody was quantitated colorimetrically by incu-
bation with streptavidin-conjugated alkaline phosphatase 
and p-nitrophenyl phosphate as substrate. The wells were 
read at 405 nm against the reagent blank in a microtlter well 
reader (model EL 311, Bio-Tek Instruments, Winooski, Vl). 
For each assay, a standard curve utilizing four pure protein 
standards was prepared, to ensure that CAT or f3-Gal con-
centrations of sample extracts fell within the linear range of 
the assay. All experiments were repeated two to three times 
with different animals since transcriptional activity may vary 
between different batches of oocytes. 
ELISA for Total T3 
Ten oocytes per sample, either incubated in 100 nM T3 for 20 
h and subsequently washed three times in OR-2 or cultured 
in OR-2 only, were homogenized in 100 p,l 0.25 M Tris buffer, 
pH 7.5, and centrifuged at 10,000 x 9 in a microfuge at 4 C 
for 10 min. The supernatant was then centrifuged as before. 
This extract was used In the quantitative determinati.on of 
total T3, both bound and free hormone, in oocytes by ELISA (Enzymun-Test T3 , Boehringer Mannheim, Auckland, New 
Zealand). Test tubes coated with streptavldin were incubated 
with oocyte extracts or T3 standards, together with anti-Ta 
antibody-horseradish peroxidase conjugate. T3 standards 
were prepared in 0.25 M Tris buffer, pH 7.5, at 0,0.1,1,10, 
and 100 nM. Binding of sample T3 to anti-T3 antibodies was 
then competed by addition of biotinylated T3 polyhapten, 
which anchors previously unbound anti-T3 antibodies to the 
streptavldln-coated test tube wall. After washing, bound an-
ti-T3 antibody-horseradish peroxidase conjugate was quan-
titated colorimetrically by incubation with 2,2'-azino-di-[3-
ethyl-benzthiazoline sulfonate (6)]fH20 2• The samples were 
Oocytes Constitute a Novel Context for v-ErbA and TR 
transferred to microcuvettes and read against buffer at 420 
nm in a spectrophotometer. For each assay, a standard curve 
utilizing the five T3 standards was prepared. Two indepen-
dent determinations were carried out with oocytes from two 
different animals, and four replicates (10 oocytes per repli-
cate) were assayed in each determination. 
Preparation of Nuclear Protein Extracts from 
Ovine Anterior Pituitary Cells and Cytoplasmic 
Injection 
Nuclear protein extracts were prepared essentially as de-
scribed by Maxon et al. (39). All procedures were carried out 
at 4 C. Ten milliliters of sheep anterior pituitary cells main-
tained in primary cell culture (4.8 x 106 viable cells/ml) were 
concentrated by centrifugation, washed in PBS, and then 
washed once in 1.5 M glucose. The resultant partially lysed 
cells were homogenized gently in 10 vol low-salt buffer (4 mM 
magnesium acetate, 50 mM Tris, pH 7.4, 0.5% Nonidet P-40, 
10 mM 2-mercaptoethanol, 0.1 mM phenylmethylsulfonyl flu-
oride [PMSF)). Two to five strokes in a Dounce glass homog-
enizer were sufficient to complete lysis. The homogenate was 
overlaid (15 ml per tube) on step sucrose gradients consisting 
of 5 ml 1.7 M sucrose on 5 ml 2.2 M sucrose in 30-ml Nalgene 
tubes. The gradients were centrifuged at 5,000 x g for 15 
min, and the gray nuclei were collected from the interface 
between the two sucrose solutions. The nuclei were diluted 
2-fold with a buffer containing 75 mM NaCI, 25 mM EDTA, 5 
mM Tris, pH 7.5, 20 mM 2-mercaptoethanol, and 0.1 mM 
PMSF. Partially lysed nuclei and chromatin were collected by 
centrifugation at 10,000 x g for 30 min. The chromatin-nuclei 
pel/et was suspended in extraction buffer [0,45 M NaCl, 20 
mM Tris, pH 7.0, 1 mM EDTA, 1 mM EGTA, 0.5 mM dithioth-
reitol (DTT), 0.1 mM PMSF) and vortexed for several minutes, 
and the insoluble material was collected by centrifugation at 
10,000 x g for 30 min. The supernatant was set aside, and 
the extraction and centrifugation were repeated on the resid-
ual nuclear material with extraction buffer containing 1 M NaCI 
and then 2 M NaCI. The extracts of all three salt washes were 
pooled and concentrated by precipitation with ammonium 
sulfate (0.35 g/ml), dialyzed for 24 h against several changes 
of injection buffer (100 mM NaCI, 20 mM Tris, pH 7.0, 5 mM 
MgCI2 ,1 mM EDTA, 0.1 mM EGTA, 5% glycerol, 0.5 mM DTT, 
0.1 mM PMSF), and concentrated severalfold by centrifuga-
tion in centricon 10 microconcentrators (Amicon, Beverly, 
MA). Extracts were stored frozen at -80 C. Five hours before 
microinjection of gene templates, oocytes were microin-
jected with 20 nl extract into the cytoplasm. 
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Appendix 2 
. Solutions 
O-R2. pH 7.6 (working concentrations): 
O-R2 working solution: 
O-R2 Stock A (lOX): 
825 mM NaCI 
25 mM KC1 
10mMN~HP04 
50 mM Hepes 
38 mM NaOH 
'" freshly made, 0.4 g/10 ml ddH20 
O-R2 Stock B (lOX): 
NET-2: 
10 mM MgCl2 
10 mM CaC12 
82.5 mM NaCI 
2.5 mM KCI 
1.0 mM CaCl2 
1.0 mM MgCl2 
1.0 mM N~HP04 
5.0 mM Hepes 
3.8 mM NaOH 
10 ml Stock A 
10 ml Stock B 
80 mt sterile dd H20 
4.820 g 
0.186 g 
0.142 g 
1.190 g 
3.8 ml (1M stock)* 
0.203 g (or 10 mt of 100 mM) 
0.147 g (or 10 ml of 100 mM) 
50 mM Tris-HCI, pH 7.4 
150 mM NaCI 
0.05% NP-40 (add after autoclaving) 
